<html lang="en" class="js"><head><link rel="preload" href="/static/fonts/HardingText-Regular-Web-cecd90984f.woff2" as="font" type="font/woff2" crossorigin=""><script async="" src="//cdn.jsdelivr.net/npm/mathjax@2.7.5/MathJax.js?config=TeX-AMS-MML_SVG.js"></script><script async="" src="https://scripts.webcontentassessor.com/scripts/93dabb8d80079a87fec7bb6f67b807fce90e1688f8957ad7ad152bfd58ea01c2"></script><script type="text/javascript" async="" src="https://pagead2.googlesyndication.com/tag/js/gpt.js"></script><script async="" src="https://www.googletagmanager.com/gtm.js?id=GTM-MRVXSHQ"></script><script type="text/javascript" src="https://www.nature.com/oTtmH8TE4NhM-fldT71nahjvPpT3aPooL8iobSXL54BXQCoJ1EPqQbyqbAWQ9DdWlJ4HfUuIDgyKOeDckSuv4w=="></script><script src="https://cmp.nature.com/production_live/en/consent-bundle-8-85.js" onload="initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')"></script>
    <title>Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine</title>
    
        
<link rel="alternate" type="application/rss+xml" href="https://www.nature.com/nm.rss">


    
        

        <script id="save-data-connection-testing">
            function hasConnection() {
                return navigator.connection || navigator.mozConnection || navigator.webkitConnection || navigator.msConnection;
            }

            function createLink(src) {
                var preloadLink = document.createElement("link");
                preloadLink.rel = "preload";
                preloadLink.href = src;
                preloadLink.as = "font";
                preloadLink.type = "font/woff2";
                preloadLink.crossOrigin = "";
                document.head.insertBefore(preloadLink, document.head.firstChild);
            }

            var connectionDetail = {
                saveDataEnabled: false,
                slowConnection: false
            };

            var connection = hasConnection();
            if (connection) {
                connectionDetail.saveDataEnabled = connection.saveData;
                if (/\slow-2g|2g/.test(connection.effectiveType)) {
                    connectionDetail.slowConnection = true;
                }
            }

            if (!(connectionDetail.saveDataEnabled || connectionDetail.slowConnection)) {
                createLink("/static/fonts/HardingText-Regular-Web-cecd90984f.woff2");
            } else {
                document.documentElement.classList.add('save-data');
            }
        </script>
    

<link rel="preconnect" href="https://cmp.nature.com" crossorigin="">

<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="applicable-device" content="pc,mobile">
<meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=5,user-scalable=yes">
<meta name="360-site-verification" content="5a2dc4ab3fcb9b0393241ffbbb490480">

<script data-test="dataLayer">
    window.dataLayer = [{"content":{"category":{"contentType":"article","legacy":{"webtrendsPrimaryArticleType":"research","webtrendsSubjectTerms":"machine-learning;predictive-markers;predictive-medicine;randomized-controlled-trials;rheumatoid-arthritis","webtrendsContentCategory":null,"webtrendsContentCollection":null,"webtrendsContentGroup":"Nature Medicine","webtrendsContentGroupType":null,"webtrendsContentSubGroup":"Article","status":null}},"article":{"doi":"10.1038/s41591-022-01789-0"},"attributes":{"cms":null,"deliveryPlatform":"oscar","copyright":{"open":true,"legacy":{"webtrendsLicenceType":"http://creativecommons.org/licenses/by/4.0/"}}},"contentInfo":{"authors":["Felice Rivellese","Anna E. A. Surace","Katriona Goldmann","Elisabetta Sciacca","Cankut Çubuk","Giovanni Giorli","Christopher R. John","Alessandra Nerviani","Liliane Fossati-Jimack","Georgina Thorborn","Manzoor Ahmed","Edoardo Prediletto","Sarah E. Church","Briana M. Hudson","Sarah E. Warren","Paul M. McKeigue","Frances Humby","Michele Bombardieri","Michael R. Barnes","Myles J. Lewis","Costantino Pitzalis","Felice Rivellese","Giovanni Giorli","Alessandra Nerviani","Liliane Fossati-Jimack","Georgina Thorborn","Frances Humby","Michele Bombardieri","Myles J. Lewis","Patrick Durez","Maya H. Buch","Hasan Rizvi","Arti Mahto","Carlomaurizio Montecucco","Bernard Lauwerys","Nora Ng","Pauline Ho","Vasco C. Romão","João Eurico Cabral da Fonseca","Patrick Verschueren","Stephen Kelly","Pier Paolo Sainaghi","Nagui Gendi","Bhaskar Dasgupta","Alberto Cauli","Piero Reynolds","Juan D. Cañete","Julio Ramirez","Raquel Celis","Robert Moots","Peter C. Taylor","Chris J. Edwards","John Isaacs","Peter Sasieni","Ernest Choy","Charlotte Thompson","Serena Bugatti","Mattia Bellan","Mattia Congia","Christopher Holroyd","Arthur Pratt","Laura White","Louise Warren","Joanna Peel","Rebecca Hands","Gaye Hadfield","Costantino Pitzalis"],"publishedAt":1652918400,"publishedAtString":"2022-05-19","title":"Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial","legacy":null,"publishedAtTime":null,"documentType":"aplusplus","subjects":"Machine learning,Predictive markers,Predictive medicine,Randomized controlled trials,Rheumatoid arthritis"},"journal":{"pcode":"nm","title":"nature medicine","volume":"28","issue":"6","id":41591,"publishingModel":"Hybrid Access"},"authorization":{"status":true},"features":[{"name":"furtherReadingSection","present":true}],"collection":null},"page":{"category":{"pageType":"article"},"attributes":{"template":"mosaic","featureFlags":[{"name":"nature-onwards-journey","active":false}],"testGroup":null},"search":null},"privacy":{},"version":"1.0.0","product":null,"session":null,"user":null,"backHalfContent":true,"country":"BR","hasBody":true,"uneditedManuscript":false,"twitterId":["o3xnx","o43y9","o3ef7"],"baiduId":"d38bce82bcb44717ccc29a90c4b781ea","japan":false}];
    window.dataLayer.push({
        ga4MeasurementId: 'G-ERRNTNZ807',
        ga360TrackingId: 'UA-71668177-1',
        twitterId: ['3xnx', 'o43y9', 'o3ef7'],
        baiduId: 'd38bce82bcb44717ccc29a90c4b781ea',
        ga4ServerUrl: 'https://collect.nature.com',
        imprint: 'nature'
    });
</script>

<script>
    (function(w, d) {
        w.config = w.config || {};
        w.config.mustardcut = false;

        
        if (w.matchMedia && w.matchMedia('only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)').matches) {
            w.config.mustardcut = true;
            d.classList.add('js');
            d.classList.remove('grade-c');
            d.classList.remove('no-js');
        }
    })(window, document.documentElement);
</script>
 



     
    
    
        
    
    <style>@media only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark) {  .c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card--major .c-card__title,.c-card__title,.u-h2,.u-h3,h2,h3{font-weight:700;-webkit-font-smoothing:antialiased;font-family:Harding,Palatino,serif;letter-spacing:-.0117156rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card__title,.u-h3,h3{font-size:1.25rem;line-height:1.4rem}.c-reading-companion__figure-title,.u-h4,h4{font-weight:700;-webkit-font-smoothing:antialiased;line-height:1.4rem}html{line-height:1.15;text-size-adjust:100%;box-sizing:border-box;font-size:100%;height:100%;overflow-y:scroll}body{background:#eee;color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;line-height:1.76;margin:0;min-height:100%}details,main{display:block}h1{font-size:2em;margin:.67em 0}a,sup{vertical-align:baseline}a{background-color:transparent;color:#069;overflow-wrap:break-word;text-decoration:underline;text-decoration-skip-ink:auto;word-break:break-word}b{font-weight:bolder}sup{font-size:75%;line-height:0;position:relative;top:-.5em}img{border:0;height:auto;max-width:100%;vertical-align:middle}button,input,select{font-family:inherit;font-size:100%;line-height:1.15;margin:0}button,input{overflow:visible}button,select{text-transform:none}[type=submit],button{-webkit-appearance:button}[type=checkbox]{box-sizing:border-box;padding:0}summary{display:list-item}[hidden]{display:none}button{border-radius:0;cursor:pointer;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}h1{font-weight:700;-webkit-font-smoothing:antialiased;font-family:Harding,Palatino,serif;font-size:2rem;letter-spacing:-.0390625rem;line-height:2.25rem}.c-card--major .c-card__title,.u-h2,.u-h3,h2{font-family:Harding,Palatino,serif;letter-spacing:-.0117156rem}.c-card--major .c-card__title,.u-h2,h2{font-weight:700;-webkit-font-smoothing:antialiased;font-size:1.5rem;line-height:1.6rem}.u-h3{font-size:1.25rem}.c-card__title,.c-reading-companion__figure-title,.u-h3,.u-h4,h4,h5,h6{font-weight:700;-webkit-font-smoothing:antialiased;line-height:1.4rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card__title,h3{font-family:Harding,Palatino,serif;font-size:1.25rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,h3{font-weight:700;-webkit-font-smoothing:antialiased;letter-spacing:-.0117156rem;line-height:1.4rem}.c-reading-companion__figure-title,.u-h4,h4{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;letter-spacing:-.0117156rem}input+label{padding-left:.5em}nav ol,nav ul{list-style:none none}p:empty{display:none}.sans-serif{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.article-page{background:#fff}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-title{font-size:1.5rem;line-height:1.25;margin:0 0 16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list svg{margin-left:4px}.c-article-author-list__show-more{display:none;margin-right:4px}.c-article-author-list__button,.js .c-article-author-list__item--hide,.js .c-article-author-list__show-more{display:none}.js .c-article-author-list--long .c-article-author-list__show-more,.js .c-article-author-list--long+.c-article-author-list__button{display:inline}@media only screen and (max-width:539px){.js .c-article-author-list__item--hide-small-screen{display:none}.js .c-article-author-list--short .c-article-author-list__show-more,.js .c-article-author-list--short+.c-article-author-list__button{display:inline}}#uptodate-client,.js .c-article-author-list--expanded .c-article-author-list__show-more{display:none!important}.js .c-article-author-list--expanded .c-article-author-list__item--hide-small-screen{display:inline!important}.c-article-author-list__button,.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-article-author-list__button svg,.c-button-author-list svg{margin:1px 4px 0 0}.c-article-author-list__button:hover,.c-button-author-list:hover{background:#069;border-color:transparent;color:#fff}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:16px 0}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Harding,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;margin:0;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-associated-content__container .c-article-associated-content__title{margin-bottom:8px}.c-article-body p{margin-bottom:24px;margin-top:0}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article-authors-search{margin-bottom:24px;margin-top:0}.c-article-authors-search__item,.c-article-authors-search__title{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-article-authors-search__title{color:#626262;font-size:1.05rem;font-weight:700;margin:0;padding:0}.c-article-authors-search__item{font-size:1rem}.c-article-authors-search__text{margin:0}.c-code-block{border:1px solid #eee;font-family:monospace;margin:0 0 24px;padding:20px}.c-code-block__heading{font-weight:400;margin-bottom:16px}.c-code-block__line{display:block;overflow-wrap:break-word;white-space:pre-wrap}.c-article-share-box__no-sharelink-info{font-size:.813rem;font-weight:700;margin-bottom:24px;padding-top:4px}.c-article-share-box__only-read-input{border:1px solid #d5d5d5;box-sizing:content-box;display:inline-block;font-size:.875rem;font-weight:700;height:24px;margin-bottom:8px;padding:8px 10px}.c-article-share-box__button--link-like{background-color:transparent;border:0;color:#069;cursor:pointer;font-size:.875rem;margin-bottom:8px;margin-left:10px}.c-article-editorial-summary__container{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem}.c-article-editorial-summary__container .c-article-editorial-summary__content p:last-child{margin-bottom:0}.c-article-editorial-summary__container .c-article-editorial-summary__content--less{max-height:9.5rem;overflow:hidden}.c-article-editorial-summary__container .c-article-editorial-summary__button{background-color:#fff;border:0;color:#069;font-size:.875rem;margin-bottom:16px}.c-article-editorial-summary__container .c-article-editorial-summary__button.active,.c-article-editorial-summary__container .c-article-editorial-summary__button.hover,.c-article-editorial-summary__container .c-article-editorial-summary__button:active,.c-article-editorial-summary__container .c-article-editorial-summary__button:hover{text-decoration:underline;text-decoration-skip-ink:auto}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title{line-height:1.3}.c-context-bar{box-shadow:0 0 10px 0 rgba(51,51,51,.2);position:relative;width:100%}.c-context-bar__title{display:none}.c-reading-companion{clear:both;min-height:389px}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#069;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__figures-list,.c-reading-companion__references-list{list-style:none;min-height:389px;padding:0}.c-reading-companion__references-list--numeric{list-style:decimal inside}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1.5;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-reading-companion__figure-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:16px 8px 16px 0}.c-reading-companion__figure-item:first-child{border-top:none;padding-top:8px}.c-reading-companion__reference-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:8px 8px 8px 16px}.c-reading-companion__reference-item:first-child{border-top:none}.c-reading-companion__reference-item a{word-break:break-word}.c-reading-companion__reference-citation{display:inline}.c-reading-companion__reference-links{font-size:.813rem;font-weight:700;list-style:none;margin:8px 0 0;padding:0;text-align:right}.c-reading-companion__reference-links>a{display:inline-block;padding-left:8px}.c-reading-companion__reference-links>a:first-child{display:inline-block;padding-left:0}.c-reading-companion__figure-title{display:block;margin:0 0 8px}.c-reading-companion__figure-links{display:flex;justify-content:space-between;margin:8px 0 0}.c-reading-companion__figure-links>a{align-items:center;display:flex}.c-reading-companion__figure-full-link svg{height:.8em;margin-left:2px}.c-reading-companion__panel{border-top:none;display:none;margin-top:0;padding-top:0}.c-cod,.c-reading-companion__panel--active{display:block}.c-cod{font-size:1rem;width:100%}.c-cod__form{background:#ebf0f3}.c-cod__prompt{font-size:1.125rem;line-height:1.3;margin:0 0 24px}.c-cod__label{display:block;margin:0 0 4px}.c-cod__row{display:flex;margin:0 0 16px}.c-cod__row:last-child{margin:0}.c-cod__input{border:1px solid #d5d5d5;border-radius:2px;flex-basis:75%;flex-shrink:0;margin:0;padding:13px}.c-cod__input--submit{background-color:#069;border:1px solid #069;color:#fff;flex-shrink:1;margin-left:8px;transition:background-color .2s ease-out 0s,color .2s ease-out 0s}.c-cod__input--submit-single{flex-basis:100%;flex-shrink:0;margin:0}.c-cod__input--submit:focus,.c-cod__input--submit:hover{background-color:#fff;color:#069}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{display:flex;flex:1 1 0%}.c-pdf-download__link:hover{text-decoration:none}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}.c-context-bar--sticky .c-pdf-download{display:block;margin-bottom:0;white-space:nowrap}@media only screen and (max-width:539px){.c-pdf-download .u-sticky-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}}.c-pdf-container{display:flex;justify-content:flex-end}@media only screen and (max-width:539px){.c-pdf-container .c-pdf-download{display:flex;flex-basis:100%}}.c-pdf-container .c-pdf-download+.c-pdf-download{margin-left:16px}.c-article-extras .c-pdf-container .c-pdf-download{width:100%}.c-article-extras .c-pdf-container .c-pdf-download+.c-pdf-download{margin-left:0}@media only screen and (min-width:540px){.c-context-bar--sticky .c-pdf-download__link{align-items:center;flex:1 1 183px}}@media only screen and (max-width:320px){.c-context-bar--sticky .c-pdf-download__link{padding:16px}}.article-page--commercial .c-article-main-column .c-pdf-button__container .c-pdf-download{display:none}@media only screen and (max-width:1023px){.article-page--commercial .c-article-main-column .c-pdf-button__container .c-pdf-download{display:block}}.c-recommendations-column-switch .c-meta{margin-top:auto}.c-article-recommendations-card__meta-type,.c-meta .c-meta__item:first-child{font-weight:700}.c-article-metrics__heading a,.c-article-metrics__posts .c-card__title a{color:inherit}.c-article-metrics__posts .c-card__title{font-size:1.05rem}.c-article-metrics__posts .c-card__title+span{color:#6f6f6f;font-size:1rem}p{overflow-wrap:break-word;word-break:break-word}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad__label{color:#333;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;font-weight:400;line-height:1.5;margin-bottom:4px}.app-author-list{color:#6f6f6f;font-family:inherit;font-size:1rem;line-height:inherit;list-style:none;margin:0;padding:0}.app-author-list>li,.c-breadcrumbs>li,.c-footer__links>li,.js .app-author-list,.u-list-comma-separated>li,.u-list-inline>li{display:inline}.app-author-list>li:not(:first-child):not(:last-child):before{content:", "}.app-author-list>li:not(:only-child):last-child:before{content:" & "}.app-author-list--compact{font-size:.875rem;line-height:1.4}.app-author-list--truncated>li:not(:only-child):last-child:before{content:" ... "}.js .app-author-list__hide{display:none;visibility:hidden}.js .app-author-list__hide:first-child+*{margin-block-start:0}.c-meta{color:inherit;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;line-height:1.4;list-style:none;margin:0;padding:0}.c-meta--large{font-size:1rem}.c-meta--large .c-meta__item{margin-bottom:8px}.c-meta__item{display:inline-block;margin-bottom:4px}.c-meta__item:not(:last-child){border-right:1px solid #d5d5d5;margin-right:4px;padding-right:4px}@media only screen and (max-width:539px){.c-meta__item--block-sm-max{display:block}.c-meta__item--block-sm-max:not(:last-child){border-right:none;margin-right:0;padding-right:0}}@media only screen and (min-width:1024px){.c-meta__item--block-at-lg{display:block}.c-meta__item--block-at-lg:not(:last-child){border-right:none;margin-right:0;padding-right:0}}.c-meta__type{font-weight:700;text-transform:none}.c-skip-link{background:#069;bottom:auto;color:#fff;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:link{color:#fff}.c-status-message{align-items:center;box-sizing:border-box;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;position:relative;width:100%}.c-card__summary>p:last-child,.c-status-message :last-child{margin-bottom:0}.c-status-message--boxed{background-color:#fff;border:1px solid #eee;border-radius:2px;line-height:1.4;padding:16px}.c-status-message__heading{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;font-weight:700}.c-status-message__icon{fill:currentcolor;display:inline-block;flex:0 0 auto;height:1.5em;margin-right:8px;transform:translate(0);vertical-align:text-top;width:1.5em}.c-status-message__icon--top{align-self:flex-start}.c-status-message--info .c-status-message__icon{color:#003f8d}.c-status-message--boxed.c-status-message--info{border-bottom:4px solid #003f8d}.c-status-message--error .c-status-message__icon{color:#c40606}.c-status-message--boxed.c-status-message--error{border-bottom:4px solid #c40606}.c-status-message--success .c-status-message__icon{color:#00b8b0}.c-status-message--boxed.c-status-message--success{border-bottom:4px solid #00b8b0}.c-status-message--warning .c-status-message__icon{color:#edbc53}.c-status-message--boxed.c-status-message--warning{border-bottom:4px solid #edbc53}.c-breadcrumbs{color:#000;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;list-style:none;margin:0;padding:0}.c-breadcrumbs__link{color:#666}svg.c-breadcrumbs__chevron{margin:4px 4px 0;fill:#888;height:10px;width:10px}@media only screen and (max-width:539px){.c-breadcrumbs .c-breadcrumbs__item{display:none}.c-breadcrumbs .c-breadcrumbs__item:last-child,.c-breadcrumbs .c-breadcrumbs__item:nth-last-child(2){display:inline}}.c-card{background-color:transparent;border:0;box-shadow:none;display:flex;flex-direction:column;font-size:14px;min-width:0;overflow:hidden;padding:0;position:relative}.c-card--no-shape{background:0 0;border:0;box-shadow:none}.c-card__image{display:flex;justify-content:center;overflow:hidden;padding-bottom:56.25%;position:relative}@supports (aspect-ratio:1/1){.c-card__image{padding-bottom:0}}.c-card__image img{left:0;min-height:100%;min-width:100%;position:absolute}@supports ((-o-object-fit:cover) or (object-fit:cover)){.c-card__image img{height:100%;object-fit:cover;width:100%}}.c-card__body{flex:1 1 auto;padding:16px}.c-card--no-shape .c-card__body{padding:0}.c-card--no-shape .c-card__body:not(:first-child){padding-top:16px}.c-card__title{letter-spacing:-.01875rem;margin-bottom:8px;margin-top:0}[lang=de] .c-card__title{hyphens:auto}.c-card__summary{line-height:1.4}.c-card__summary>p{margin-bottom:5px}.c-card__summary a{text-decoration:underline}.c-card__link:not(.c-card__link--no-block-link):before{bottom:0;content:"";left:0;position:absolute;right:0;top:0}.c-card--flush .c-card__body{padding:0}.c-card--major{font-size:1rem}.c-card--dark{background-color:#29303c;border-width:0;color:#e3e4e5}.c-card--dark .c-card__title{color:#fff}.c-card--dark .c-card__link,.c-card--dark .c-card__summary a{color:inherit}.c-header{background-color:#fff;border-bottom:5px solid #000;font-size:1rem;line-height:1.4;margin-bottom:16px}.c-header__row{padding:0;position:relative}.c-header__row:not(:last-child){border-bottom:1px solid #eee}.c-header__split{align-items:center;display:flex;justify-content:space-between}.c-header__logo-container{flex:1 1 0px;line-height:0;margin:8px 24px 8px 0}.c-header__logo{transform:translateZ(0)}.c-header__logo img{max-height:32px}.c-header__container{margin:0 auto;max-width:1280px}.c-header__menu{align-items:center;display:flex;flex:0 1 auto;flex-wrap:wrap;font-weight:700;gap:8px 8px;line-height:1.4;list-style:none;margin:0 -8px;padding:0}@media print{.c-header__menu{display:none}}@media only screen and (max-width:1023px){.c-header__menu--hide-lg-max{display:none;visibility:hidden}}.c-header__menu--global{font-weight:400;justify-content:flex-end}.c-header__menu--global svg{display:none;visibility:hidden}.c-header__menu--global svg:first-child+*{margin-block-start:0}@media only screen and (min-width:540px){.c-header__menu--global svg{display:block;visibility:visible}}.c-header__menu--journal{font-size:.875rem;margin:8px 0 8px -8px}@media only screen and (min-width:540px){.c-header__menu--journal{flex-wrap:nowrap;font-size:1rem}}.c-header__item{padding-bottom:0;padding-top:0;position:static}.c-header__item--pipe{border-left:2px solid #eee;padding-left:8px}.c-header__item--padding{padding-bottom:8px;padding-top:8px}@media only screen and (min-width:540px){.c-header__item--dropdown-menu{position:relative}}@media only screen and (min-width:1024px){.c-header__item--hide-lg{display:none;visibility:hidden}}@media only screen and (max-width:767px){.c-header__item--hide-md-max{display:none;visibility:hidden}.c-header__item--hide-md-max:first-child+*{margin-block-start:0}}.c-header__link{align-items:center;color:inherit;display:inline-flex;gap:4px 4px;padding:8px;white-space:nowrap}.c-header__link svg{transition-duration:.2s}.c-header__show-text{display:none;visibility:hidden}.has-tethered .c-header__heading--js-hide:first-child+*{margin-block-start:0}@media only screen and (min-width:540px){.c-header__show-text{display:inline;visibility:visible}}.c-header__dropdown{background-color:#000;border-bottom:1px solid #2f2f2f;color:#eee;font-size:.875rem;line-height:1.2;padding:16px 0}@media print{.c-header__dropdown{display:none}}.c-header__heading{display:inline-block;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.25rem;font-weight:400;line-height:1.4;margin-bottom:8px}.c-header__heading--keyline{border-top:1px solid;border-color:#2f2f2f;margin-top:16px;padding-top:16px;width:100%}.c-header__list{display:flex;flex-wrap:wrap;gap:0 16px;list-style:none;margin:0 -8px}.c-header__flush{margin:0 -8px}.c-header__visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.c-header__search-form{margin-bottom:8px}.c-header__search-layout{display:flex;flex-wrap:wrap;gap:16px 16px}.c-header__search-layout>:first-child{flex:999 1 auto}.c-header__search-layout>*{flex:1 1 auto}.c-header__search-layout--max-width{max-width:720px}.c-header__search-button{align-items:center;background-color:transparent;background-image:none;border:1px solid #fff;border-radius:2px;color:#fff;cursor:pointer;display:flex;font-family:sans-serif;font-size:1rem;justify-content:center;line-height:1.15;margin:0;padding:8px 16px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:100%}.u-button svg,.u-button--primary svg{fill:currentcolor}.c-header__input,.c-header__select{border:1px solid;border-radius:3px;box-sizing:border-box;font-size:1rem;padding:8px 16px;width:100%}.c-header__select{-webkit-appearance:none;background-image:url("data:image/svg+xml,%3Csvg height='16' viewBox='0 0 16 16' width='16' xmlns='http://www.w3.org/2000/svg'%3E%3Cpath d='m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z' fill='%23333' fill-rule='evenodd' transform='matrix(0 1 -1 0 11 3)'/%3E%3C/svg%3E");background-position:right .7em top 50%;background-repeat:no-repeat;background-size:1em;box-shadow:0 1px 0 1px rgba(0,0,0,.04);display:block;margin:0;max-width:100%;min-width:150px}@media only screen and (min-width:540px){.c-header__menu--journal .c-header__item--dropdown-menu:last-child .c-header__dropdown.has-tethered{left:auto;right:0}}@media only screen and (min-width:768px){.c-header__menu--journal .c-header__item--dropdown-menu:last-child .c-header__dropdown.has-tethered{left:0;right:auto}}.c-header__dropdown.has-tethered{border-bottom:0;border-radius:0 0 2px 2px;left:0;position:absolute;top:100%;transform:translateY(5px);width:100%;z-index:1}@media only screen and (min-width:540px){.c-header__dropdown.has-tethered{transform:translateY(8px);width:auto}}@media only screen and (min-width:768px){.c-header__dropdown.has-tethered{min-width:225px}}.c-header__dropdown--full-width.has-tethered{padding:32px 0 24px;transform:none;width:100%}.has-tethered .c-header__heading--js-hide{display:none;visibility:hidden}.has-tethered .c-header__list--js-stack{flex-direction:column}.has-tethered .c-header__item--keyline,.has-tethered .c-header__list~.c-header__list .c-header__item:first-child{border-top:1px solid #d5d5d5;margin-top:8px;padding-top:8px}.c-header__item--snid-account-widget{display:flex}.c-header__container{padding:0 4px}.c-header__list{padding:0 12px}.c-header__menu .c-header__link{font-size:14px}.c-header__item--snid-account-widget .c-header__link{padding:8px}.c-header__menu--journal{margin-left:0}@media only screen and (min-width:540px){.c-header__container{padding:0 16px}.c-header__menu--journal{margin-left:-8px}.c-header__menu .c-header__link{font-size:16px}.c-header__link--search{gap:13px 13px}}.u-button{align-items:center;background-color:transparent;background-image:none;border:1px solid #069;border-radius:2px;color:#069;cursor:pointer;display:inline-flex;font-family:sans-serif;font-size:1rem;justify-content:center;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:auto}.u-button--primary{background-color:#069;background-image:none;border:1px solid #069;color:#fff}.u-button--full-width{display:flex;width:100%}.u-display-none{display:none}.js .u-js-hide,.u-hide{display:none;visibility:hidden}.u-hide:first-child+*{margin-block-start:0}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media print{.u-hide-print{display:none}}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}.u-hide-at-lg:first-child+*{margin-block-start:0}}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-color-open-access{color:#b74616}.u-float-left{float:left}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-full-height{height:100%}.u-list-reset{list-style:none;margin:0;padding:0}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-justify-content-space-between{justify-content:space-between}.u-mt-32{margin-top:32px}.u-mb-8{margin-bottom:8px}.u-mb-16{margin-bottom:16px}.u-mb-24{margin-bottom:24px}.u-mb-32{margin-bottom:32px}.c-nature-box svg+.c-article__button-text,.u-ml-8{margin-left:8px}.u-pa-16{padding:16px}html *,html :after,html :before{box-sizing:inherit}.c-article-section__title,.c-article-title{font-weight:700}.c-card__title{line-height:1.4em}.c-article__button{background-color:#069;border:1px solid #069;border-radius:2px;color:#fff;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;line-height:1.4;margin-bottom:16px;padding:13px;transition:background-color .2s ease-out 0s,color .2s ease-out 0s}.c-article__button,.c-article__button:hover{text-decoration:none}.c-article__button--inverted,.c-article__button:hover{background-color:#fff;color:#069}.c-article__button--inverted:hover{background-color:#069;color:#fff}.c-header__link{text-decoration:inherit}.grade-c-hide{display:block}.c-nature-box{background-color:#fff;border:1px solid #d5d5d5;border-radius:2px;box-shadow:0 0 5px 0 rgba(51,51,51,.1);line-height:1.3;margin-bottom:24px;padding:16px 16px 3px}.c-nature-box__text{font-size:1rem;margin-bottom:16px}.c-nature-box--access-to-pdf{display:none}@media only screen and (min-width:1024px){.c-nature-box--mobile{display:none}}.c-nature-box .c-pdf-download{margin-bottom:16px!important}.c-nature-box--version{background-color:#eee}.c-nature-box__wrapper{transform:translateZ(0)}.c-nature-box__wrapper--placeholder{min-height:165px}.c-pdf-download__link{padding:13px 24px} } </style>




    
        <link data-test="critical-css-handler" data-inline-css-source="critical-css" rel="stylesheet" href="/static/css/enhanced-article-nature-branded-1dd982e2cc.css" media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)" onload="this.media='only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)';this.onload=null">
    
    <noscript>
        <link rel="stylesheet" type="text/css" href="/static/css/enhanced-article-nature-branded-1dd982e2cc.css" media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)">
    </noscript>

<link rel="stylesheet" type="text/css" href="/static/css/article-print-c9121fecab.css" media="print">
    



<link rel="apple-touch-icon" sizes="180x180" href="/static/images/favicons/nature/apple-touch-icon-f39cb19454.png">
<link rel="icon" type="image/png" sizes="48x48" href="/static/images/favicons/nature/favicon-48x48-b52890008c.png">
<link rel="icon" type="image/png" sizes="32x32" href="/static/images/favicons/nature/favicon-32x32-3fe59ece92.png">
<link rel="icon" type="image/png" sizes="16x16" href="/static/images/favicons/nature/favicon-16x16-951651ab72.png">
<link rel="manifest" href="/static/manifest.json" crossorigin="use-credentials">
<link rel="mask-icon" href="/static/images/favicons/nature/safari-pinned-tab-69bff48fe6.svg" color="#000000">
<link rel="shortcut icon" href="/static/images/favicons/nature/favicon.ico">
<meta name="msapplication-TileColor" content="#000000">
<meta name="msapplication-config" content="/static/browserconfig.xml">
<meta name="theme-color" content="#000000">
<meta name="application-name" content="Nature">


<script>
    (function () {
        if ( typeof window.CustomEvent === "function" ) return false;
        function CustomEvent ( event, params ) {
            params = params || { bubbles: false, cancelable: false, detail: null };
            var evt = document.createEvent( 'CustomEvent' );
            evt.initCustomEvent( event, params.bubbles, params.cancelable, params.detail );
            return evt;
        }

        CustomEvent.prototype = window.Event.prototype;

        window.CustomEvent = CustomEvent;
    })();
</script>



<!-- Google Tag Manager -->
<script data-test="gtm-head">
    window.initGTM = function() {
        if (window.config.mustardcut) {
            (function (w, d, s, l, i) {
                w[l] = w[l] || [];
                w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});
                var f = d.getElementsByTagName(s)[0],
                        j = d.createElement(s),
                        dl = l != 'dataLayer' ? '&l=' + l : '';
                j.async = true;
                j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl;
                f.parentNode.insertBefore(j, f);
            })(window, document, 'script', 'dataLayer', 'GTM-MRVXSHQ');
        }
    }
</script>
<!-- End Google Tag Manager -->

    <script>
    (function(w,d,t) {
        function cc() {
            var h = w.location.hostname;
            if (h.indexOf('preview-www.nature.com') > -1) return;

            var e = d.createElement(t),
                    s = d.getElementsByTagName(t)[0];

            if (h.indexOf('nature.com') > -1) {
                if (h.indexOf('test-www.nature.com') > -1) {
                    e.src = 'https://cmp.nature.com/production_live/en/consent-bundle-8-85.js';
                    e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
                } else {
                    e.src = 'https://cmp.nature.com/production_live/en/consent-bundle-8-85.js';
                    e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
                }
            } else {
                e.src = '/static/js/cookie-consent-es5-bundle-cb57c2c98a.js';
                e.setAttribute('data-consent', h);
            }
            s.insertAdjacentElement('afterend', e);
        }

        cc();
    })(window,document,'script');
</script>


<script id="js-position0">
    (function(w, d) {
        w.idpVerifyPrefix = 'https://verify.nature.com';
        w.ra21Host = 'https://wayf.springernature.com';
        var moduleSupport = (function() {
            return 'noModule' in d.createElement('script');
        })();

        if (w.config.mustardcut === true) {
            w.loader = {
                index: 0,
                registered: [],
                scripts: [
                    
                        {src: '/static/js/global-article-es6-bundle-c8a573ca90.js', test: 'global-article-js', module: true},
                        {src: '/static/js/global-article-es5-bundle-d17603b9e9.js', test: 'global-article-js', nomodule: true},
                        {src: '/static/js/shared-es6-bundle-e9d2061c95.js', test: 'shared-js', module: true},
                        {src: '/static/js/shared-es5-bundle-1cbf3a8b56.js', test: 'shared-js', nomodule: true},
                        {src: '/static/js/header-150-es6-bundle-5bb959eaa1.js', test: 'header-150-js', module: true},
                        {src: '/static/js/header-150-es5-bundle-994fde5b1d.js', test: 'header-150-js', nomodule: true}
                    
                ].filter(function (s) {
                    if (s.src === null) return false;
                    if (moduleSupport && s.nomodule) return false;
                    return !(!moduleSupport && s.module);
                }),

                register: function (value) {
                    this.registered.push(value);
                },

                ready: function () {
                    if (this.registered.length === this.scripts.length) {
                        this.registered.forEach(function (fn) {
                            if (typeof fn === 'function') {
                                setTimeout(fn, 0); 
                            }
                        });
                        this.ready = function () {};
                    }
                },

                insert: function (s) {
                    var t = d.getElementById('js-position' + this.index);
                    if (t && t.insertAdjacentElement) {
                        t.insertAdjacentElement('afterend', s);
                    } else {
                        d.head.appendChild(s);
                    }
                    ++this.index;
                },

                createScript: function (script, beforeLoad) {
                    var s = d.createElement('script');
                    s.id = 'js-position' + (this.index + 1);
                    s.setAttribute('data-test', script.test);
                    if (beforeLoad) {
                        s.defer = 'defer';
                        s.onload = function () {
                            if (script.noinit) {
                                loader.register(true);
                            }
                            if (d.readyState === 'interactive' || d.readyState === 'complete') {
                                loader.ready();
                            }
                        };
                    } else {
                        s.async = 'async';
                    }
                    s.src = script.src;
                    return s;
                },

                init: function () {
                    this.scripts.forEach(function (s) {
                        loader.insert(loader.createScript(s, true));
                    });

                    d.addEventListener('DOMContentLoaded', function () {
                        loader.ready();
                        var conditionalScripts;
                        
                            conditionalScripts = [
                                {match: 'div[data-pan-container]', src: '/static/js/pan-zoom-es6-bundle-464a2af269.js', test: 'pan-zoom-js',  module: true },
                                {match: 'div[data-pan-container]', src: '/static/js/pan-zoom-es5-bundle-98fb9b653b.js', test: 'pan-zoom-js',  nomodule: true },
                                {match: 'math,span.mathjax-tex', src: '/static/js/math-es6-bundle-23597ae350.js', test: 'math-js', module: true},
                                {match: 'math,span.mathjax-tex', src: '/static/js/math-es5-bundle-6532c6f78b.js', test: 'math-js', nomodule: true}
                            ];
                        

                        if (conditionalScripts) {
                            conditionalScripts.filter(function (script) {
                                return !!document.querySelector(script.match) && !((moduleSupport && script.nomodule) || (!moduleSupport && script.module));
                            }).forEach(function (script) {
                                loader.insert(loader.createScript(script));
                            });
                        }
                    }, false);
                }
            };
            loader.init();
        }
    })(window, document);
</script><script id="js-position1" data-test="global-article-js" defer="" src="/static/js/global-article-es6-bundle-c8a573ca90.js"></script><script id="js-position2" data-test="shared-js" defer="" src="/static/js/shared-es6-bundle-e9d2061c95.js"></script><script id="js-position3" data-test="header-150-js" defer="" src="/static/js/header-150-es6-bundle-5bb959eaa1.js"></script><script id="js-position4" data-test="math-js" async="" src="/static/js/math-es6-bundle-23597ae350.js"></script>










<meta name="robots" content="noarchive">
<meta name="access" content="Yes">


<link rel="search" href="https://www.nature.com/search">
<link rel="search" href="https://www.nature.com/opensearch/opensearch.xml" type="application/opensearchdescription+xml" title="nature.com">
<link rel="search" href="https://www.nature.com/opensearch/request" type="application/sru+xml" title="nature.com">





    
    <script type="application/ld+json">{"mainEntity":{"headline":"Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial","description":"Patients with rheumatoid arthritis (RA) receive highly targeted biologic therapies without previous knowledge of target expression levels in the diseased tissue. Approximately 40% of patients do not respond to individual biologic therapies and 5–20% are refractory to all. In a biopsy-based, precision-medicine, randomized clinical trial in RA (R4RA; n = 164), patients with low/absent synovial B cell molecular signature had a lower response to rituximab (anti-CD20 monoclonal antibody) compared with that to tocilizumab (anti-IL6R monoclonal antibody) although the exact mechanisms of response/nonresponse remain to be established. Here, in-depth histological/molecular analyses of R4RA synovial biopsies identify humoral immune response gene signatures associated with response to rituximab and tocilizumab, and a stromal/fibroblast signature in patients refractory to all medications. Post-treatment changes in synovial gene expression and cell infiltration highlighted divergent effects of rituximab and tocilizumab relating to differing response/nonresponse mechanisms. Using ten-by-tenfold nested cross-validation, we developed machine learning algorithms predictive of response to rituximab (area under the curve (AUC) = 0.74), tocilizumab (AUC = 0.68) and, notably, multidrug resistance (AUC = 0.69). This study supports the notion that disease endotypes, driven by diverse molecular pathology pathways in the diseased tissue, determine diverse clinical and treatment–response phenotypes. It also highlights the importance of integration of molecular pathology signatures into clinical algorithms to optimize the future use of existing medications and inform the development of new drugs for refractory patients. Biomarker analysis of the phase 4 R4RA trial identifies pretreatment synovial biopsy features selectively associated with response to rituximab or tocilizumab, and leads to the development of models that might predict treatment benefit in patients with rheumatoid arthritis","datePublished":"2022-05-19T00:00:00Z","dateModified":"2022-05-19T00:00:00Z","pageStart":"1256","pageEnd":"1268","license":"http://creativecommons.org/licenses/by/4.0/","sameAs":"https://doi.org/10.1038/s41591-022-01789-0","keywords":["Machine learning","Predictive markers","Predictive medicine","Randomized controlled trials","Rheumatoid arthritis","Biomedicine","general","Cancer Research","Metabolic Diseases","Infectious Diseases","Molecular Medicine","Neurosciences"],"image":["https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig1_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig2_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig3_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig4_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig5_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig6_HTML.png"],"isPartOf":{"name":"Nature Medicine","issn":["1546-170X","1078-8956"],"volumeNumber":"28","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"Nature Publishing Group US","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Felice Rivellese","url":"http://orcid.org/0000-0002-6759-7521","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"},{"name":"Queen Mary University of London","address":{"name":"Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Anna E. A. Surace","url":"http://orcid.org/0000-0001-9589-3005","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"},{"name":"Queen Mary University of London","address":{"name":"Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Katriona Goldmann","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"},{"name":"Queen Mary University of London","address":{"name":"Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Elisabetta Sciacca","url":"http://orcid.org/0000-0001-7525-1558","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"},{"name":"Queen Mary University of London","address":{"name":"Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Cankut Çubuk","url":"http://orcid.org/0000-0003-4646-0849","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"},{"name":"Queen Mary University of London","address":{"name":"Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Giovanni Giorli","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"},{"name":"Queen Mary University of London","address":{"name":"Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Christopher R. John","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"},{"name":"Queen Mary University of London","address":{"name":"Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Alessandra Nerviani","url":"http://orcid.org/0000-0003-4064-4014","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Liliane Fossati-Jimack","url":"http://orcid.org/0000-0003-3757-3999","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Georgina Thorborn","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Manzoor Ahmed","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Edoardo Prediletto","url":"http://orcid.org/0000-0001-6830-0614","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Sarah E. Church","url":"http://orcid.org/0000-0002-7194-4282","affiliation":[{"name":"NanoString Technologies Inc.","address":{"name":"NanoString Technologies Inc., Seattle, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Briana M. Hudson","affiliation":[{"name":"NanoString Technologies Inc.","address":{"name":"NanoString Technologies Inc., Seattle, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Sarah E. Warren","affiliation":[{"name":"NanoString Technologies Inc.","address":{"name":"NanoString Technologies Inc., Seattle, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Paul M. McKeigue","affiliation":[{"name":"University of Edinburgh","address":{"name":"Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Frances Humby","url":"http://orcid.org/0000-0003-1280-9133","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Michele Bombardieri","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Michael R. Barnes","url":"http://orcid.org/0000-0001-9097-7381","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Myles J. Lewis","url":"http://orcid.org/0000-0001-9365-5345","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"},{"name":"Queen Mary University of London","address":{"name":"Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"email":"myles.lewis@qmul.ac.uk","@type":"Person"},{"name":"Costantino Pitzalis","url":"http://orcid.org/0000-0003-1326-5051","affiliation":[{"name":"Queen Mary University of London","address":{"name":"Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK","@type":"PostalAddress"},"@type":"Organization"}],"email":"c.pitzalis@qmul.ac.uk","@type":"Person"}],"isAccessibleForFree":true,"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>




    
    
    


    
    <link rel="canonical" href="https://www.nature.com/articles/s41591-022-01789-0">
    
    
    <meta name="journal_id" content="41591">
    <meta name="dc.title" content="Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial">
    <meta name="dc.source" content="Nature Medicine 2022 28:6">
    <meta name="dc.format" content="text/html">
    <meta name="dc.publisher" content="Nature Publishing Group">
    <meta name="dc.date" content="2022-05-19">
    <meta name="dc.type" content="OriginalPaper">
    <meta name="dc.language" content="En">
    <meta name="dc.copyright" content="2022 Crown">
    <meta name="dc.rights" content="2022 Crown">
    <meta name="dc.rightsAgent" content="journalpermissions@springernature.com">
    <meta name="dc.description" content="Patients with rheumatoid arthritis (RA) receive highly targeted biologic therapies without previous knowledge of target expression levels in the diseased tissue. Approximately 40% of patients do not respond to individual biologic therapies and 5–20% are refractory to all. In a biopsy-based, precision-medicine, randomized clinical trial in RA (R4RA; n = 164), patients with low/absent synovial B cell molecular signature had a lower response to rituximab (anti-CD20 monoclonal antibody) compared with that to tocilizumab (anti-IL6R monoclonal antibody) although the exact mechanisms of response/nonresponse remain to be established. Here, in-depth histological/molecular analyses of R4RA synovial biopsies identify humoral immune response gene signatures associated with response to rituximab and tocilizumab, and a stromal/fibroblast signature in patients refractory to all medications. Post-treatment changes in synovial gene expression and cell infiltration highlighted divergent effects of rituximab and tocilizumab relating to differing response/nonresponse mechanisms. Using ten-by-tenfold nested cross-validation, we developed machine learning algorithms predictive of response to rituximab (area under the curve (AUC) = 0.74), tocilizumab (AUC = 0.68) and, notably, multidrug resistance (AUC = 0.69). This study supports the notion that disease endotypes, driven by diverse molecular pathology pathways in the diseased tissue, determine diverse clinical and treatment–response phenotypes. It also highlights the importance of integration of molecular pathology signatures into clinical algorithms to optimize the future use of existing medications and inform the development of new drugs for refractory patients. Biomarker analysis of the phase 4 R4RA trial identifies pretreatment synovial biopsy features selectively associated with response to rituximab or tocilizumab, and leads to the development of models that might predict treatment benefit in patients with rheumatoid arthritis">
    <meta name="prism.issn" content="1546-170X">
    <meta name="prism.publicationName" content="Nature Medicine">
    <meta name="prism.publicationDate" content="2022-05-19">
    <meta name="prism.volume" content="28">
    <meta name="prism.number" content="6">
    <meta name="prism.section" content="OriginalPaper">
    <meta name="prism.startingPage" content="1256">
    <meta name="prism.endingPage" content="1268">
    <meta name="prism.copyright" content="2022 Crown">
    <meta name="prism.rightsAgent" content="journalpermissions@springernature.com">
    <meta name="prism.url" content="https://www.nature.com/articles/s41591-022-01789-0">
    <meta name="prism.doi" content="doi:10.1038/s41591-022-01789-0">
    <meta name="citation_pdf_url" content="https://www.nature.com/articles/s41591-022-01789-0.pdf">
    <meta name="citation_fulltext_html_url" content="https://www.nature.com/articles/s41591-022-01789-0">
    <meta name="citation_journal_title" content="Nature Medicine">
    <meta name="citation_journal_abbrev" content="Nat Med">
    <meta name="citation_publisher" content="Nature Publishing Group">
    <meta name="citation_issn" content="1546-170X">
    <meta name="citation_title" content="Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial">
    <meta name="citation_volume" content="28">
    <meta name="citation_issue" content="6">
    <meta name="citation_publication_date" content="2022/06">
    <meta name="citation_online_date" content="2022/05/19">
    <meta name="citation_firstpage" content="1256">
    <meta name="citation_lastpage" content="1268">
    <meta name="citation_article_type" content="Article">
    <meta name="citation_fulltext_world_readable" content="">
    <meta name="citation_language" content="en">
    <meta name="dc.identifier" content="doi:10.1038/s41591-022-01789-0">
    <meta name="DOI" content="10.1038/s41591-022-01789-0">
    <meta name="size" content="281747">
    <meta name="citation_doi" content="10.1038/s41591-022-01789-0">
    <meta name="citation_springer_api_url" content="http://api.springer.com/xmldata/jats?q=doi:10.1038/s41591-022-01789-0&amp;api_key=">
    <meta name="description" content="Patients with rheumatoid arthritis (RA) receive highly targeted biologic therapies without previous knowledge of target expression levels in the diseased tissue. Approximately 40% of patients do not respond to individual biologic therapies and 5–20% are refractory to all. In a biopsy-based, precision-medicine, randomized clinical trial in RA (R4RA; n = 164), patients with low/absent synovial B cell molecular signature had a lower response to rituximab (anti-CD20 monoclonal antibody) compared with that to tocilizumab (anti-IL6R monoclonal antibody) although the exact mechanisms of response/nonresponse remain to be established. Here, in-depth histological/molecular analyses of R4RA synovial biopsies identify humoral immune response gene signatures associated with response to rituximab and tocilizumab, and a stromal/fibroblast signature in patients refractory to all medications. Post-treatment changes in synovial gene expression and cell infiltration highlighted divergent effects of rituximab and tocilizumab relating to differing response/nonresponse mechanisms. Using ten-by-tenfold nested cross-validation, we developed machine learning algorithms predictive of response to rituximab (area under the curve (AUC) = 0.74), tocilizumab (AUC = 0.68) and, notably, multidrug resistance (AUC = 0.69). This study supports the notion that disease endotypes, driven by diverse molecular pathology pathways in the diseased tissue, determine diverse clinical and treatment–response phenotypes. It also highlights the importance of integration of molecular pathology signatures into clinical algorithms to optimize the future use of existing medications and inform the development of new drugs for refractory patients. Biomarker analysis of the phase 4 R4RA trial identifies pretreatment synovial biopsy features selectively associated with response to rituximab or tocilizumab, and leads to the development of models that might predict treatment benefit in patients with rheumatoid arthritis">
    <meta name="dc.creator" content="Rivellese, Felice">
    <meta name="dc.creator" content="Surace, Anna E. A.">
    <meta name="dc.creator" content="Goldmann, Katriona">
    <meta name="dc.creator" content="Sciacca, Elisabetta">
    <meta name="dc.creator" content="Çubuk, Cankut">
    <meta name="dc.creator" content="Giorli, Giovanni">
    <meta name="dc.creator" content="John, Christopher R.">
    <meta name="dc.creator" content="Nerviani, Alessandra">
    <meta name="dc.creator" content="Fossati-Jimack, Liliane">
    <meta name="dc.creator" content="Thorborn, Georgina">
    <meta name="dc.creator" content="Ahmed, Manzoor">
    <meta name="dc.creator" content="Prediletto, Edoardo">
    <meta name="dc.creator" content="Church, Sarah E.">
    <meta name="dc.creator" content="Hudson, Briana M.">
    <meta name="dc.creator" content="Warren, Sarah E.">
    <meta name="dc.creator" content="McKeigue, Paul M.">
    <meta name="dc.creator" content="Humby, Frances">
    <meta name="dc.creator" content="Bombardieri, Michele">
    <meta name="dc.creator" content="Barnes, Michael R.">
    <meta name="dc.creator" content="Lewis, Myles J.">
    <meta name="dc.creator" content="Pitzalis, Costantino">
    <meta name="dc.subject" content="Machine learning">
    <meta name="dc.subject" content="Predictive markers">
    <meta name="dc.subject" content="Predictive medicine">
    <meta name="dc.subject" content="Randomized controlled trials">
    <meta name="dc.subject" content="Rheumatoid arthritis">
    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Dis. Prim.; citation_title=Rheumatoid arthritis; citation_author=JS Smolen; citation_volume=4; citation_publication_date=2018; citation_pages=18001; citation_doi=10.1038/nrdp.2018.1; citation_id=CR1">
    <meta name="citation_reference" content="citation_journal_title=Ann. Rheum. Dis.; citation_title=Defining refractory rheumatoid arthritis; citation_author=MH Buch; citation_volume=77; citation_publication_date=2018; citation_pages=966-969; citation_doi=10.1136/annrheumdis-2017-212862; citation_id=CR2">
    <meta name="citation_reference" content="citation_journal_title=N. Engl. J. Med.; citation_title=Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer; citation_author=H Borghaei; citation_volume=373; citation_publication_date=2015; citation_pages=1627-1639; citation_doi=10.1056/NEJMoa1507643; citation_id=CR3">
    <meta name="citation_reference" content="citation_journal_title=Clin. Breast Cancer; citation_title=Effectiveness of targeted therapy in patients with previously untreated metastatic breast cancer: a systematic review and meta-analysis; citation_author=P Kawalec, S Łopuch, A Mikrut; citation_volume=15; citation_publication_date=2015; citation_pages=90-100; citation_doi=10.1016/j.clbc.2014.10.006; citation_id=CR4">
    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Rheumatol.; citation_title=Transforming clinical trials in rheumatology: towards patient-centric precision medicine; citation_author=C Pitzalis, EHS Choy, MH Buch; citation_volume=16; citation_publication_date=2020; citation_pages=590-599; citation_doi=10.1038/s41584-020-0491-4; citation_id=CR5">
    <meta name="citation_reference" content="citation_journal_title=Cell Rep.; citation_title=Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes; citation_author=MJ Lewis; citation_volume=28; citation_publication_date=2019; citation_pages=2455-2470; citation_doi=10.1016/j.celrep.2019.07.091; citation_id=CR6">
    <meta name="citation_reference" content="citation_journal_title=Ann. Rheum. Dis.; citation_title=Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients; citation_author=F Humby; citation_volume=78; citation_publication_date=2019; citation_pages=761-772; citation_doi=10.1136/annrheumdis-2018-214539; citation_id=CR7">
    <meta name="citation_reference" content="citation_journal_title=Autoimmun. Rev.; citation_title=The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and experts’ consensus; citation_author=R Giacomelli; citation_volume=20; citation_publication_date=2021; citation_pages=102738; citation_doi=10.1016/j.autrev.2020.102738; citation_id=CR8">
    <meta name="citation_reference" content="citation_journal_title=Lancet; citation_title=Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial; citation_author=F Humby; citation_volume=397; citation_publication_date=2021; citation_pages=305-317; citation_doi=10.1016/S0140-6736(20)32341-2; citation_id=CR9">
    <meta name="citation_reference" content="citation_journal_title=Genome Biol.; citation_title=Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression; citation_author=E Becht; citation_volume=17; citation_publication_date=2016; citation_doi=10.1186/s13059-016-1070-5; citation_id=CR10">
    <meta name="citation_reference" content="citation_journal_title=Sci. Rep.; citation_title=M3C: Monte Carlo reference-based consensus clustering; citation_author=CR John; citation_volume=10; citation_publication_date=2020; citation_doi=10.1038/s41598-020-58766-1; citation_id=CR11">
    <meta name="citation_reference" content="citation_journal_title=Nat. Immunol.; citation_title=Molecular signatures of antibody responses derived from a systems biology study of five human vaccines; citation_author=S Li; citation_volume=15; citation_publication_date=2014; citation_pages=195-204; citation_doi=10.1038/ni.2789; citation_id=CR12">
    <meta name="citation_reference" content="citation_journal_title=Nat. Commun.; citation_title=Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation; citation_author=W Stephenson; citation_volume=9; citation_publication_date=2018; citation_doi=10.1038/s41467-017-02659-x; citation_id=CR13">
    <meta name="citation_reference" content="citation_journal_title=Nat. Immunol.; citation_title=Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry; citation_author=F Zhang; citation_volume=20; citation_publication_date=2019; citation_pages=928-942; citation_doi=10.1038/s41590-019-0378-1; citation_id=CR14">
    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Notch signalling drives synovial fibroblast identity and arthritis pathology; citation_author=K Wei; citation_volume=582; citation_publication_date=2020; citation_pages=259-264; citation_doi=10.1038/s41586-020-2222-z; citation_id=CR15">
    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Distinct fibroblast subsets drive inflammation and damage in arthritis; citation_author=AP Croft; citation_volume=570; citation_publication_date=2019; citation_pages=246-251; citation_doi=10.1038/s41586-019-1263-7; citation_id=CR16">
    <meta name="citation_reference" content="citation_journal_title=J. Immunol.; citation_title=Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8α+ type; citation_author=K Crozat; citation_volume=187; citation_publication_date=2011; citation_pages=4411-4415; citation_doi=10.4049/jimmunol.1101717; citation_id=CR17">
    <meta name="citation_reference" content="citation_journal_title=J. Biol. Chem.; citation_title=Prolectin, a glycan-binding receptor on dividing B cells in germinal centers; citation_author=SA Graham; citation_volume=284; citation_publication_date=2009; citation_pages=18537-18544; citation_doi=10.1074/jbc.M109.012807; citation_id=CR18">
    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Rheumatol.; citation_title=PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets; citation_author=AM Curran, P Naik, JT Giles, E Darrah; citation_volume=16; citation_publication_date=2020; citation_pages=301-315; citation_doi=10.1038/s41584-020-0409-1; citation_id=CR19">
    <meta name="citation_reference" content="citation_journal_title=Ann. Rheum. Dis.; citation_title=Synovial tissue macrophages and joint erosion in rheumatoid arthritis; citation_author=G Yanni, A Whelan, C Feighery, B Bresnihan; citation_volume=53; citation_publication_date=1994; citation_pages=39-44; citation_doi=10.1136/ard.53.1.39; citation_id=CR20">
    <meta name="citation_reference" content="citation_journal_title=J. Rheumatol.; citation_title=Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers; citation_author=B Bresnihan; citation_volume=36; citation_publication_date=2009; citation_pages=1800-1802; citation_doi=10.3899/jrheum.090348; citation_id=CR21">
    <meta name="citation_reference" content="citation_journal_title=Arthritis Rheum.; citation_title=Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment; citation_author=YK Teng; citation_volume=56; citation_publication_date=2007; citation_pages=3909-3918; citation_doi=10.1002/art.22967; citation_id=CR22">
    <meta name="citation_reference" content="citation_journal_title=Ann. Rheum. Dis.; citation_title=Pretreatment synovial transcriptional profile is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab; citation_author=VE Hogan; citation_volume=71; citation_publication_date=2012; citation_pages=1888-1894; citation_doi=10.1136/annrheumdis-2011-201115; citation_id=CR23">
    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Rheumatol.; citation_title=Translating IL-6 biology into effective treatments; citation_author=EH Choy; citation_volume=16; citation_publication_date=2020; citation_pages=335-345; citation_doi=10.1038/s41584-020-0419-z; citation_id=CR24">
    <meta name="citation_reference" content="citation_journal_title=Arthritis Res. Ther.; citation_title=The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients; citation_author=HG Raterman; citation_volume=14; citation_publication_date=2012; citation_pages=R95; citation_doi=10.1186/ar3819; citation_id=CR25">
    <meta name="citation_reference" content="citation_journal_title=Arthritis Rheum.; citation_title=Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients; citation_author=RM Thurlings; citation_volume=62; citation_publication_date=2010; citation_pages=3607-3614; citation_doi=10.1002/art.27702; citation_id=CR26">
    <meta name="citation_reference" content="citation_journal_title=Ann. Rheum. Dis.; citation_title=Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC); citation_author=G Lliso-Ribera; citation_volume=78; citation_publication_date=2019; citation_pages=1642-1652; citation_doi=10.1136/annrheumdis-2019-215751; citation_id=CR27">
    <meta name="citation_reference" content="citation_journal_title=Front. Immunol.; citation_title=A pauci-immune synovial pathotype predicts inadequate response to TNFα-blockade in rheumatoid arthritis patients; citation_author=A Nerviani; citation_volume=11; citation_publication_date=2020; citation_pages=845; citation_doi=10.3389/fimmu.2020.00845; citation_id=CR28">
    <meta name="citation_reference" content="citation_journal_title=Nat. Commun.; citation_title=Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis; citation_author=F Mizoguchi; citation_volume=9; citation_publication_date=2018; citation_doi=10.1038/s41467-018-02892-y; citation_id=CR29">
    <meta name="citation_reference" content="citation_journal_title=Nat. Commun.; citation_title=Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts; citation_author=N Ferrari; citation_volume=10; citation_publication_date=2019; citation_doi=10.1038/s41467-018-07987-0; citation_id=CR30">
    <meta name="citation_reference" content="citation_journal_title=Immunol. Rev.; citation_title=Fibroblast pathology in inflammatory joint disease; citation_author=LJ Marsh, S Kemble, P Reis Nisa, R Singh, AP Croft; citation_volume=302; citation_publication_date=2021; citation_pages=163-183; citation_doi=10.1111/imr.12986; citation_id=CR31">
    <meta name="citation_reference" content="citation_journal_title=Rheumatology (Oxford); citation_title=Monocyte chemoattractant protein-4 (MCP-4)/CCL13 is highly expressed in cartilage from patients with rheumatoid arthritis; citation_author=T Iwamoto; citation_volume=45; citation_publication_date=2006; citation_pages=421-424; citation_doi=10.1093/rheumatology/kei209; citation_id=CR32">
    <meta name="citation_reference" content="citation_journal_title=Arthritis Res. Ther.; citation_title=Th17 and CD24(hi)CD27(+) regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis; citation_author=S Salomon; citation_volume=19; citation_publication_date=2017; citation_pages=33; citation_doi=10.1186/s13075-017-1244-x; citation_id=CR33">
    <meta name="citation_reference" content="citation_journal_title=Ann. Rheum. Dis.; citation_title=EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update; citation_author=JS Smolen; citation_volume=79; citation_publication_date=2020; citation_pages=685-699; citation_doi=10.1136/annrheumdis-2019-216655; citation_id=CR34">
    <meta name="citation_reference" content="citation_journal_title=Arthritis Rheum.; citation_title=The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation; citation_author=B Vandooren, T Cantaert, T Noordenbos, PP Tak, D Baeten; citation_volume=58; citation_publication_date=2008; citation_pages=718-729; citation_doi=10.1002/art.23290; citation_id=CR35">
    <meta name="citation_reference" content="citation_journal_title=Ann. Rheum. Dis.; citation_title=Assessment of rituximab’s immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results; citation_author=A Kavanaugh; citation_volume=67; citation_publication_date=2008; citation_pages=402-408; citation_doi=10.1136/ard.2007.074229; citation_id=CR36">
    <meta name="citation_reference" content="citation_journal_title=Rheumatology (Oxford); citation_title=Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis; citation_author=TH Ramwadhdoebe; citation_volume=58; citation_publication_date=2019; citation_pages=1075-1085; citation_doi=10.1093/rheumatology/key428; citation_id=CR37">
    <meta name="citation_reference" content="citation_journal_title=Cytokine; citation_title=Emerging roles for IL-6 family cytokines as positive and negative regulators of ectopic lymphoid structures; citation_author=DG Hill, A Ward, LB Nicholson, GW Jones; citation_volume=146; citation_publication_date=2021; citation_pages=155650; citation_doi=10.1016/j.cyto.2021.155650; citation_id=CR38">
    <meta name="citation_reference" content="citation_journal_title=Rheumatology (Oxford); citation_title=Predicting treatment response to IL6R blockers in rheumatoid arthritis; citation_author=B Nouri, N Nair, A Barton; citation_volume=59; citation_publication_date=2020; citation_pages=3603-3610; citation_doi=10.1093/rheumatology/keaa529; citation_id=CR39">
    <meta name="citation_reference" content="citation_journal_title=Ann. Rheum. Dis.; citation_title=Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis; citation_author=JD Isaacs; citation_volume=72; citation_publication_date=2013; citation_pages=329-336; citation_doi=10.1136/annrheumdis-2011-201117; citation_id=CR40">
    <meta name="citation_reference" content="citation_journal_title=Stat. Methods Med. Res.; citation_title=Sample size requirements for learning to classify with high-dimensional biomarker panels; citation_author=P McKeigue; citation_volume=28; citation_publication_date=2019; citation_pages=904-910; citation_doi=10.1177/0962280217738807; citation_id=CR41">
    <meta name="citation_reference" content="citation_journal_title=Ann. Rheum. Dis.; citation_title=Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients; citation_author=S Kelly; citation_volume=74; citation_publication_date=2015; citation_pages=611-617; citation_doi=10.1136/annrheumdis-2013-204603; citation_id=CR42">
    <meta name="citation_reference" content="citation_journal_title=Rheumatology (Oxford); citation_title=High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease; citation_author=S Bugatti; citation_volume=53; citation_publication_date=2014; citation_pages=1886-1895; citation_doi=10.1093/rheumatology/keu163; citation_id=CR43">
    <meta name="citation_reference" content="citation_journal_title=Arthritis Rheumatol.; citation_title=B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure; citation_author=F Rivellese; citation_volume=72; citation_publication_date=2020; citation_pages=714-725; citation_doi=10.1002/art.41184; citation_id=CR44">
    <meta name="citation_reference" content="citation_journal_title=Histopathology; citation_title=Synovitis score: discrimination between chronic low-grade and high-grade synovitis; citation_author=V Krenn; citation_volume=49; citation_publication_date=2006; citation_pages=358-364; citation_doi=10.1111/j.1365-2559.2006.02508.x; citation_id=CR45">
    <meta name="citation_reference" content="citation_journal_title=Nat. Methods; citation_title=Salmon provides fast and bias-aware quantification of transcript expression; citation_author=R Patro, G Duggal, MI Love, RA Irizarry, C Kingsford; citation_volume=14; citation_publication_date=2017; citation_pages=417-419; citation_doi=10.1038/nmeth.4197; citation_id=CR46">
    <meta name="citation_reference" content="citation_journal_title=Genome Biol.; citation_title=Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2; citation_author=MI Love, W Huber, S Anders; citation_volume=15; citation_publication_date=2014; citation_doi=10.1186/s13059-014-0550-8; citation_id=CR47">
    <meta name="citation_reference" content="citation_journal_title=Genome Biol.; citation_title=voom: Precision weights unlock linear model analysis tools for RNA-seq read counts; citation_author=CW Law, Y Chen, W Shi, GK Smyth; citation_volume=15; citation_publication_date=2014; citation_doi=10.1186/gb-2014-15-2-r29; citation_id=CR48">
    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=B cells and tertiary lymphoid structures promote immunotherapy response; citation_author=BA Helmink; citation_volume=577; citation_publication_date=2020; citation_pages=549-555; citation_doi=10.1038/s41586-019-1922-8; citation_id=CR49">
    <meta name="citation_reference" content="citation_journal_title=Brief. Bioinform.; citation_title=An approach for normalization and quality control for NanoString RNA expression data; citation_author=A Bhattacharya; citation_volume=22; citation_publication_date=2021; citation_pages=bbaa163; citation_doi=10.1093/bib/bbaa163; citation_id=CR50">
    <meta name="citation_author" content="Rivellese, Felice">
    <meta name="citation_author_institution" content="Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author_institution" content="Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author" content="Surace, Anna E. A.">
    <meta name="citation_author_institution" content="Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author_institution" content="Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author" content="Goldmann, Katriona">
    <meta name="citation_author_institution" content="Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author_institution" content="Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author" content="Sciacca, Elisabetta">
    <meta name="citation_author_institution" content="Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author_institution" content="Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author" content="Çubuk, Cankut">
    <meta name="citation_author_institution" content="Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author_institution" content="Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author" content="Giorli, Giovanni">
    <meta name="citation_author_institution" content="Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author_institution" content="Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author" content="John, Christopher R.">
    <meta name="citation_author_institution" content="Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author_institution" content="Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author" content="Nerviani, Alessandra">
    <meta name="citation_author_institution" content="Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author" content="Fossati-Jimack, Liliane">
    <meta name="citation_author_institution" content="Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author" content="Thorborn, Georgina">
    <meta name="citation_author_institution" content="Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author" content="Ahmed, Manzoor">
    <meta name="citation_author_institution" content="Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author" content="Prediletto, Edoardo">
    <meta name="citation_author_institution" content="Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author" content="Church, Sarah E.">
    <meta name="citation_author_institution" content="NanoString Technologies Inc., Seattle, USA">
    <meta name="citation_author" content="Hudson, Briana M.">
    <meta name="citation_author_institution" content="NanoString Technologies Inc., Seattle, USA">
    <meta name="citation_author" content="Warren, Sarah E.">
    <meta name="citation_author_institution" content="NanoString Technologies Inc., Seattle, USA">
    <meta name="citation_author" content="McKeigue, Paul M.">
    <meta name="citation_author_institution" content="Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK">
    <meta name="citation_author" content="Humby, Frances">
    <meta name="citation_author_institution" content="Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author" content="Bombardieri, Michele">
    <meta name="citation_author_institution" content="Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author" content="Barnes, Michael R.">
    <meta name="citation_author_institution" content="Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author" content="Lewis, Myles J.">
    <meta name="citation_author_institution" content="Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author_institution" content="Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="citation_author" content="Pitzalis, Costantino">
    <meta name="citation_author_institution" content="Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK">
    <meta name="access_endpoint" content="https://www.nature.com/platform/readcube-access">
    <meta name="twitter:site" content="@naturemedicine">
    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:image:alt" content="Content cover image">
    <meta name="twitter:title" content="Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial">
    <meta name="twitter:description" content="Nature Medicine - Biomarker analysis of the phase 4 R4RA trial identifies pretreatment synovial biopsy features selectively associated with response to rituximab or tocilizumab, and leads to the...">
    <meta name="twitter:image" content="https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig1_HTML.png">
    

    
    
    <meta property="og:url" content="https://www.nature.com/articles/s41591-022-01789-0">
    <meta property="og:type" content="article">
    <meta property="og:site_name" content="Nature">
    <meta property="og:title" content="Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial - Nature Medicine">
    <meta property="og:description" content="Biomarker analysis of the phase 4 R4RA trial identifies pretreatment synovial biopsy features selectively associated with response to rituximab or tocilizumab, and leads to the development of models that might predict treatment benefit in patients with rheumatoid arthritis">
    <meta property="og:image" content="https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig1_HTML.png">
    

    <script>
        window.eligibleForRa21 = 'false'; 
    </script>
<style type="text/css">.cc-banner{background-color:#01324b;border:none!important;bottom:0;box-sizing:border-box;color:#fff!important;left:0;line-height:1.3;margin:auto 0 0;max-width:100%;outline:0;overflow:visible;padding:0;position:fixed;right:0;width:100%;z-index:99999}.cc-banner::backdrop{background-color:#0000004d}.cc-banner *{color:inherit!important}.cc-banner:focus{box-shadow:none;outline:0}.cc-banner a{color:#fff!important;text-decoration:underline}.cc-banner a:active,.cc-banner a:focus,.cc-banner a:hover{color:inherit;text-decoration:none}.cc-banner a:focus{outline:3px solid #08c!important}.cc-banner h2,.cc-banner h3,.cc-banner h4,.cc-banner h5,.cc-banner h6{font-family:sans-serif;font-style:normal;font-weight:700;margin:0 0 .5em}.cc-banner .cc-h2,.cc-banner h2{font-size:18px}.cc-banner .cc-h3,.cc-banner h3{font-size:16px}.cc-banner .cc-h4,.cc-banner .cc-h5,.cc-banner .cc-h6,.cc-banner h4,.cc-banner h5,.cc-banner h6{font-size:14px}.cc-banner .cc-button{font-size:16px}.cc-banner__content{background-color:#01324b;display:flex;flex-direction:column;margin:0 auto;max-height:90vh;max-width:100%;padding:16px;position:relative}.cc-banner__content:focus{outline:0}@media (min-width:680px){.cc-banner__content{padding:12px}}@media (min-width:980px){.cc-banner__content{max-height:60vh;padding-bottom:20px;padding-top:20px}}@media (min-width:1320px){.cc-banner__content{padding-bottom:40px;padding-top:40px}}.cc-banner__container{display:flex;flex-direction:column;margin:auto;max-width:1320px;overflow:auto}.cc-banner__title{background:none!important;border:0;flex-shrink:0;font-size:18px!important;font-size:22px!important;font-weight:700!important;letter-spacing:normal;margin:0 0 12px!important;padding:0}@media (min-width:680px){.cc-banner__title{font-size:24px!important;margin:0 0 16px!important}}@media (min-width:1320px){.cc-banner__title{font-size:26px!important;margin:0 0 24px!important}}.cc-banner__body{display:flex;flex-direction:column;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif!important;overflow-x:hidden;overflow-y:auto;padding:3px 3px 16px}@media (min-width:980px){.cc-banner__body{flex-direction:row}}.cc-banner__policy p{font-size:16px!important;margin:0;max-width:none;padding:0}.cc-banner__policy p:not(:last-child){margin:0 0 16px}@media (min-width:980px){.cc-banner__policy p:not(:last-child){margin:0 0 24px}}.cc-banner__policy p a{font-size:16px!important;font-weight:700}.cc-banner__footer{box-shadow:none;flex-shrink:0;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif !important!important;margin:0;padding:12px 0 3px 3px;position:relative}@media (min-width:380px){.cc-banner__footer{align-items:stretch;display:flex;flex-wrap:wrap}}@media (min-width:680px){.cc-banner__footer{box-shadow:none;flex-wrap:nowrap;width:40%}}.cc-banner__footer .cc-banner__button{flex:1 1 auto;font-weight:700;overflow:hidden;padding:.5em 1em;width:100%}@media (min-width:680px){.cc-banner__footer .cc-banner__button{max-width:275px}}.cc-banner__footer .cc-banner__button:not(:last-child){margin-bottom:12px}@media (min-width:680px){.cc-banner__footer .cc-banner__button:not(:last-child){margin-bottom:0;margin-right:16px}}@media (min-width:980px){.cc-banner__footer .cc-banner__button:not(:last-child){margin-right:24px}}@media (min-width:680px){html[dir=rtl] .cc-banner__footer .cc-banner__button:not(:last-child){margin-left:16px!important;margin-right:0!important}}@media (min-width:980px){html[dir=rtl] .cc-banner__footer .cc-banner__button:not(:last-child){margin-left:24px!important;margin-right:0!important}}.cc-banner__button-preferences{padding-left:0;padding-right:0}@media (min-width:380px){.cc-banner__button-preferences{flex:0 0 auto;margin:auto}}@media (min-width:680px){.cc-banner__button-preferences{margin:0}}@media (min-width:380px) and (max-width:680px){.cc-banner__button-break{display:block}}@media (min-width:680px){.cc-banner--is-tcf .cc-banner__footer{width:auto}}@media (min-width:980px){.cc-banner--is-tcf .cc-banner__footer{padding-right:48px;width:66%}}.cc-banner--is-tcf .cc-banner__stacks-intro{font-size:16px!important}.cc-banner--is-tcf .cc-banner__stacks{margin:16px 0 0}@media (min-width:980px){.cc-banner--is-tcf .cc-banner__stacks{display:flex;flex:0 0 33%;flex-direction:column;margin:0 0 0 48px;overflow:auto}}.cc-banner--is-tcf .cc-banner__stacks-intro{font-size:16px;margin:0 0 12px}.cc-banner--is-tcf .cc-banner__stacks-details{padding:0 3px}.cc-banner--is-tcf .cc-banner .cc-details{border-color:#fff3!important}.cc-box{border-radius:10px;padding:12px}.cc-box--info{background-color:#eff6fb}.cc-box--light{background-color:#faf9f6}.cc-button{border:2px solid #0000;border-radius:32px!important;color:inherit;cursor:pointer;font-size:14px;font-weight:700!important;left:auto;line-height:1.2;margin:0;padding:.5em 1em;right:auto;text-transform:none!important;transition:all .2s}@media (min-width:680px){.cc-button{font-size:14px;padding:.75em 1em}}.cc-button--sm{font-size:12px;padding:2px 8px!important}.cc-button--primary{background-color:#025e8d!important;border-color:#025e8d!important;color:#fff!important}.cc-button--primary:focus{outline:3px solid #08c}.cc-button--primary:focus,.cc-button--primary:hover,.cc-button--secondary{background-color:#fff!important;border-color:#025e8d!important;color:#025e8d!important}.cc-button--secondary:focus{background-color:#025e8d!important;border-color:#fff!important;color:#fff!important;outline:3px solid #08c!important}.cc-button--secondary:hover{background-color:#025e8d!important;border-color:#025e8d!important;color:#fff!important}.cc-button--secondary:active{border:2px solid #01324b!important}.cc-button--secondary.cc-button--contrast{border-color:#fff!important}.cc-button--secondary.cc-button--contrast:hover{background-color:initial!important;color:#fff!important}.cc-button--tertiary{background-color:#f0f7fc!important;background-image:none;border:2px solid #f0f7fc;color:#025e8d!important;text-decoration:underline!important;text-underline-offset:.25em}.cc-button--tertiary:focus{outline:3px solid #08c!important}.cc-button--tertiary:hover{text-decoration-thickness:.25em}.cc-button--tertiary:active{color:#013c5b}.cc-button--link{background-color:initial!important;border-color:#0000!important;border-radius:0!important;color:inherit!important;padding:0!important;text-decoration:underline!important;width:inherit!important}.cc-button--link:focus{outline:3px solid #08c}.cc-button--link:hover{background-color:initial!important;box-shadow:none;text-decoration:none}.cc-button--text{border-radius:0;padding:0}.cc-button--details{padding-right:24px!important;position:relative;width:auto}.cc-button--details:after,.cc-button--details:before{background-color:currentColor;content:"";position:absolute;transition:transform .25s ease-out}.cc-button--details:before{height:10px;margin-top:-5px;right:12px;top:50%;width:2px}.cc-button--details:after{height:2px;margin-top:-1px;right:8px;top:50%;width:10px}.cc-button--details.cc-active:before{transform:rotate(90deg);transform-origin:center}.cc-button--details.cc-active:after{display:none}.cc-details{border-bottom:1px solid #0000001a;padding:12px 0;position:relative;width:100%}.cc-details__summary{align-items:center;display:flex;font-size:14px;font-weight:700;list-style-type:none}.cc-details__summary:focus,.cc-details__summary:focus-visible{outline:3px solid #08c!important;will-change:auto}.cc-details__title{align-items:baseline;display:flex}.cc-details__title h2,.cc-details__title h3,.cc-details__title h4,.cc-details__title h5{line-height:1.4;margin:0!important;padding:0!important}.cc-details__title svg{flex-shrink:0;height:auto;margin-right:8px;position:relative;top:-1px;transition:all .2s;width:auto}.cc-details[open] .cc-details__title svg{top:2px;transform:rotate(90deg)}.cc-details__switch{margin-left:auto}.cc-details__section{padding:16px 0 0 18px}.cc-details__section p{margin:0}.cc-details__section p:not(:last-child){margin-bottom:12px}details summary::-webkit-details-marker{display:none}.cc-radio{align-items:center;display:flex;position:relative}.cc-radio *{cursor:pointer}.cc-radio__input{height:22px;left:0;position:absolute;top:0;width:22px}.cc-radio__input:focus{outline:none}.cc-radio__label{color:inherit;font-size:14px;font-weight:700;line-height:23px;margin:0;padding-left:28px}.cc-radio__label:after,.cc-radio__label:before{background-color:#fff;content:"";display:block;position:absolute;transition:transform .25s ease-out}.cc-radio__label:before{border:1px solid #777;border-radius:50%;height:22px;left:0;top:0;width:22px}.cc-radio__label:after{border:7px solid #025e8d;border-radius:50%;height:0;left:4px;opacity:0;top:4px;width:0}.cc-radio__input:focus+.cc-radio__label:before{box-shadow:0 0 0 2px #08c;outline:none}.cc-radio__label--hidden{display:none}.cc-radio__input:checked+.cc-radio__label:after{opacity:1}.cc-radio__input:disabled{cursor:default}.cc-radio__input:disabled+.cc-radio__label{cursor:default;opacity:.5}.cc-switch *{cursor:pointer}.cc-switch{align-items:center;display:flex;line-height:1}.cc-switch__label{cursor:pointer;display:inline-block;font-size:14px;font-weight:700;margin:0;-webkit-user-select:none;user-select:none}.cc-switch__input[type=checkbox]{-webkit-appearance:none;appearance:none;background-color:#fff!important;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='rgba(0, 0, 0, 0.25)'/%3E%3C/svg%3E")!important;background-position:0!important;background-repeat:no-repeat!important;border:1px solid #777!important;border-radius:16px!important;height:18px!important;margin:0 8px 0 0!important;transition:background-position .2s ease-in-out!important;width:32px!important}.cc-switch__input[type=checkbox]:focus{background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='%2380b3cc'/%3E%3C/svg%3E")!important}.cc-switch__input[type=checkbox]:checked{background-color:#025e8d!important;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='%23fff'/%3E%3C/svg%3E")!important;background-position:100%!important}.cc-switch__input[type=checkbox]:checked~.cc-switch__label>.cc-switch__text-off,.cc-switch__input[type=checkbox]:not(:checked)~.cc-switch__label>.cc-switch__text-on{display:none}.cc-switch__input[type=checkbox]:hover{cursor:pointer;outline:none}.cc-switch__input[type=checkbox]:focus-visible{cursor:pointer;outline:3px solid #fc0}.cc-switch__input[type=checkbox]:checked:before{background-color:none!important;color:#0000!important}html[dir=rtl] .cc-switch__input[type=checkbox]{margin-left:8px!important;margin-right:0!important}.cc-list>ul,ul.cc-list{list-style-type:disc;margin-left:0;padding-left:0}.cc-list>ul>li,ul.cc-list>li{margin-left:1em}.cc-list>ul>li:not(:last-child),ul.cc-list>li:not(:last-child){margin-bottom:4px}.cc-list__title{margin-bottom:8px!important}.cc-list--inline>ul,ul.cc-list--inline{display:flex;flex-wrap:wrap;list-style-type:none}.cc-list--inline>ul>li,ul.cc-list--inline>li{margin:0 .5em .5em 0}.cc-overlay{background-color:#0000004d;z-index:99998}.cc-overlay,.cc-preferences{bottom:0;left:0;position:fixed;right:0;top:0}.cc-preferences{background-color:#050a14f2!important;border:0;box-sizing:border-box;color:#111;font-family:sans-serif!important;line-height:1.4;margin:auto;max-height:100vh;overflow:auto;padding:0;z-index:100000}.cc-preferences:focus{outline:none}.cc-preferences *,.cc-preferences :after,.cc-preferences :before{box-sizing:inherit!important}.cc-preferences h2,.cc-preferences h3,.cc-preferences h4,.cc-preferences h5,.cc-preferences h6{font-family:sans-serif;font-style:normal;font-weight:700;margin:0 0 .5em}.cc-preferences .cc-h2,.cc-preferences h2{font-size:18px}.cc-preferences .cc-h3,.cc-preferences h3{font-size:16px}.cc-preferences .cc-h4,.cc-preferences .cc-h5,.cc-preferences .cc-h6,.cc-preferences h4,.cc-preferences h5,.cc-preferences h6{font-size:14px}.cc-preferences a{color:#025e8d;text-decoration:underline}.cc-preferences a:hover{color:inherit;text-decoration:none}.cc-preferences h3{background:none;color:#111;padding:0;text-transform:none}dialog.cc-preferences{background-color:initial}dialog.cc-preferences::backdrop{background-color:#000000e6}.cc-preferences__dialog{display:flex;flex-direction:column;margin:auto;max-height:100vh;max-width:860px;padding:12px;position:relative}.cc-preferences__dialog>:last-child{border-bottom-left-radius:10px;border-bottom-right-radius:10px}@media (min-width:980px){.cc-preferences__dialog{padding:16px}}.cc-preferences__close{background:#0000!important;border:1px solid #ececec;border-radius:50%;color:#111!important;cursor:pointer;font-family:Times New Roman,serif;font-size:40px;height:40px;left:auto;line-height:1;margin-top:-20px;padding:0!important;position:absolute;right:20px;top:50%;width:40px}.cc-preferences__close:focus{outline:3px solid #08c}.cc-preferences__close-label{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.cc-preferences__header{background:#fff!important;border-bottom:1px solid #0000001a;border-top-left-radius:10px;border-top-right-radius:10px;padding:16px;position:relative;text-align:center}.cc-preferences__title{background:none!important;color:#111!important;font-family:sans-serif!important;font-size:18px!important;font-weight:700!important;margin:0!important;padding:0 16px 0 0!important}@media (min-width:480px){.cc-preferences__title{padding-right:0!important}}@media (min-width:980px){.cc-preferences__title{font-size:22px!important}}.cc-preferences__body{background:#fff!important;flex:1 1 auto;min-height:200px;overflow-x:hidden;overflow-y:auto;padding:16px}.cc-preferences__footer{background:#fff!important;border-top:1px solid #d0d0d0;box-shadow:0 0 5px 0 #0003;margin-bottom:0;padding:12px;position:relative}@media (min-width:480px){.cc-preferences__footer{align-items:stretch;display:flex}}.cc-preferences__footer>.cc-button{display:block;width:100%}@media (min-width:480px){.cc-preferences__footer>.cc-button{flex:1 1 auto}}@media (min-width:980px){.cc-preferences__footer>.cc-button{flex-basis:auto}}@media (min-width:480px){.cc-preferences__footer>.cc-button:not(:first-child){margin-left:12px}}.cc-preferences__footer>.cc-button:not(:last-child){margin-bottom:8px}@media (min-width:480px){.cc-preferences__footer>.cc-button:not(:last-child){margin-bottom:0}}.cc-preferences__categories{list-style:none;margin:0;padding:0}.cc-preferences__category:not(:last-child){border-bottom:1px solid #0000001a;margin-bottom:12px;padding-bottom:12px}.cc-preferences__category-description{font-size:14px;margin:0 0 8px;padding:0}.cc-preferences__category-footer{align-items:center;display:flex;justify-content:space-between}.cc-preferences__status{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.cc-preferences__controls{display:flex;margin:0}.cc-preferences__controls>:not(:last-child){margin-right:12px}.cc-preferences__always-on{font-size:14px;font-weight:700;padding-left:26px;position:relative}.cc-preferences__always-on:before{background:#0000!important;border:solid;border-top-color:#0000;border-width:0 0 4px 4px;content:"";display:block;height:10px;left:0;position:absolute;top:2px;transform:rotate(-45deg);width:18px}.cc-preferences__details{background-color:#eff6fb!important;border-radius:10px;font-size:14px;margin:12px 0 0;padding:12px}.cc-preferences__cookie-list,.cc-preferences__provider-list{list-style:none;margin:0;padding:0}.cc-preferences__provider-list{columns:170px}.cc-preferences__cookie-title{font-size:1em;font-style:normal;font-weight:400;margin:0}.cc-preferences__cookie-description{font-size:1em;margin:0 0 8px}.cc-preferences__cookie-domain,.cc-preferences__cookie-lifespan{border-left:1px solid #999;color:#666;margin-left:8px;padding-left:4px}body.cc-has-preferences-open{overflow:hidden;position:relative}.cc-table{border-collapse:collapse;width:100%}.cc-table tbody tr{border-top:1px solid #0000001a}.cc-table td,.cc-table th{font-size:14px;padding:4px 8px;vertical-align:top}.cc-table+.cc-table{margin-top:8px}.cc-table--purposes td:first-child,.cc-table--purposes th:first-child{width:70%}@media (min-width:680px){.cc-table--purposes td:first-child,.cc-table--purposes th:first-child{width:80%}}.cc-table--purposes td:last-child,.cc-table--purposes th:last-child{padding-left:8px;width:40%}@media (min-width:680px){.cc-table--purposes td:last-child,.cc-table--purposes th:last-child{width:30%}}.cc-tabs,.cc-tabs>ul{background-color:#faf9f6;display:flex;list-style:none;margin:0;padding:0}.cc-tabs__panel{border-top:1px solid #ececec;margin-top:-1px}.cc-tabs__button{background-color:initial;border:0;border-left:1px solid #0000;border-right:1px solid #0000;color:#111;font-size:16px;font-weight:700;margin:0;padding:15px 16px 12px;position:relative}.cc-tabs__button:before{background-color:initial;content:"";display:block;height:3px;left:0;position:absolute;top:0;width:100%}.cc-tabs__button.cc-active{background-color:#fff;border-color:#025e8d #ececec #ececec;color:#111}.cc-tabs__button.cc-active:before{background-color:#025e8d}.cc-tabs__content{background-color:#fff;display:none;font-size:14px;padding:16px}.cc-tabs__section:not(:first-child){padding-top:24px}.cc-tcf{font-size:14px;margin-top:16px}.cc-tcf__list{list-style:none;margin:0;padding:0}.cc-vendor-count{color:#666;font-size:16px;margin:0 0 8px}.cc-hide{display:none!important}.cc-show{display:block!important}.cc-external-link{background-color:#ececec;background-image:url("data:image/svg+xml;base64,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");background-position:right 8px center;background-repeat:no-repeat;background-size:10px auto;border-radius:3px;box-shadow:0 1px 0 #0003;color:#111!important;display:inline-block;font-size:12px;padding:4px 26px 4px 8px;text-decoration:none!important}.cc-external-link:hover{text-decoration:underline!important}.cc-m-0{margin:0!important}.cc-grey{color:#666}</style><script async="" type="text/javascript" src="https://injections.readcube.com/nature/inject.fa744f3f.js"></script><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 2px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 2px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: 1em}
.MathJax_MenuRadioCheck.RTL {right: 1em; left: auto}
.MathJax_MenuLabel {padding: 2px 2em 4px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #CCCCCC; margin: 4px 1px 0px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: Highlight; color: HighlightText}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style><style type="text/css">.MJX_Assistive_MathML {position: absolute!important; top: 0; left: 0; clip: rect(1px, 1px, 1px, 1px); padding: 1px 0 0 0!important; border: 0!important; height: 1px!important; width: 1px!important; overflow: hidden!important; display: block!important; -webkit-touch-callout: none; -webkit-user-select: none; -khtml-user-select: none; -moz-user-select: none; -ms-user-select: none; user-select: none}
.MJX_Assistive_MathML.MJX_Assistive_MathML_Block {width: 100%!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MJXp-script {font-size: .8em}
.MJXp-right {-webkit-transform-origin: right; -moz-transform-origin: right; -ms-transform-origin: right; -o-transform-origin: right; transform-origin: right}
.MJXp-bold {font-weight: bold}
.MJXp-italic {font-style: italic}
.MJXp-scr {font-family: MathJax_Script,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-frak {font-family: MathJax_Fraktur,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-sf {font-family: MathJax_SansSerif,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-cal {font-family: MathJax_Caligraphic,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-mono {font-family: MathJax_Typewriter,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-largeop {font-size: 150%}
.MJXp-largeop.MJXp-int {vertical-align: -.2em}
.MJXp-math {display: inline-block; line-height: 1.2; text-indent: 0; font-family: 'Times New Roman',Times,STIXGeneral,serif; white-space: nowrap; border-collapse: collapse}
.MJXp-display {display: block; text-align: center; margin: 1em 0}
.MJXp-math span {display: inline-block}
.MJXp-box {display: block!important; text-align: center}
.MJXp-box:after {content: " "}
.MJXp-rule {display: block!important; margin-top: .1em}
.MJXp-char {display: block!important}
.MJXp-mo {margin: 0 .15em}
.MJXp-mfrac {margin: 0 .125em; vertical-align: .25em}
.MJXp-denom {display: inline-table!important; width: 100%}
.MJXp-denom > * {display: table-row!important}
.MJXp-surd {vertical-align: top}
.MJXp-surd > * {display: block!important}
.MJXp-script-box > *  {display: table!important; height: 50%}
.MJXp-script-box > * > * {display: table-cell!important; vertical-align: top}
.MJXp-script-box > *:last-child > * {vertical-align: bottom}
.MJXp-script-box > * > * > * {display: block!important}
.MJXp-mphantom {visibility: hidden}
.MJXp-munderover, .MJXp-munder {display: inline-table!important}
.MJXp-over {display: inline-block!important; text-align: center}
.MJXp-over > * {display: block!important}
.MJXp-munderover > *, .MJXp-munder > * {display: table-row!important}
.MJXp-mtable {vertical-align: .25em; margin: 0 .125em}
.MJXp-mtable > * {display: inline-table!important; vertical-align: middle}
.MJXp-mtr {display: table-row!important}
.MJXp-mtd {display: table-cell!important; text-align: center; padding: .5em 0 0 .5em}
.MJXp-mtr > .MJXp-mtd:first-child {padding-left: 0}
.MJXp-mtr:first-child > .MJXp-mtd {padding-top: 0}
.MJXp-mlabeledtr {display: table-row!important}
.MJXp-mlabeledtr > .MJXp-mtd:first-child {padding-left: 0}
.MJXp-mlabeledtr:first-child > .MJXp-mtd {padding-top: 0}
.MJXp-merror {background-color: #FFFF88; color: #CC0000; border: 1px solid #CC0000; padding: 1px 3px; font-style: normal; font-size: 90%}
.MJXp-scale0 {-webkit-transform: scaleX(.0); -moz-transform: scaleX(.0); -ms-transform: scaleX(.0); -o-transform: scaleX(.0); transform: scaleX(.0)}
.MJXp-scale1 {-webkit-transform: scaleX(.1); -moz-transform: scaleX(.1); -ms-transform: scaleX(.1); -o-transform: scaleX(.1); transform: scaleX(.1)}
.MJXp-scale2 {-webkit-transform: scaleX(.2); -moz-transform: scaleX(.2); -ms-transform: scaleX(.2); -o-transform: scaleX(.2); transform: scaleX(.2)}
.MJXp-scale3 {-webkit-transform: scaleX(.3); -moz-transform: scaleX(.3); -ms-transform: scaleX(.3); -o-transform: scaleX(.3); transform: scaleX(.3)}
.MJXp-scale4 {-webkit-transform: scaleX(.4); -moz-transform: scaleX(.4); -ms-transform: scaleX(.4); -o-transform: scaleX(.4); transform: scaleX(.4)}
.MJXp-scale5 {-webkit-transform: scaleX(.5); -moz-transform: scaleX(.5); -ms-transform: scaleX(.5); -o-transform: scaleX(.5); transform: scaleX(.5)}
.MJXp-scale6 {-webkit-transform: scaleX(.6); -moz-transform: scaleX(.6); -ms-transform: scaleX(.6); -o-transform: scaleX(.6); transform: scaleX(.6)}
.MJXp-scale7 {-webkit-transform: scaleX(.7); -moz-transform: scaleX(.7); -ms-transform: scaleX(.7); -o-transform: scaleX(.7); transform: scaleX(.7)}
.MJXp-scale8 {-webkit-transform: scaleX(.8); -moz-transform: scaleX(.8); -ms-transform: scaleX(.8); -o-transform: scaleX(.8); transform: scaleX(.8)}
.MJXp-scale9 {-webkit-transform: scaleX(.9); -moz-transform: scaleX(.9); -ms-transform: scaleX(.9); -o-transform: scaleX(.9); transform: scaleX(.9)}
.MathJax_PHTML .noError {vertical-align: ; font-size: 90%; text-align: left; color: black; padding: 1px 3px; border: 1px solid}
</style></head>
<body class="article-page"><div id="MathJax_Message" style="display: none;"></div><dialog class="cc-banner" data-cc-banner="" data-nosnippet="" aria-labelledby="cc-banner-label" open="">
		<div class="cc-banner__content" autofocus="" tabindex="-1">
			<div class="cc-banner__container">
				<div class="cc-banner__header">
					<h2 class="cc-banner__title" id="cc-banner-label">Your privacy, your choice</h2>
				</div>
				<div class="cc-banner__body">
					<div class="cc-banner__policy">
						<p>We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.</p><p>By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.</p><p>See our <a href="https://www.nature.com/info/privacy" data-cc-action="privacy">privacy policy</a> for more information on the use of your personal data.</p><p><button type="button" data-cc-action="preferences" class="cc-button cc-button--link cc-button--text">Manage preferences</button> for further information and to change your choices.</p>
					</div>
					
				</div>
				<div class="cc-banner__footer">
					
			<button data-cc-action="accept" class="cc-button cc-button--secondary cc-button--contrast cc-banner__button cc-banner__button-accept">Accept all cookies</button>
			
		
				</div>
			</div>
		</div>
	</dialog>

<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MRVXSHQ"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>



<div class="position-relative cleared z-index-50 background-white" data-test="top-containers">
    <a class="c-skip-link" href="#content">Skip to main content</a>



<div class="c-grade-c-banner u-hide">
    <div class="c-grade-c-banner__container">
        
        <p>Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
            the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
            Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
            and JavaScript.</p>

    </div>
</div>

    

    

    
    
        <div class="u-hide u-show-following-ad"></div>

    <aside class="c-ad c-ad--728x90" style="display: none !important;">
        <div class="c-ad__inner" data-container-type="banner-advert">
            <p class="c-ad__label">Advertisement</p>
            
        
            
    <div id="div-gpt-ad-top-1" class="div-gpt-ad advert leaderboard js-ad text-center hide-print grade-c-hide" data-ad-type="top" data-test="top-ad" data-pa11y-ignore="" data-gpt="" data-gpt-unitpath="/285/medicine.nature.com/article" data-gpt-sizes="728x90" data-gpt-targeting="type=article;pos=top;artid=s41591-022-01789-0;doi=10.1038/s41591-022-01789-0;subjmeta=114,1305,1670,2413,2423,2779,308,498,53,631,692,699,777;kwrd=Machine+learning,Predictive+markers,Predictive+medicine,Randomized+controlled+trials,Rheumatoid+arthritis">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/medicine.nature.com/article&amp;sz=728x90&amp;c=-134584925&amp;t=pos%3Dtop%26type%3Darticle%26artid%3Ds41591-022-01789-0%26doi%3D10.1038/s41591-022-01789-0%26subjmeta%3D114,1305,1670,2413,2423,2779,308,498,53,631,692,699,777%26kwrd%3DMachine+learning,Predictive+markers,Predictive+medicine,Randomized+controlled+trials,Rheumatoid+arthritis">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/medicine.nature.com/article&amp;sz=728x90&amp;c=-134584925&amp;t=pos%3Dtop%26type%3Darticle%26artid%3Ds41591-022-01789-0%26doi%3D10.1038/s41591-022-01789-0%26subjmeta%3D114,1305,1670,2413,2423,2779,308,498,53,631,692,699,777%26kwrd%3DMachine+learning,Predictive+markers,Predictive+medicine,Randomized+controlled+trials,Rheumatoid+arthritis"
                     alt="Advertisement"
                     width="728"
                     height="90"></a>
        </noscript>
    </div>

        
    
        </div>
    </aside>


    <header class="c-header" id="header" data-header="" data-track-component="nature-150-split-header" style="border-color:#e40428">
        <div class="c-header__row">
            <div class="c-header__container">
                <div class="c-header__split">
                    
                    
                    <div class="c-header__logo-container">
                        
                        <a href="/nm" data-track="click" data-track-action="home" data-track-label="image">
                            <picture class="c-header__logo">
                                <source srcset="https://media.springernature.com/full/nature-cms/uploads/product/nm/header-95e59e63930e5d6009bad2c23a42ab2d.svg" media="(min-width: 875px)">
                                <img src="https://media.springernature.com/full/nature-cms/uploads/product/nm/header-95e59e63930e5d6009bad2c23a42ab2d.svg" height="32" alt="Nature Medicine">
                            </picture>
                        </a>
                    
                    </div>
                    
                    <ul class="c-header__menu c-header__menu--global">
                        <li class="c-header__item c-header__item--padding c-header__item--hide-md-max">
                            <a class="c-header__link" href="https://www.nature.com/siteindex" data-test="siteindex-link" data-track="click" data-track-action="open nature research index" data-track-label="link">
                                <span>View all journals</span>
                            </a>
                        </li>
                        <li class="c-header__item c-header__item--padding c-header__item--pipe">
                            <a class="c-header__link c-header__link--search" href="javascript:;" data-header-expander="" data-test="search-link" data-track="click" data-track-action="open search tray" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                <svg role="img" aria-hidden="true" focusable="false" height="22" width="22" viewBox="0 0 18 18" xmlns="http://www.w3.org/2000/svg"><path d="M16.48 15.455c.283.282.29.749.007 1.032a.738.738 0 01-1.032-.007l-3.045-3.044a7 7 0 111.026-1.026zM8 14A6 6 0 108 2a6 6 0 000 12z"></path></svg><span>Search</span>
                            </a><div id="search-menu" class="c-header__dropdown c-header__dropdown--full-width has-tethered u-js-hide" data-track-component="nature-150-split-header" hidden="">
    <div class="c-header__container">
        <h2 class="c-header__visually-hidden">Search</h2>
        <form class="c-header__search-form" action="/search" method="get" role="search" autocomplete="off" data-test="inline-search">
            <label class="c-header__heading" for="keywords">Search articles by subject, keyword or author</label>
            <div class="c-header__search-layout c-header__search-layout--max-width">
                <div>
                    <input type="text" required="" class="c-header__input" id="keywords" name="q" value="">
                </div>
                <div class="c-header__search-layout">
                    <div>
                        <label for="results-from" class="c-header__visually-hidden">Show results from</label>
                        <select id="results-from" name="journal" class="c-header__select">
                            
                                
                                    <option value="" selected="">All journals</option>
                                    <option value="nm">This journal</option>
                                
                            
                        </select>
                    </div>
                    <div>
                        <button type="submit" class="c-header__search-button">Search</button>
                    </div>
                </div>

            </div>
        </form>

        <div class="c-header__flush">
            <a class="c-header__link" href="/search/advanced" data-track="click" data-track-action="advanced search" data-track-label="link">
                Advanced search
            </a>
        </div>

        <h3 class="c-header__heading c-header__heading--keyline">Quick links</h3>
        <ul class="c-header__list">
            <li><a class="c-header__link" href="/subjects" data-track="click" data-track-action="explore articles by subject" data-track-label="link">Explore articles by subject</a></li>
            <li><a class="c-header__link" href="/naturecareers" data-track="click" data-track-action="find a job" data-track-label="link">Find a job</a></li>
            <li><a class="c-header__link" href="/authors/index.html" data-track="click" data-track-action="guide to authors" data-track-label="link">Guide to authors</a></li>
            <li><a class="c-header__link" href="/authors/editorial_policies/" data-track="click" data-track-action="editorial policies" data-track-label="link">Editorial policies</a></li>
        </ul>
    </div>
</div>
                        </li>
                        <li class="c-header__item c-header__item--padding c-header__item--snid-account-widget c-header__item--pipe">
                            
                                <a class="c-header__link eds-c-header__link" id="identity-account-widget" data-track="click_login" data-track-context="header" href="https://idp.nature.com/auth/personal/springernature?redirect_uri=https://www.nature.com/articles/s41591-022-01789-0"><span class="eds-c-header__widget-fragment-title">Log in</span></a>
                            
                        </li>
                    </ul>
                </div>
            </div>
        </div>
        
            <div class="c-header__row">
                <div class="c-header__container" data-test="navigation-row">
                    <div class="c-header__split">
                        <ul class="c-header__menu c-header__menu--journal">
                            
                                <li class="c-header__item c-header__item--dropdown-menu" data-test="explore-content-button">
                                    <a href="javascript:;" class="c-header__link" data-header-expander="" data-test="menu-button--explore" data-track="click" data-track-action="open explore expander" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                        <span><span class="c-header__show-text">Explore</span> content</span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
                                    </a><nav class="c-header__dropdown has-tethered u-js-hide" aria-labelledby="Explore-content" data-test="Explore-content" id="explore" data-track-component="nature-150-split-header" hidden="">
            <div class="c-header__container">
                <h2 id="Explore-content" class="c-header__heading c-header__heading--js-hide">Explore content</h2>
                <ul class="c-header__list c-header__list--js-stack">
                    
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/research-articles" data-track="click" data-track-action="research articles" data-track-label="link" data-test="explore-nav-item">
                                    Research articles
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/reviews-and-analysis" data-track="click" data-track-action="reviews &amp; analysis" data-track-label="link" data-test="explore-nav-item">
                                    Reviews &amp; Analysis
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/news-and-comment" data-track="click" data-track-action="news &amp; comment" data-track-label="link" data-test="explore-nav-item">
                                    News &amp; Comment
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/podcast" data-track="click" data-track-action="podcasts" data-track-label="link" data-test="explore-nav-item">
                                    Podcasts
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/current-issue" data-track="click" data-track-action="current issue" data-track-label="link" data-test="explore-nav-item">
                                    Current issue
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/collections" data-track="click" data-track-action="collections" data-track-label="link" data-test="explore-nav-item">
                                    Collections
                                </a>
                            </li>
                        
                    
                </ul>
                <ul class="c-header__list c-header__list--js-stack">
                    
                        <li class="c-header__item">
                            <a class="c-header__link" href="https://www.facebook.com/Nature-Medicine-193691346949/" data-track="click" data-track-action="facebook" data-track-label="link">Follow us on Facebook
                            </a>
                        </li>
                    
                    
                        <li class="c-header__item">
                            <a class="c-header__link" href="https://twitter.com/naturemedicine" data-track="click" data-track-action="twitter" data-track-label="link">Follow us on Twitter
                            </a>
                        </li>
                    
                    
                    
                        <li class="c-header__item c-header__item--hide-lg">
                            <a class="c-header__link" href="https://www.nature.com/my-account/alerts/subscribe-journal?list-id=5" rel="nofollow" data-track="nav_sign_up_for_alerts" data-track-action="Sign up for alerts" data-track-external="" data-track-label="link (mobile dropdown)">Sign up for alerts<svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill="#fff"></path></svg>
                            </a>
                        </li>
                    
                    
                        <li class="c-header__item c-header__item--hide-lg">
                            <a class="c-header__link" href="https://www.nature.com/nm.rss" data-track="click" data-track-action="rss feed" data-track-label="link">
                                <span>RSS feed</span>
                            </a>
                        </li>
                    
                </ul>
            </div>
        </nav>
                                </li>
                            
                            
                                <li class="c-header__item c-header__item--dropdown-menu">
                                    <a href="javascript:;" class="c-header__link" data-header-expander="" data-test="menu-button--about-the-journal" data-track="click" data-track-action="open about the journal expander" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                        <span>About <span class="c-header__show-text">the journal</span></span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
                                    </a><nav class="c-header__dropdown has-tethered u-js-hide" aria-labelledby="About-the-journal" id="about-the-journal" data-test="about-the-journal" data-track-component="nature-150-split-header" hidden="">
                <div class="c-header__container">
                    <h2 id="About-the-journal" class="c-header__heading c-header__heading--js-hide">About the journal</h2>
                    <ul class="c-header__list c-header__list--js-stack">
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/aims" data-track="click" data-track-action="aims &amp; scope" data-track-label="link">
                                    Aims &amp; Scope
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/journal-information" data-track="click" data-track-action="journal information" data-track-label="link">
                                    Journal Information
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/journal-impact" data-track="click" data-track-action="journal metrics" data-track-label="link">
                                    Journal Metrics
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/editors" data-track="click" data-track-action="about the editors" data-track-label="link">
                                    About the Editors
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/research-cross-journal-editorial-team" data-track="click" data-track-action="research cross-journal editorial team" data-track-label="link">
                                    Research Cross-Journal Editorial Team
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/reviews-cross-journal-editorial-team" data-track="click" data-track-action="reviews cross-journal editorial team" data-track-label="link">
                                    Reviews Cross-Journal Editorial Team
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/statistics-advisory-panel" data-track="click" data-track-action="statistical advisory panel" data-track-label="link">
                                    Statistical Advisory Panel
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/our-publishing-models" data-track="click" data-track-action="our publishing models" data-track-label="link">
                                    Our publishing models
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/editorial-values-statement" data-track="click" data-track-action="editorial values statement" data-track-label="link">
                                    Editorial Values Statement
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/editorial-policies" data-track="click" data-track-action="editorial policies" data-track-label="link">
                                    Editorial Policies
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/content" data-track="click" data-track-action="content types" data-track-label="link">
                                    Content Types
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/web-feeds" data-track="click" data-track-action="web feeds" data-track-label="link">
                                    Web Feeds
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/contact" data-track="click" data-track-action="contact" data-track-label="link">
                                    Contact
                                </a>
                            </li>
                        
                    </ul>
                </div>
            </nav>
                                </li>
                                
                                    <li class="c-header__item c-header__item--dropdown-menu" data-test="publish-with-us-button">
                                        <a href="javascript:;" class="c-header__link c-header__link--dropdown-menu" data-header-expander="" data-test="menu-button--publish" data-track="click" data-track-action="open publish with us expander" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                            <span>Publish <span class="c-header__show-text">with us</span></span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
                                        </a><nav class="c-header__dropdown has-tethered u-js-hide" aria-labelledby="Publish-with-us-label" id="publish-with-us" data-test="publish-with-us" data-track-component="nature-150-split-header" hidden="">
                <div class="c-header__container">
                    <h2 id="Publish-with-us-label" class="c-header__heading c-header__heading--js-hide">Publish with us</h2>
                    <ul class="c-header__list c-header__list--js-stack">
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/submission-guidelines" data-track="click" data-track-action="submission guidelines" data-track-label="link">
                                    Submission Guidelines
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/for-reviewers" data-track="click" data-track-action="for reviewers" data-track-label="link">
                                    For Reviewers
                                </a>
                            </li>
                        
                        
                            <li class="c-header__item">
                                <a class="c-header__link" data-test="nature-author-services" data-track="nav_language_services" data-track-context="header publish with us dropdown menu" data-track-action="manuscript author services" data-track-label="link manuscript author services" href="https://authorservices.springernature.com/go/sn/?utm_source=For+Authors&amp;utm_medium=Website_Nature&amp;utm_campaign=Platform+Experimentation+2022&amp;utm_id=PE2022">
                                    Language editing services
                                </a>
                            </li>
                        
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/open-access-funding" data-test="funding-eligibility-link" data-track="click_explore_funding" data-track-context="header publish with us" data-track-action="funding eligibility">Open access funding</a>
                            </li>
                        
                        
                            <li class="c-header__item c-header__item--keyline">
                                <a class="c-header__link" href="https://mts-nmed.nature.com/cgi-bin/main.plex" data-track="click_submit_manuscript" data-track-context="submit link in Nature header dropdown menu" data-track-action="submit manuscript" data-track-label="link (publish with us dropdown menu)" data-track-external="" data-gtm-criteo="submit-manuscript">Submit manuscript<svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m15 0c1.1045695 0 2 .8954305 2 2v5.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-5.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h7.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-7.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-.5442863 8.18867991 3.3545404 3.35454039c.2508994.2508994.2538696.6596433.0035959.909917-.2429543.2429542-.6561449.2462671-.9065387-.0089489l-2.2609825-2.3045251.0010427 7.2231989c0 .3569916-.2898381.6371378-.6473715.6371378-.3470771 0-.6473715-.2852563-.6473715-.6371378l-.0010428-7.2231995-2.2611222 2.3046654c-.2531661.2580415-.6562868.2592444-.9065605.0089707-.24295423-.2429542-.24865597-.6576651.0036132-.9099343l3.3546673-3.35466731c.2509089-.25090888.6612706-.25227691.9135302-.00001728zm-.9557137-3.18867991c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm-8.5-3.587-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1zm8.5 1.587c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill="#fff"></path></svg>
                                </a>
                            </li>
                        
                    </ul>
                </div>
            </nav>
                                    </li>
                                
                            
                            
                        </ul>
                        <ul class="c-header__menu c-header__menu--hide-lg-max">
                            
                                <li class="c-header__item" data-test="alert-link">
                                    <a class="c-header__link" href="https://journal-alerts.springernature.com/subscribe?journal_id=41591" rel="nofollow" data-track="nav_sign_up_for_alerts" data-track-action="Sign up for alerts" data-track-label="link (desktop site header)" data-track-external="">
                                        <span>Sign up for alerts</span><svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill="#222"></path></svg>
                                    </a>
                                </li>
                            
                            
                                <li class="c-header__item c-header__item--pipe">
                                    <a class="c-header__link" href="https://www.nature.com/nm.rss" data-track="click" data-track-action="rss feed" data-track-label="link">
                                            <span>RSS feed</span>
                                    </a>
                                </li>
                            
                        </ul>
                    </div>
                </div>
            </div>
        
    </header>


    
    
        <nav class="u-mb-16" aria-label="breadcrumbs">
            <div class="u-container">
                <ol class="c-breadcrumbs" itemscope="" itemtype="https://schema.org/BreadcrumbList">
                    <li class="c-breadcrumbs__item" id="breadcrumb0" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link" href="/" itemprop="item" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:nature"><span itemprop="name">nature</span></a><meta itemprop="position" content="1">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10" xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb1" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link" href="/nm" itemprop="item" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:nature medicine"><span itemprop="name">nature medicine</span></a><meta itemprop="position" content="2">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10" xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb2" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link" href="/nm/articles?type=article" itemprop="item" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:articles"><span itemprop="name">articles</span></a><meta itemprop="position" content="3">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10" xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb3" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem">
                                    <span itemprop="name">article</span><meta itemprop="position" content="4"></li>
                </ol>
            </div>
        </nav>
    



    

</div>


<div class="u-container u-mt-32 u-mb-32 u-clearfix" id="content" data-component="article-container" data-container-type="article">
    <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
        
            
                <div class="c-context-bar u-hide" id="js-enable-context-bar" data-test="context-bar" data-context-bar="" aria-hidden="true">
                    <div class="c-context-bar__container u-container" data-track-context="sticky banner">
                        <div class="c-context-bar__title">
                            Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
                        </div>
                        
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41591-022-01789-0.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external="" download="">
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"></use></svg>
            </a>
        </div>
    

                    </div>
                </div>
            
        
        <article lang="en">
            
                <div class="c-pdf-button__container u-mb-16 u-hide-at-lg js-context-bar-sticky-point-mobile">
                    <div class="c-pdf-container" data-track-context="article body">
                        
                            
                                
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41591-022-01789-0.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external="" download="">
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"></use></svg>
            </a>
        </div>
    

                            
                        
                    </div>
                </div>
            
            <div class="c-article-header">
                <header>
                    <ul class="c-article-identifiers" data-test="article-identifier">
                        
        <li class="c-article-identifiers__item" data-test="article-category">Article</li>
    
        <li class="c-article-identifiers__item">
            <a href="https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research" data-track="click" data-track-action="open access" data-track-label="link" class="u-color-open-access" data-test="open-access">Open access</a>
        </li>
    
    

                        <li class="c-article-identifiers__item">Published: <time datetime="2022-05-19">19 May 2022</time></li>
                    </ul>

                    <h1 class="c-article-title" data-test="article-title" data-article-title="">Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial</h1>
                    <ul class="c-article-author-list c-article-author-list--short js-no-scroll" data-test="authors-list" data-component-authors-activator="authors-list"><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Felice-Rivellese-Aff1-Aff2" data-author-popup="auth-Felice-Rivellese-Aff1-Aff2" data-author-search="Rivellese, Felice" data-track-context="researcher popup with no profile" data-track-index="1_22">Felice Rivellese</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0002-6759-7521"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0002-6759-7521</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a>,<a href="#Aff2" tabindex="-1">2</a></sup><sup class="u-js-hide">&nbsp;<a href="#na1" tabindex="-1">na1</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Anna_E__A_-Surace-Aff1-Aff2" data-author-popup="auth-Anna_E__A_-Surace-Aff1-Aff2" data-author-search="Surace, Anna E. A." data-track-context="researcher popup with no profile" data-track-index="2_22">Anna E. A. Surace</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0001-9589-3005"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0001-9589-3005</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a>,<a href="#Aff2" tabindex="-1">2</a></sup><sup class="u-js-hide">&nbsp;<a href="#na1" tabindex="-1">na1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Katriona-Goldmann-Aff1-Aff2" data-author-popup="auth-Katriona-Goldmann-Aff1-Aff2" data-author-search="Goldmann, Katriona" data-track-context="researcher popup with no profile" data-track-index="3_22">Katriona Goldmann</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a>,<a href="#Aff2" tabindex="-1">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Elisabetta-Sciacca-Aff1-Aff2" data-author-popup="auth-Elisabetta-Sciacca-Aff1-Aff2" data-author-search="Sciacca, Elisabetta" data-track-context="researcher popup with no profile" data-track-index="4_22">Elisabetta Sciacca</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0001-7525-1558"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0001-7525-1558</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a>,<a href="#Aff2" tabindex="-1">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Cankut-_ubuk-Aff1-Aff2" data-author-popup="auth-Cankut-_ubuk-Aff1-Aff2" data-author-search="Çubuk, Cankut" data-track-context="researcher popup with no profile" data-track-index="5_22">Cankut Çubuk</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0003-4646-0849"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0003-4646-0849</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a>,<a href="#Aff2" tabindex="-1">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Giovanni-Giorli-Aff1-Aff2" data-author-popup="auth-Giovanni-Giorli-Aff1-Aff2" data-author-search="Giorli, Giovanni" data-track-context="researcher popup with no profile" data-track-index="6_22">Giovanni Giorli</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a>,<a href="#Aff2" tabindex="-1">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Christopher_R_-John-Aff1-Aff2" data-author-popup="auth-Christopher_R_-John-Aff1-Aff2" data-author-search="John, Christopher R." data-track-context="researcher popup with no profile" data-track-index="7_22">Christopher R. John</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a>,<a href="#Aff2" tabindex="-1">2</a></sup><sup class="u-js-hide">&nbsp;<a href="#na2" tabindex="-1">na2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Alessandra-Nerviani-Aff1" data-author-popup="auth-Alessandra-Nerviani-Aff1" data-author-search="Nerviani, Alessandra" data-track-context="researcher popup with no profile" data-track-index="8_22">Alessandra Nerviani</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0003-4064-4014"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0003-4064-4014</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Liliane-Fossati_Jimack-Aff1" data-author-popup="auth-Liliane-Fossati_Jimack-Aff1" data-author-search="Fossati-Jimack, Liliane" data-track-context="researcher popup with no profile" data-track-index="9_22">Liliane Fossati-Jimack</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0003-3757-3999"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0003-3757-3999</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Georgina-Thorborn-Aff1" data-author-popup="auth-Georgina-Thorborn-Aff1" data-author-search="Thorborn, Georgina" data-track-context="researcher popup with no profile" data-track-index="10_22">Georgina Thorborn</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Manzoor-Ahmed-Aff1" data-author-popup="auth-Manzoor-Ahmed-Aff1" data-author-search="Ahmed, Manzoor" data-track-context="researcher popup with no profile" data-track-index="11_22">Manzoor Ahmed</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Edoardo-Prediletto-Aff1" data-author-popup="auth-Edoardo-Prediletto-Aff1" data-author-search="Prediletto, Edoardo" data-track-context="researcher popup with no profile" data-track-index="12_22">Edoardo Prediletto</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0001-6830-0614"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0001-6830-0614</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Sarah_E_-Church-Aff3" data-author-popup="auth-Sarah_E_-Church-Aff3" data-author-search="Church, Sarah E." data-track-context="researcher popup with no profile" data-track-index="13_22">Sarah E. Church</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0002-7194-4282"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0002-7194-4282</a></span><sup class="u-js-hide"><a href="#Aff3" tabindex="-1">3</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Briana_M_-Hudson-Aff3" data-author-popup="auth-Briana_M_-Hudson-Aff3" data-author-search="Hudson, Briana M." data-track-context="researcher popup with no profile" data-track-index="14_22">Briana M. Hudson</a><sup class="u-js-hide"><a href="#Aff3" tabindex="-1">3</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Sarah_E_-Warren-Aff3" data-author-popup="auth-Sarah_E_-Warren-Aff3" data-author-search="Warren, Sarah E." data-track-context="researcher popup with no profile" data-track-index="15_22">Sarah E. Warren</a><sup class="u-js-hide"><a href="#Aff3" tabindex="-1">3</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Paul_M_-McKeigue-Aff4" data-author-popup="auth-Paul_M_-McKeigue-Aff4" data-author-search="McKeigue, Paul M." data-track-context="researcher popup with no profile" data-track-index="16_22">Paul M. McKeigue</a><sup class="u-js-hide"><a href="#Aff4" tabindex="-1">4</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Frances-Humby-Aff1" data-author-popup="auth-Frances-Humby-Aff1" data-author-search="Humby, Frances" data-track-context="researcher popup with no profile" data-track-index="17_22">Frances Humby</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0003-1280-9133"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0003-1280-9133</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Michele-Bombardieri-Aff1" data-author-popup="auth-Michele-Bombardieri-Aff1" data-author-search="Bombardieri, Michele" data-track-context="researcher popup with no profile" data-track-index="18_22">Michele Bombardieri</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Michael_R_-Barnes-Aff2" data-author-popup="auth-Michael_R_-Barnes-Aff2" data-author-search="Barnes, Michael R." data-track-context="researcher popup with no profile" data-track-index="19_22">Michael R. Barnes</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0001-9097-7381"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0001-9097-7381</a></span><sup class="u-js-hide"><a href="#Aff2" tabindex="-1">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Myles_J_-Lewis-Aff1-Aff2" data-author-popup="auth-Myles_J_-Lewis-Aff1-Aff2" data-author-search="Lewis, Myles J." data-corresp-id="c1" data-track-context="researcher popup with no profile" data-track-index="20_22">Myles J. Lewis<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-mail-medium"></use></svg></a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0001-9365-5345"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0001-9365-5345</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a>,<a href="#Aff2" tabindex="-1">2</a></sup><sup class="u-js-hide">&nbsp;<a href="#na3" tabindex="-1">na3</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Costantino-Pitzalis-Aff1" data-author-popup="auth-Costantino-Pitzalis-Aff1" data-author-search="Pitzalis, Costantino" data-corresp-id="c2" data-track-context="researcher popup with no profile" data-track-index="21_22">Costantino Pitzalis<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-mail-medium"></use></svg></a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0003-1326-5051"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0003-1326-5051</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup><sup class="u-js-hide">&nbsp;<a href="#na3" tabindex="-1">na3</a></sup> &amp; </li><li class="c-article-author-list__item"><a data-test="author-name" data-author-popup="group-1" href="#group-1" data-track-context="researcher popup with no profile" data-track-index="22_22">the R4RA collaborative group</a></li></ul><button aria-expanded="false" class="c-article-author-list__button"><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-down-medium"></use></svg><span>Show authors</span></button>

                    

                    <p class="c-article-info-details" data-container-section="info">
                        
    <a data-test="journal-link" href="/nm" data-track="click" data-track-action="journal homepage" data-track-category="article body" data-track-label="link"><i data-test="journal-title">Nature Medicine</i></a>

                        <b data-test="journal-volume"><span class="u-visually-hidden">volume</span>&nbsp;28</b>,&nbsp;<span class="u-visually-hidden">pages </span>1256–1268 (<span data-test="article-publication-year">2022</span>)<a href="#citeas" class="c-article-info-details__cite-as u-hide-print" data-track="click" data-track-action="cite this article" data-track-label="link">Cite this article</a>
                    </p>
                    
        <div class="c-article-metrics-bar__wrapper u-clear-both">
            <ul class="c-article-metrics-bar u-list-reset">
                
                    <li class=" c-article-metrics-bar__item" data-test="access-count">
                        <p class="c-article-metrics-bar__count">36k <span class="c-article-metrics-bar__label">Accesses</span></p>
                    </li>
                
                
                    <li class="c-article-metrics-bar__item" data-test="citation-count">
                        <p class="c-article-metrics-bar__count">164 <span class="c-article-metrics-bar__label">Citations</span></p>
                    </li>
                
                
                    
                        <li class="c-article-metrics-bar__item" data-test="altmetric-score">
                            <p class="c-article-metrics-bar__count">157 <span class="c-article-metrics-bar__label">Altmetric</span></p>
                        </li>
                    
                
                <li class="c-article-metrics-bar__item">
                    <p class="c-article-metrics-bar__details"><a href="/articles/s41591-022-01789-0/metrics" data-track="click" data-track-action="view metrics" data-track-label="link" rel="nofollow">Metrics <span class="u-visually-hidden">details</span></a></p>
                </li>
            </ul>
        </div>
    
                    
                </header>

                
    

                
    
    

    
    

                
            </div>

        <div class="c-article-body">
            <section aria-labelledby="Abs1" data-title="Abstract" lang="en"><div class="c-article-section" id="Abs1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Abs1">Abstract</h2><div class="c-article-section__content" id="Abs1-content"><p>Patients with rheumatoid arthritis (RA) receive highly targeted biologic therapies without previous knowledge of target expression levels in the diseased tissue. Approximately 40% of patients do not respond to individual biologic therapies and 5–20% are refractory to all. In a biopsy-based, precision-medicine, randomized clinical trial in RA (R4RA; <i>n</i> = 164), patients with low/absent synovial B cell molecular signature had a lower response to rituximab (anti-CD20 monoclonal antibody) compared with that to tocilizumab (anti-IL6R monoclonal antibody) although the exact mechanisms of response/nonresponse remain to be established. Here, in-depth histological/molecular analyses of R4RA synovial biopsies identify humoral immune response gene signatures associated with response to rituximab and tocilizumab, and a stromal/fibroblast signature in patients refractory to all medications. Post-treatment changes in synovial gene expression and cell infiltration highlighted divergent effects of rituximab and tocilizumab relating to differing response/nonresponse mechanisms. Using ten-by-tenfold nested cross-validation, we developed machine learning algorithms predictive of response to rituximab (area under the curve (AUC) = 0.74), tocilizumab (AUC = 0.68) and, notably, multidrug resistance (AUC = 0.69). This study supports the notion that disease endotypes, driven by diverse molecular pathology pathways in the diseased tissue, determine diverse clinical and treatment–response phenotypes. It also highlights the importance of integration of molecular pathology signatures into clinical algorithms to optimize the future use of existing medications and inform the development of new drugs for refractory patients.</p></div></div></section>

            
                
            

            
                
                    
        
            <section aria-labelledby="inline-recommendations" data-title="Inline Recommendations" class="c-article-recommendations" data-track-component="inline-recommendations">
                <h3 class="c-article-recommendations-title" id="inline-recommendations">Similar content being viewed by others</h3>
                <div class="c-article-recommendations-list">
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope="" itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41584-020-0491-4/MediaObjects/41584_2020_491_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link" itemprop="url" href="https://www.nature.com/articles/s41584-020-0491-4?fromPaywallRec=false" data-track="select_recommendations_1" data-track-context="inline recommendations" data-track-action="click recommendations inline - 1" data-track-label="10.1038/s41584-020-0491-4">Transforming clinical trials in rheumatology: towards patient-centric precision medicine
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                        
                                         <span class="c-article-meta-recommendations__date">04 September 2020</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope="" itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41467-024-51012-6/MediaObjects/41467_2024_51012_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link" itemprop="url" href="https://www.nature.com/articles/s41467-024-51012-6?fromPaywallRec=false" data-track="select_recommendations_2" data-track-context="inline recommendations" data-track-action="click recommendations inline - 2" data-track-label="10.1038/s41467-024-51012-6">Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">29 August 2024</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope="" itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41591-020-0939-8/MediaObjects/41591_2020_939_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link" itemprop="url" href="https://www.nature.com/articles/s41591-020-0939-8?fromPaywallRec=false" data-track="select_recommendations_3" data-track-context="inline recommendations" data-track-action="click recommendations inline - 3" data-track-label="10.1038/s41591-020-0939-8">Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                        
                                         <span class="c-article-meta-recommendations__date">29 June 2020</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                </div>
            </section>
        
            <script>
                window.dataLayer = window.dataLayer || [];
                window.dataLayer.push({
                    recommendations: {
                        recommender: 'semantic',
                        model: 'specter',
                        policy_id: 'NA',
                        timestamp: 1749517882,
                        embedded_user: 'null'
                    }
                });
            </script>
        
    
                
                
                <div class="main-content">
                    
                        <section data-title="Main"><div class="c-article-section" id="Sec1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec1">Main</h2><div class="c-article-section__content" id="Sec1-content"><p>Treatment of RA has been transformed by the introduction of therapeutics directed against soluble mediators (for example, tumor necrosis factor (TNF) inhibitors and IL6R blockers), immune cells (for example, B cells) and intracellular signaling pathways (Janus kinase inhibitors)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Smolen, J. S. et al. Rheumatoid arthritis. Nat. Rev. Dis. Prim. 4, 18001 (2018)." href="/articles/s41591-022-01789-0#ref-CR1" id="ref-link-section-d51120563e1883">1</a></sup>. However, approximately 40% of patients do not respond to individual agents while 5–20% are resistant to all current medications<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Buch, M. H. Defining refractory rheumatoid arthritis. Ann. Rheum. Dis. 77, 966–969 (2018)." href="/articles/s41591-022-01789-0#ref-CR2" id="ref-link-section-d51120563e1887">2</a></sup>. The mechanisms of nonresponse are largely unknown and, unlike in other medical fields such as cancer where molecular pathology guides the use of targeted therapies<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Borghaei, H. et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N. Engl. J. Med. 373, 1627–1639 (2015)." href="/articles/s41591-022-01789-0#ref-CR3" id="ref-link-section-d51120563e1891">3</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Kawalec, P., Łopuch, S. &amp; Mikrut, A. Effectiveness of targeted therapy in patients with previously untreated metastatic breast cancer: a systematic review and meta-analysis. Clin. Breast Cancer 15, 90–100 (2015)." href="/articles/s41591-022-01789-0#ref-CR4" id="ref-link-section-d51120563e1894">4</a></sup>, biomarkers able to predict response to specific agents in RA are still lacking<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Pitzalis, C., Choy, E. H. S. &amp; Buch, M. H. Transforming clinical trials in rheumatology: towards patient-centric precision medicine. Nat. Rev. Rheumatol. 16, 590–599 (2020)." href="/articles/s41591-022-01789-0#ref-CR5" id="ref-link-section-d51120563e1898">5</a></sup>. Because RA is highly heterogeneous, it is plausible that different pathways are active in individual patients<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Lewis, M. J. et al. Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes. Cell Rep. 28, 2455–2470 (2019)." href="/articles/s41591-022-01789-0#ref-CR6" id="ref-link-section-d51120563e1902">6</a></sup>. For example, because approximately 50% of patients with RA display low/absent CD20<sup>+</sup> B cells in diseased joint tissue (synovium)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Humby, F. et al. Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients. Ann. Rheum. Dis. 78, 761–772 (2019)." href="/articles/s41591-022-01789-0#ref-CR7" id="ref-link-section-d51120563e1909">7</a></sup>, the target for the anti-CD20 rituximab monoclonal antibody, it has been postulated that the level of synovial B cells/B cell-related pathways would influence treatment response to rituximab. However, results from small observational studies provide inconsistent and inconclusive results<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Giacomelli, R. et al. The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and experts’ consensus. Autoimmun. Rev. 20, 102738 (2021)." href="/articles/s41591-022-01789-0#ref-CR8" id="ref-link-section-d51120563e1913">8</a></sup>.</p><p>To address this hypothesis we carried out a biopsy-driven, randomized clinical trial in RA (R4RA)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Humby, F. et al. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. Lancet 397, 305–317 (2021)." href="/articles/s41591-022-01789-0#ref-CR9" id="ref-link-section-d51120563e1920">9</a></sup> in which TNF-inhibitor-inadequate responders were randomized to either rituximab (anti-CD20 monoclonal antibody) or tocilizumab (anti-IL6R monoclonal antibody) after stratification according to synovial B cell signatures. The trial results demonstrated that only 12% of patients with a low synovial B cell molecular signature responded to rituximab while 50% responded to tocilizumab. In contrast, in patients with high synovial B cell lineage signature, the two drugs appeared comparably effective.</p><p>Here, we investigated the mechanisms of response and nonresponse to these two targeted biologics through deep histopathological and molecular (RNA-sequencing (RNA-Seq)) characterization of synovial tissue at baseline, and longitudinally in post-treatment biopsies at 16 weeks. We identified specific signatures associated with therapeutic response and developed machine learning classifiers to predict treatment response. Additionally, we provide insights into the cellular and molecular pathways underpinning multidrug resistance defining a refractory phenotype, characterized by a stromal/fibroblast signature. Finally, digital spatial profiling of synovial biopsies highlighted differences in gene expression in specific synovial regions with relevance to disease pathogenesis and treatment response.</p></div></div></section><section data-title="Results"><div class="c-article-section" id="Sec2-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec2">Results</h2><div class="c-article-section__content" id="Sec2-content"><h3 class="c-article__sub-heading" id="Sec3">Histological and in silico cell lineages correlate with drug response</h3><p>To assess the association of synovial immune cells with treatment response, we compared semiquantitative immunohistochemistry (IHC) scores (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig7">1a,b</a>) in pretreatment synovial biopsies of responders (<i>n</i> = 28 for rituximab, <i>n</i> = 37 for tocilizumab) and nonresponders (<i>n</i> = 54 and <i>n</i> = 42, respectively), showing no differences (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig7">1c</a>). However, when patients were stratified according to previously described<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Lewis, M. J. et al. Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes. Cell Rep. 28, 2455–2470 (2019)." href="/articles/s41591-022-01789-0#ref-CR6" id="ref-link-section-d51120563e1958">6</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Humby, F. et al. Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients. Ann. Rheum. Dis. 78, 761–772 (2019)." href="/articles/s41591-022-01789-0#ref-CR7" id="ref-link-section-d51120563e1961">7</a></sup> synovial histological patterns, also known as pathotypes (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig1">1a</a>), patients with a diffuse-myeloid pathotype, i.e. with myeloid lineage predominance but low in B/plasma cells, displayed a significantly higher response to tocilizumab (13/16, 81%) versus rituximab (7/20, 35%) (<i>P</i> = 0.008, odds ratio (OR) = 7.53, 95% confidence interval (CI) 1.4–55.7). In contrast, similar response rates between treatments were observed in patients with a lymphomyeloid pathotype, dominated by lymphoid-lineage cells (T, B and plasma cells) in addition to myeloid cells, and a fibroid/pauci-immune pathotype, characterized by few immune cells and prevalent stromal cells. To further dissect synovial cell types, we applied an in silico deconvolution analysis (MCP-counter<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 10" title="Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17, 218 (2016)." href="/articles/s41591-022-01789-0#ref-CR10" id="ref-link-section-d51120563e1971">10</a></sup>; Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig1">1b</a>), showing significantly higher CD8 T cells in responders to rituximab and higher macrophage-monocytes and myeloid dendritic cells (mDCs) in responders to tocilizumab (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig1">1c</a>). Moreover, when we stratified patients according to MCP-counter scores, patients poor in B cells showed significantly higher response rates to tocilizumab (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig1">1d</a>), consistent with the primary results of the trial<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Humby, F. et al. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. Lancet 397, 305–317 (2021)." href="/articles/s41591-022-01789-0#ref-CR9" id="ref-link-section-d51120563e1985">9</a></sup>, while no difference was found in patients rich in B cells. In contrast, macrophage- and mDC-rich individuals showed higher response to tocilizumab (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig1">1e</a>). Combined scores (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig1">1f</a>) demonstrated that patients poor in B cells but rich in macrophages/mDCs had a significantly higher response to tocilizumab (77% responders to tocilizumab versus 14% responders to rituximab; <i>P</i> = 0.017, OR = 16.48, 95%CI 1.29–1,000.5). Furthermore, by analysis of disease activity over time, we found a statistically significant interaction effect between treatments and time in patients who were B cell poor (<i>P</i> = 0.003), T cell poor (<i>P</i> = 0.022) (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig1">1g</a>), mDC rich (<i>P</i> = 0.029) (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig1">1h</a>) and B cell poor/macrophage/mDC rich (<i>P</i> = 0.006) (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig1">1i</a>). There were significantly lower disease activity scores (clinical disease activity index (CDAI)) at weeks 6, 12 and 16 in patients treated with tocilizumab who were B cell poor and macrophage/mDC rich (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig1">1i</a>) versus those treated with rituximab. Overall, these results point to myeloid cell infiltration in synovia as one of the key factors explaining the enhanced response to tocilizumab in patients with B cell-poor synovitis.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-1" data-title="Synovial histological markers at baseline associate with response to rituximab and tocilizumab."><figure><figcaption><b id="Fig1" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 1: Synovial histological markers at baseline associate with response to rituximab and tocilizumab.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-022-01789-0/figures/1" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig1_HTML.png?as=webp"><img aria-describedby="Fig1" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig1_HTML.png" alt="figure 1" loading="lazy" width="685" height="1260"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-1-desc"><p><b>a</b>, Classification into synovial pathotypes according to semiquantitative scores for CD3<sup>+</sup> T cells, CD20<sup>+</sup> B cells, CD68<sup>+</sup> macrophages and CD138<sup>+</sup> plasma cells, with representative examples from patients classified as lymphomyeloid (CD20 ≥ 2 and/or CD138≥2), diffuse-myeloid (CD68SL≥2, and CD20/CD138&lt;2) or fibroid/pauci-immune (CD68SL/CD20/CD138&lt;2). Right, 16-week CDAI 50% response in patients stratified by pathotype (<i>n</i> = 152). Bar plots showing the proportion of CDAI 50% responders for rituximab (in blue) and tocilizumab (in yellow) within each pathotype, with corresponding exact numbers. Fisher's test, exact <i>P</i> values for <i>P</i> &lt; 0.05. <b>b</b>, Approach to in silico deconvolution of synovial tissue using MCP-counter. <b>c</b>, MCP-counter scores for each cell type compared among CDAI 50% responders (R) and nonresponders (NR). Bar plots indicate nominal log<sub>10</sub> <i>P</i> values for tocilizumab and –log<sub>10</sub> <i>P</i> values for rituximab (two-sided Mann–Whitney test); dashed lines correspond to <i>P</i> = 0.05. Boxplots (right) show median and first and third quartiles, whiskers extending to the highest and lowest values. <b>d</b>–<b>f</b>, 16-week CDAI 50% response in patients stratified into B and T cell poor/rich (<b>d</b>) and macrophage/mDC poor/rich (<b>e</b>) according to median MCP-counter scores for individual cells (rich if above median, poor if below), or by combining B cell and macrophage/mDC scores from <b>d</b>,<b>e</b> (<b>f</b>). Exact <i>P</i> values shown when &lt;0.05, two-sided Fisher's test comparing the proportions of responders to rituximab (in blue) and tocilizumab (in yellow). <b>g</b>–<b>i</b>, Longitudinal disease activity scores (CDAI), shown as mean ± s.d., for each month from baseline to 16 weeks for patients randomized to rituximab (in blue) or tocilizumab (in yellow) and classified as B and T cell poor/rich (<b>g</b>), macrophage/mDC poor/rich (<b>h</b>) and combined B cell/macrophage poor/rich (<b>i</b>). Comparison of CDAI between the two medications at individual time points by two-sided Mann–Whitney test, exact <i>P</i> values for &lt;0.05 (adjustment for multiple comparisons by FDR). <i>P</i> values for the drug × time interaction term (two-way repeated-measures analysis of covariance) are shown when &lt;0.05. <b>c</b>–<b>i</b>, <i>n</i> = 133 patients with baseline RNA-seq. NK, natural killer cells. mDC, myeloid dendritic cells.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-022-01789-0/figures/1" data-track-dest="link:Figure1 Full size image" aria-label="Full size image figure 1" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><h3 class="c-article__sub-heading" id="Sec4">Unsupervised clustering defines treatment response diversity</h3><p>Next, we used unsupervised analyses to explore the relationship of multiple genes/pathways with response to treatment. First, we applied principal component analysis (PCA) to identify underlying subgroup structures. PC1 and PC3 correlated with inflammatory cell infiltration in synovial biopsies, while they also associated with histological pathotypes primarily separating the lympho-myeloid and fibroid pathotypes (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig8">2a,b</a>).</p><p>Unsupervised Monte Carlo consensus clustering (M3C)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="John, C. R. et al. M3C: Monte Carlo reference-based consensus clustering. Sci. Rep. 10, 1816 (2020)." href="/articles/s41591-022-01789-0#ref-CR11" id="ref-link-section-d51120563e2155">11</a></sup> showed 71% of rituximab responders (<i>n</i> = 24) in cluster 1 compared with only 29% (<i>n</i> = 10) in cluster 2 (<i>P</i> = 0.0004; Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig2">2a</a>). Genes relevant for B cell biology were significantly higher in cluster 1 in patients treated with rituximab (Extended Data Figs. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig8">2e</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig9">3a</a>). Cluster 1 was also linked with significant upregulation of the B cell gene module S136 from weighted gene correlation network analysis (WGCNA)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Lewis, M. J. et al. Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes. Cell Rep. 28, 2455–2470 (2019)." href="/articles/s41591-022-01789-0#ref-CR6" id="ref-link-section-d51120563e2178">6</a></sup>, together with upregulation of the proinflammatory M1 macrophage module S39 and downregulation of the fibroblast module S115 (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig8">2e</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-2" data-title="Molecular signatures of response and nonresponse to rituximab and tocilizumab."><figure><figcaption><b id="Fig2" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 2: Molecular signatures of response and nonresponse to rituximab and tocilizumab.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-022-01789-0/figures/2" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig2_HTML.png?as=webp"><img aria-describedby="Fig2" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig2_HTML.png" alt="figure 2" loading="lazy" width="685" height="805"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-2-desc"><p><b>a</b>,<b>b</b>, Monte Carlo reference-based consensus clustering of the 22,256 most variable genes identified a high-inflammatory-consensus cluster 1 (blue) and low-inflammatory cluster 2 (yellow). Heatmaps were produced for patients treated with rituximab (<i>n</i> = 68, <b>a</b>) and tocilizumab (<i>n</i> = 65, <b>b</b>) using Pearson’s distance metric and the complete linkage method using the ComplexHeatmap package in R. Upper tracks show consensus cluster, cell type (B cell rich/poor), the overall pathotype, CDAI 50% response, EULAR response and histological scores for CD20, CD138, CD68L, CD68SL and CD3. <b>c</b>,<b>d</b>, Volcano plots of DEGs using DESeq2 comparing CDAI 50% responders versus nonresponders to rituximab (<b>c</b>) and tocilizumab (<b>d</b>). Comparison between groups using Wald's test and correcting for multiple testing, Storey’s <i>q</i>-value (<i>q</i> &lt; 0.05 significant, shown in blue). Positive and negative values represent upregulation and downregulation, respectively, in responders and nonresponders. <b>e</b>,<b>f</b>, Modular analysis applying QuSAGE to responders versus nonresponders to rituximab (<b>e</b>) and tocilizumab (<b>f</b>); log<sub>2</sub> fold changes of responders (positive values) and nonresponders (negative values) are plotted for blood microarray-based modules<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Li, S. et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. 15, 195–204 (2014)." href="/articles/s41591-022-01789-0#ref-CR12" id="ref-link-section-d51120563e2248">12</a></sup>, with WGCNA modules summarized in one plot and dots color coded for their <i>q</i>-value.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-022-01789-0/figures/2" data-track-dest="link:Figure2 Full size image" aria-label="Full size image figure 2" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>Clustering of patients treated with tocilizumab was less distinctive, with 46% of responders (<i>n</i> = 21) in cluster 1 and 54% in cluster 2 (<i>n</i> = 25) (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig2">2b</a>). However, cluster 1 was significantly associated with IL-6 pathway genes (Extended Data Figs. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig8">2f</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig9">3b</a>), together with upregulation of B cell and M1 macrophage modules and downregulation of fibroblast modules. In keeping with the increase in immune cell-related modules in cluster 1 for both treatments, semiquantitative IHC scores for synovial immune cells were significantly higher in cluster 1 (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig8">2g</a>), indicating that immune cell infiltration is linked to gene expression in cluster 1, as inferred by the loss of significance when adjusting differentially expressed gene (DEG) analysis between consensus clusters 1 and 2 for immune cell content using PC1 as a covariate (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig9">3c,d</a>). The strong correlation of PC1 with histology markers and immune cell-related genes (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig9">3e</a>) is probably linked to this effect.</p><h3 class="c-article__sub-heading" id="Sec5">Molecular signatures of treatment response</h3><p>Next, we performed DEG analysis to identify genes associated with treatment response on all patients who at any point in the trial had received rituximab or tocilizumab (as described in <a data-track="click" data-track-label="link" data-track-action="section anchor" href="/articles/s41591-022-01789-0#Sec11">Methods</a> and Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM1">1</a>). A total of 6,625 genes were significantly different (false discovery rate (FDR) &lt; 0.05) in rituximab responders compared with nonresponders (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig2">2c</a> and Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM3">1</a>), and 85 for tocilizumab (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig2">2d</a> and Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM3">1</a>). Genes upregulated in the synovial tissue of rituximab responders included members of the immunoglobulin (Ig) superfamily and leukocyte-related genes. Nonresponse to rituximab, on the other hand, was associated with complement genes, bone morphogenic proteins, fibroblast-related genes and several Hox genes. Interestingly, lymphocyte and Ig genes were also upregulated in the synovial tissue of tocilizumab responders. Both nonresponder groups showed upregulation of extracellular matrix genes, including integrin-binding sialoprotein, aggrecan and collagen, and genes linked to tissue remodeling, cell infiltration and cell–cell interaction. Following adjustment for immune cell infiltration by PC1, DEGs for rituximab remained significant and, in the case of tocilizumab, the number of identified DEGs increased (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig9">3f</a> for rituximab and Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig9">3g</a> for tocilizumab; Supplementary Data1), suggesting that DEG analysis provides an additional dimension to the inflammatory cell infiltrate alone that differentiates responders from nonresponders. Of note, inclusion of covariates such as age, gender and ethnicity was not associated with major differences in the statistical significance of DEGs (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM3">1</a>).</p><p>To investigate the functional role of the above genes, we applied quantitative set analysis for gene expression (QuSAGE) modular analysis<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Li, S. et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. 15, 195–204 (2014)." href="/articles/s41591-022-01789-0#ref-CR12" id="ref-link-section-d51120563e2331">12</a></sup> using blood- and synovium-specific WGCNA modules (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig2">2e,f</a>)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Lewis, M. J. et al. Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes. Cell Rep. 28, 2455–2470 (2019)." href="/articles/s41591-022-01789-0#ref-CR6" id="ref-link-section-d51120563e2338">6</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Stephenson, W. et al. Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation. Nat. Commun. 9, 791 (2018)." href="/articles/s41591-022-01789-0#ref-CR13" id="ref-link-section-d51120563e2341">13</a></sup>. Antigen presentation, T and B cell-related modules and interferon signaling were significantly increased in rituximab responders, while Hox gene and fibroblast modules were increased in rituximab nonresponders (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig2">2e</a>).</p><p>Myeloid cell cytokine, peroxisome proliferator-activated receptor (PPAR) and metabolic pathways were upregulated in tocilizumab responders (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig2">2f</a>). Although none of the modules was significantly modulated in nonresponders to tocilizumab, fibroblast modules were also detected in nonresponders to tocilizumab, suggesting the possible existence of a shared treatment-resistant signature.</p><h3 class="c-article__sub-heading" id="Sec6">Refractory disease is linked to a stromal/fibroblast signature</h3><p>To further explore the hypothesis of a common refractory signature following treatment switch at 16 weeks (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM1">1</a>), we compared patients in whom both rituximab and tocilizumab failed to induce response (multidrug resistant/refractory, <i>n</i> = 40 for histology, <i>n</i> = 32 for RNA-seq) with (1) patients who responded exclusively to rituximab after tocilizumab failure (pro-rituximab, <i>n</i> = 11 for histology and <i>n</i> = 9 for RNA-seq) and (2) patients who responded exclusively to tocilizumab after rituximab failure (pro-tocilizumab, <i>n</i> = 13 for histology and <i>n</i> = 12 for RNA-seq) (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig3">3a</a>). We identified 1,980 genes upregulated in both pro-rituximab and pro-tocilizumab patients, 175 exclusive to the pro-rituximab group and 306 exclusive to the pro-tocilizumab (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig3">3b</a> and Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM4">2</a>). Among genes upregulated in responders to both medications were lymphoid, myeloid and many cytokine genes (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig3">3c,d</a>). Chemokines and lymphocyte genes were upregulated in pro-rituximab patients, while lymphocyte and myeloid lineage genes were upregulated in pro-tocilizumab.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-3" data-title="Identification of multidrug nonresponse (refractory) signature."><figure><figcaption><b id="Fig3" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 3: Identification of multidrug nonresponse (refractory) signature.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-022-01789-0/figures/3" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig3_HTML.png?as=webp"><img aria-describedby="Fig3" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig3_HTML.png" alt="figure 3" loading="lazy" width="685" height="772"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-3-desc"><p><b>a</b>, Patient classification according to treatment switch (complete scheme shown in Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM1">1</a>): patients responding to rituximab (RTX) following tocilizumab (TOC) failure (pro-rituximab, blue), patients responding to tocilizumab following rituximab failure (pro-tocilizumab, yellow) and patients in whom both drugs failed sequentially (refractory, red). Numbers in brackets denote patients with available RNA-seq. <b>b</b>, Venn diagram showing the overlap of DEGs between patients classified as in <b>a</b>. <b>c</b>,<b>d</b>, Three-way DEG analysis on baseline synovial biopsies of patients classified as in <b>a</b>, with side (<b>c</b>) and top view (<b>d</b>). Significant differences in pro-rituximab (blue), pro-tocilizumab (yellow) and refractory (red) patients and significant genes overlapping in pro-rituximab and pro-tocilizumab patients (green) are color coded. Significance was internally estimated by the volcano3D package combining significance (<i>q</i> &lt; 0.05) from both LRT and pairwise Wald test via DESeq2. <b>e</b>, Three-way QuSAGE radial plot showing differential WGCNA module expression in patients classified as above. <b>f</b>, Histological semiquantitative scores for immune cells in refractory patients (<i>n</i> = 40) and responders to one of any two medications (<i>n</i> = 24). Boxplots showing median and first and third quartiles. Two-way Mann–Whitney test, exact <i>P</i> values FDR adjusted for multiple comparisons. <b>g</b>, Deconvolution of immune cells using MCP-counter in patients classified as refractory or responders as in <b>a</b>. Boxplots showing median and first and third quartiles, dot-plots showing individual patients. Two-way Mann–Whitney test, exact <i>P</i> values FDR adjusted for multiple comparisons. <b>h</b>, Fibroblast single-cell subset enrichment scores in refractory patients (<i>n</i> = 32) or responders to either rituximab or tocilizumab (<i>n</i> = 21), as in <b>a</b>. Boxplots showing median and first and third quartiles, whiskers extending to the highest and lowest values. Exact <i>P</i> values are shown, two-sided Mann–Whitney test. <b>i</b>, Multiplex immunofluorescence in refractory and responder patients; nuclear staining (blue), CD45 (red), CD90 (green), DKK3 (yellow) (all top) and DKK3 single staining (yellow, bottom). *, DKK3<sup>+</sup>CD45<sup>+</sup> lymphocytes; arrowheads, DKK3<sup>+</sup>CD90<sup>+</sup> fibroblasts. A larger overview and individual stainings are provided in Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig10">4</a>. Representative images out of a total of three refractory and three responders. Scale bars, 50 μm. NS, not significant.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-022-01789-0/figures/3" data-track-dest="link:Figure3 Full size image" aria-label="Full size image figure 3" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>Modular analysis showed antigen presentation and dendritic, macrophage and plasma cell infiltration modules upregulated in responders to both biologics (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig3">3e</a>). Similarly, the CD8 and Tph T cell module was upregulated in each drug response group, with greater change for the rituximab responder group (proximity to pro-rituximab axis), while Toll-like receptor signaling and macrophage chemokine and cytokine signaling were significantly increased in pro-rituximab patients only. Modules for T cells, plasma cells and the TNF receptor superfamily gene were upregulated in pro-tocilizumab patients only (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig3">3e</a>).</p><p>Notably, 1,277 significant genes were unique to multidrug-resistant/refractory patients (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig3">3c,d</a> and Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM4">2</a>), including fibroblast and extracellular matrix-encoding genes such as fibroblast growth factor (<i>FGF</i>), homeobox (<i>HOX</i>) and <i>NOTCH</i> family genes, together with multiple cell-adhesion-molecule- and collagen-encoding genes (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig3">3e</a> and Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM5">3</a>).</p><p>In line with molecular signatures, baseline histological scores for CD3<sup>+</sup> T cells and CD79a<sup>+</sup> B-cells and CD138<sup>+</sup> plasma cells were significantly lower in refractory patients (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig3">3f</a>). Additionally, in silico deconvolution showed significantly lower levels of CD8<sup>+</sup> T cells, monocytes and mDCs and a trend towards increase in endothelial cells, neutrophils and fibroblasts in refractory patients (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig3">3g</a>).</p><p>To further characterize the association of synovial fibroblast genes with multidrug resistance, we complemented MCP-counter deconvolution by examining enrichment in synovium-specific fibroblast gene modules derived from RA synovial single-cell RNA-seq<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Zhang, F. et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat. Immunol. 20, 928–942 (2019)." href="/articles/s41591-022-01789-0#ref-CR14" id="ref-link-section-d51120563e2559">14</a></sup>. As shown in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig3">3h</a>, the signature for HLA-DRA<sup>high</sup> sublining fibroblasts (SC-F2), a proinflammatory subset associated with leukocyte-rich synovial infiltration in RA, was significantly higher in responders (<i>P</i> = 0.027) as opposed to CD34<sup>+</sup> sublining fibroblasts (SC-F1) and, in particular, to the newly described DKK3<sup>+</sup> sublining fibroblasts (SC-F3), both increased in refractory patients (<i>P</i> = 0.036 and 0.00055, respectively).</p><p>For orthogonal confirmation of these findings at the protein level, we used multiplex immunofluorescence to detect DKK3<sup>+</sup> fibroblasts in the synovial lining and sublining of refractory patients (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig3">3i</a> and Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig10">4</a>).</p><p>Together, these results show that baseline histological and molecular signatures are associated with response to individual drugs, while nonresponse to multiple biologics is linked to a specific pretreatment signature associated with fibroblasts.</p><h3 class="c-article__sub-heading" id="Sec7">Digital spatial profiling of refractory RA</h3><p>Because immune and stromal cells are known to exhibit positional identity relevant to the pathogenesis of RA<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Wei, K. et al. Notch signalling drives synovial fibroblast identity and arthritis pathology. Nature 582, 259–264 (2020)." href="/articles/s41591-022-01789-0#ref-CR15" id="ref-link-section-d51120563e2602">15</a></sup>, we used digital spatial profiling (DSP) to characterize the spatial positioning of cell signatures in association with treatment response/resistance. We employed GeoMx DSP (NanoString), which uses a set of protein lineage markers to define regions of interest (ROIs) that undergo whole-transcriptomic spatial RNA expression (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig4">4a</a>). First, we compared gene expression in responders and refractory patients across all ROIs: lining/superficial sublining, deep sublining and lymphoid aggregates (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig4">4b</a>). Consistent with the above bulk RNA-seq modules and protein expression, multiple genes related to the DKK3<sup>+</sup> fibroblast subset (<i>PRELP</i>, <i>OGN</i>, <i>CAM1KD</i>) were significantly higher in refractory patients (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig4">4c</a>). When looking at individual ROIs, we found specific genes differentially expressed in responders versus refractory patients in each synovial region. For example, the gene encoding for the fibroblast marker FAP<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Croft, A. P. et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature 570, 246–251 (2019)." href="/articles/s41591-022-01789-0#ref-CR16" id="ref-link-section-d51120563e2627">16</a></sup> was significantly upregulated in the deep sublining of refractory patients, the gene for the osteoclast marker RANK (<i>TNFRSR11A</i>) was significantly higher in the lining/superficial sublining of responders and <i>CD24</i> encoding a lymphocyte marker was significantly higher in the lymphoid aggregates of responders (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig4">4d</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-4" data-title="DSP of refractory RA."><figure><figcaption><b id="Fig4" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 4: DSP of refractory RA.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-022-01789-0/figures/4" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig4_HTML.png?as=webp"><img aria-describedby="Fig4" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig4_HTML.png" alt="figure 4" loading="lazy" width="685" height="393"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-4-desc"><p><b>a</b>, Scheme showing the approach to DSP, including selection of ROIs: CD68<sup>+</sup> lining and superficial sublining, CD20<sup>–</sup>CD3<sup>–</sup> deep sublining and CD3<sup>+</sup>CD20<sup>+</sup> lymphoid aggregates. <b>b</b>, MA plot showing mean expression (log<sub>2</sub>) on the <i>x</i> axis and fold change on the <i>y</i> axis comparing responders and refractory patients across all ROIs. Genes significantly upregulated (FDR&lt;0.05) in responders are shown in blue (top), and those upregulated in refractory in red (bottom); in grey, genes with <i>FDR</i> &gt; 0.05; <i>P</i> values were calculated using a negative binomial linear model applied to count data using DESeq2 (Wald test) and were FDR adjusted <i>n</i> = 12 patients, six ROIs per patient. <b>c</b>, Example of individual genes differentially expressed in refractory (red) or responders (green). Scatterplots showing individual ROIs, boxplots showing median and first and third quartiles. FDR-adjusted <i>P</i> values calculated as in <b>b</b> are shown for differentially expressed genes between refractory and responder individuals; <i>n</i> = 12 patients (4 responders to rituximab, 4 responders to tocilizimab and 4 refractory). <b>d</b>, Examples of individual genes differentially expressed in refractory (red) or responders (green) in different ROIs. Scatterplots showing individual ROIs (<i>n</i> = 12 patients, six ROIs per patient), boxplots showing median and first and third quartiles. FDR-adjusted <i>P</i> values calculated as in <b>b</b> are shown for differentially expressed genes between refractory and responder individuals. L, lining/superficial sublining; SL, deep sublining; A, lymphoid aggregates (as shown in <b>a</b>).</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-022-01789-0/figures/4" data-track-dest="link:Figure4 Full size image" aria-label="Full size image figure 4" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><h3 class="c-article__sub-heading" id="Sec8">Pre- and post-treatment histopathological and molecular analyses</h3><p>To explore the longitudinal effects of each drug on synovial immune cell infiltration and gene expression, we compared paired synovial samples at baseline and 16 weeks (rituximab, <i>n</i> = 41 for histology and <i>n</i> = 29 for RNA-seq; tocilizumab, <i>n</i> = 24 and <i>n</i> = 15, respectively) (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig11">5a</a> and Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01789-0#Tab1">1</a>). First, by histology, we showed a significant reduction in synovial CD20<sup>+</sup> total B cells, CD79a<sup>+</sup> B cells and CD138<sup>+</sup> plasma cells in patients treated with rituximab, in line with the rituximab mechanism of action targeting CD20<sup>+</sup> B cells (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig5">5a</a>). Conversely, patients treated with tocilizumab showed a significant reduction in CD68<sup>+</sup> sublining macrophages but not B-cells (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig5">5a</a>). Analysis of covariance showed a significantly higher reduction of CD20<sup>+</sup> and CD79a<sup>+</sup> B cells in patients treated with rituximab, and a significantly higher reduction in CD68<sup>+</sup> sublining macrophages in those treated with tocilizumab (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig11">5b</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-5" data-title="Histological and molecular analysis of paired pre- and post-treatment synovial biopsies."><figure><figcaption><b id="Fig5" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 5: Histological and molecular analysis of paired pre- and post-treatment synovial biopsies.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-022-01789-0/figures/5" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig5_HTML.png?as=webp"><img aria-describedby="Fig5" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig5_HTML.png" alt="figure 5" loading="lazy" width="685" height="693"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-5-desc"><p><b>a</b>, Semiquantitative histological scores of synovial immune cells at baseline and 16 weeks in patients treated with rituximab and tocilizumab. Boxplots showing median and first and third quartiles. <i>P</i> values shown when &lt;0.05, two-sided Wilcoxon signed-rank test (paired) comparing baseline and 16 weeks, adjusted for multiple testing by FDR; <i>n</i> = 65 patients with matched baseline and 16-week samples (41 randomized to rituximab, 24 to tocilizumab). <b>b</b>, Scatter plots comparing longitudinal gene expression changes between drugs over 16 weeks of treatment in 88 paired biopsies from 44 patients following treatment with rituximab (<i>n</i> = 29) or tocilizumab (<i>n</i> = 15). log<sub>2</sub> fold change in expression following rituximab or tocilizumab is represented on the <i>x</i> and <i>y</i> axis, respectively. Genes equally affected by each drug lie along the line of identity. Fold change and statistical analysis of longitudinal differential gene expression were calculated by negative binomial general linear mixed-effects model. Genes in green show significant (FDR &lt; 0.05) overall change in expression over time; those in blue/yellow show significantly differential change in expression over time between the two drugs based on significant (FDR &lt; 0.05) interaction term <i>time</i> <i>×</i> <i>medication</i> (<a data-track="click" data-track-label="link" data-track-action="section anchor" href="/articles/s41591-022-01789-0#Sec11">Methods</a>). Genes with greater absolute fold change following rituximab or tocilizumab are shown in blue and yellow, respectively. <b>c</b>, Scatter plots for selected genes with colored points showing regression line of fitted mixed-effects model, with error bars showing 95% CIs (fixed effects). Gray points and lines show raw paired count data, with numbers as per the analysis above. <b>d</b>–<b>f</b>, Pathway analysis using a two-sided hypergeometric test to enrich downregulated genes between baseline and 16 weeks in patients treated with rituximab (<b>d</b>), responders and nonresponders to rituximab (<b>e</b>) and responders to tocilizumab (<b>f</b>). Dashed line indicates adjusted <i>P</i> = 0.05 (Bonferroni adjustment).</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-022-01789-0/figures/5" data-track-dest="link:Figure5 Full size image" aria-label="Full size image figure 5" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>Similar results were obtained when comparing MCP-counter immune cell signatures. Namely, patients treated with rituximab showed a significant reduction in B cells, T cells and monocytes/macrophages while those treated with tocilizumab showed a significant reduction in monocytes/macrophages and T cells, but also in neutrophils and mDCs and, interestingly, an increase in fibroblast signature (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig11">5c</a>). This suggests that both biologics have an effect on immune cells but that tocilizumab can potentially also affect stromal cells.</p><p>To further dissect these longitudinal molecular signatures, we developed an R package to fit negative binomial mixed-effects models at the individual gene level (general linear mixed-effects model (glmmSeq)), because mainstream RNA-seq analysis tools are unable to fit mixed-effects linear models (<a data-track="click" data-track-label="link" data-track-action="section anchor" href="/articles/s41591-022-01789-0#Sec11">Methods</a>).</p><p>Using glmmSeq to compare gene expression over time in paired synovial biopsies, 7,316 genes were significantly up- or downregulated by both drugs while 345 were differentially affected by either drug based on significance (FDR &lt; 0.05) of the interaction term <i>time</i> <i>×</i> <i>medication</i> (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig5">5b</a> and Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM6">4a</a>). Of note, <i>MS4A1</i> (encoding CD20), <i>PAX5</i> and <i>BLK</i> were significantly downregulated in response to rituximab, consistent with B cell depletion mechanism and histology results (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig5">5c</a>), while tocilizumab induced a reduction in IL-6-related transcripts, also consistent with the IL6 acting mechanism of tocilizumab, not the CD20 mechanism of rituximab.</p><p>When patients were stratified according to response, a significant reduction in CD138 and CD79a plasmablasts/plasma cells was observed only in rituximab responders, while a significant reduction in CD68SL macrophages was observed only in responders to tocilizumab (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig11">5d</a>), indicating that reduction in B and synovial plasma cells and macrophages is associated with response to rituximab and tocilizumab, respectively.</p><p>The mixed-effects model allowed us to further examine various changes in gene expression following therapy between responders and nonresponders to each drug (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig11">5e–h</a>). Rituximab had a general effect on 1,796 genes, with 349 showing significant (FDR &lt; 0.05) differential expression change over time between responders and nonresponders (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig11">5e</a> and Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM6">4b</a>). Rituximab responders showed a greater decrease in <i>SAA1</i> and <i>SAA2</i> (serum amyloid proteins 1 and 2), as well as greater decreases in Ig chain genes <i>IGHV3-64D</i> and <i>IGKV1-13</i>, suggesting that a drop in antibody-secreting B cells is associated with response to rituximab (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig11">5g</a>). Chemokine-encoding <i>CXCL11</i>, the citrullination enzyme encoding <i>PADI2</i> (peptidyl-arginine-deiminase2) and the key Th17 and mucosal-associated invariant T (MAIT) cell transcriptional regulator RORgamma (<i>RORC</i>) gene were also modulated in rituximab responders (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig11">5g</a>).</p><p>Tocilizumab treatment resulted in modulation of 1,609 genes, with an additional 136 showing differential change in gene expression between responders and nonresponders (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig11">5f</a> and Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM6">4</a><a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM1">c</a>). Reduction in pro-lymphoid follicle development genes encoding for lymphotoxin-A (<i>LTA</i>), complement receptor-2 (<i>CR2</i>), lymphoid-tissue-resident dendritic cell marker <i>XCR1</i><sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Crozat, K. et al. Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8α+ type. J. Immunol. 187, 4411–4415 (2011)." href="/articles/s41591-022-01789-0#ref-CR17" id="ref-link-section-d51120563e2969">17</a></sup> and prolactin (<i>CLEC17A</i>), expressed on proliferating germinal center B cells<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Graham, S. A. et al. Prolectin, a glycan-binding receptor on dividing B cells in germinal centers. J. Biol. Chem. 284, 18537–18544 (2009)." href="/articles/s41591-022-01789-0#ref-CR18" id="ref-link-section-d51120563e2976">18</a></sup>, augured response to tocilizumab (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig11">5h</a>).</p><p>To further investigate pathway modulation induced by treatment, genes identified in the longitudinal mixed-effects model analysis were analyzed for Gene Ontology (GO)/pathway enrichment. Rituximab treatment induced significant downregulation of B cell receptor pathways, as well as bone resorption and remodeling pathways (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig5">5d</a>). When stratifying patients according to response, responders to rituximab showed significant downregulation of T cell receptor complex, lymphocyte chemotaxis and migration, chemokines and IL-1-related pathways (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig5">5e</a>), suggesting that rituximab response is linked to additional immunomodulation in addition to reduction in B cell-related pathways. Responders to tocilizumab showed significant decrease in humoral immune response, Ig, B cell and complement activation (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig5">5f</a>), in line with the known effect of IL-6 on B cell growth/differentiation.</p><p>In summary, longitudinal analyses of matched pre- and post-treatment biopsies indicate that specific biological changes are associated with response to individual treatments.</p><h3 class="c-article__sub-heading" id="Sec9">Machine learning models predict drug response and multidrug resistance</h3><p>To establish the ability of synovial tissue gene expression in prediction of treatment response/resistance, we developed machine learning predictive models with the dataset partitioned for training and testing using ten-by-tenfold nested cross-validation, as detailed in <a data-track="click" data-track-label="link" data-track-action="section anchor" href="/articles/s41591-022-01789-0#Sec11">Methods</a> and schematically in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig6">6a</a>. Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM1">1</a> shows the performance of models used to predict (1) rituximab response, (2) tocilizumab response and (3) refractory state. Final models (Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM1">2</a>) were trained on the entire dataset to extract variable importance (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig6">6a</a>, bottom right and Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01789-0#Tab2">2</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-6" data-title="Predictive models using nested ten-by-ten-fold cross-validation for response to rituximab and tocilizumab."><figure><figcaption><b id="Fig6" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 6: Predictive models using nested ten-by-ten-fold cross-validation for response to rituximab and tocilizumab.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-022-01789-0/figures/6" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig6_HTML.png?as=webp"><img aria-describedby="Fig6" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig6_HTML.png" alt="figure 6" loading="lazy" width="685" height="726"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-6-desc"><p><b>a</b>, Machine learning pipeline utilized to predict CDAI 50% response to rituximab and/or tocilizumab using gene expression, clinical data and histological data as features (<i>n</i> = 133). Data processing (1) involved selection of protein-coding genes with the highest variance and removal of highly correlated genes. Data were split into ten inner and ten outer folds for building machine learning models (2). In models built using gene expression, RFE or univariate filtering was used to select the most important/predictive features for each model. Each model was evaluated on both the test set and the set omitted during cross-validation (3). Average tuned parameters from the outer folds were used to fit to the whole dataset to determine the importance of features selected for each model (4). <b>b</b>, Grid of plots showing optimal predictive models for different treatments (left, glmnet rituximab response prediction; middle, glmnet tocilizumab response prediction; right, GBM refractory response prediction) using gene expression and baseline clinical parameters as features. From top to bottom, plots show ROC curves for the best model on the test dataset (from outer fold), ROC curves on the omitted dataset (from inner fold) and variable importance when fit to the whole dataset.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-022-01789-0/figures/6" data-track-dest="link:Figure6 Full size image" aria-label="Full size image figure 6" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>As shown in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig6">6b</a>, the optimal predictive models included gene elastic net regression for rituximab and tocilizumab response, with 40 genes (AUC = 0.744) and 39 genes (AUC = 0.681), respectively, and gradient-boosted machine (GBM) for refractory state, with 53 genes (AUC = 0.686) (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig12">6a</a>). Notably, no clinical features were selected by the final models (Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01789-0#Tab2">2</a>) and, in comparison with RNA-seq, predictive models built using clinical and histology parameters alone performed quite poorly (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig12">6b</a>). AUC values in the omitted inner cross-validation folds were consistent with AUC results in the true test folds. Multiple genes were shared across models, with only 85 required to build all three prediction models and 32 shared between at least one model (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig12">6a</a> and Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01789-0#Tab2">2</a>). Each model selected multiple genes of biological relevance to synovial tissue inflammatory and repair responses, as well as to bone and cartilage biology. Key prediction genes shared between all three models included genes encoding for: <i>XCR1</i>, a marker of DC1 migratory DCs;<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Crozat, K. et al. Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8α+ type. J. Immunol. 187, 4411–4415 (2011)." href="/articles/s41591-022-01789-0#ref-CR17" id="ref-link-section-d51120563e3078">17</a></sup> chemokine <i>CXCL14</i>; acute phase reactant <i>SAA2</i>; and <i>IGHV7-4-1</i>, probably reflecting tissue-resident plasma cells. The refractory state model, which contained the largest number of unique genes, included several linked to the fibroid pathotype such as <i>TNFRSF11B</i>, which encodes the osteoclast negative regulator osteoprotegerin and the chondrocyte adhesion mediator <i>CHAD</i> (chondroadherin), but also the citrullination enzyme PAD4 encoding gene <i>PADI4</i><sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Curran, A. M., Naik, P., Giles, J. T. &amp; Darrah, E. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets. Nat. Rev. Rheumatol. 16, 301–315 (2020)." href="/articles/s41591-022-01789-0#ref-CR19" id="ref-link-section-d51120563e3100">19</a></sup>, consistent with a role of persistent tissue destruction and remodeling in the refractory RA state.</p><p>Although the original clinical trial was not powered for these types of analyses, and larger cohorts will be required to further validate the models and improve their predictive power, these results show that predictive models can harness molecular information from synovial biopsies at baseline before treatment and thus are of potential clinical utility for prediction of response to therapy.</p></div></div></section><section data-title="Discussion"><div class="c-article-section" id="Sec10-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec10">Discussion</h2><div class="c-article-section__content" id="Sec10-content"><p>Our study provides an in-depth molecular and histological profiling of joint tissue from a biopsy-driven, randomized clinical trial in RA (R4RA)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Humby, F. et al. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. Lancet 397, 305–317 (2021)." href="/articles/s41591-022-01789-0#ref-CR9" id="ref-link-section-d51120563e3116">9</a></sup>, affording insights into the cellular and molecular pathways underpinning the diverse treatment response to two commonly used targeted biologic therapies directed against B cells (rituximab) and the IL-6 receptor (tocilizumab). Using both conventional histology and in silico deconvolution, we observed that lymphoid cells were associated with response to rituximab while myeloid cells were associated with response to tocilizumab. Although the importance of synovial macrophages as a predictor of response to anti-TNF has been described<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Yanni, G., Whelan, A., Feighery, C. &amp; Bresnihan, B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann. Rheum. Dis. 53, 39–44 (1994)." href="/articles/s41591-022-01789-0#ref-CR20" id="ref-link-section-d51120563e3120">20</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Bresnihan, B. et al. Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers. J. Rheumatol. 36, 1800–1802 (2009)." href="/articles/s41591-022-01789-0#ref-CR21" id="ref-link-section-d51120563e3123">21</a></sup>, here we report that within the synovial B cell-poor group, an enhanced response to tocilizumab is associated with the presence of myeloid cells. In regard to rituximab, previous small observational studies reported pretreatment synovial CD79a<sup>+</sup> B cells<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Teng, Y. K. et al. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment. Arthritis Rheum. 56, 3909–3918 (2007)." href="/articles/s41591-022-01789-0#ref-CR22" id="ref-link-section-d51120563e3129">22</a></sup> and synovial molecular signatures<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Hogan, V. E. et al. Pretreatment synovial transcriptional profile is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab. Ann. Rheum. Dis. 71, 1888–1894 (2012)." href="/articles/s41591-022-01789-0#ref-CR23" id="ref-link-section-d51120563e3133">23</a></sup> as potential response predictors.</p><p>In this larger, randomized clinical trial cohort we confirmed some of these findings and, combining histological assessment with advanced molecular analyses, we identified genes and pathways linked to the cognate drug targets in association with response. For rituximab these were B cell genes, Igs, chemokines and leukocyte genes. Response to tocilizumab was associated with IL-6 pathway genes, but also with lymphocyte and immunoglobulin genes, which is not surprising since IL-6 is a well-known B cell growth factor<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Choy, E. H. et al. Translating IL-6 biology into effective treatments. Nat. Rev. Rheumatol. 16, 335–345 (2020)." href="/articles/s41591-022-01789-0#ref-CR24" id="ref-link-section-d51120563e3140">24</a></sup>.</p><p>Modular analyses demonstrated how genes increased in rituximab responders were functionally related to antigen presentation and lymphocyte activation, together with interferon signaling genes, in keeping with previous reports linking increased type I interferon with response to rituximab<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Raterman, H. G. et al. The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients. Arthritis Res. Ther. 14, R95 (2012)." href="/articles/s41591-022-01789-0#ref-CR25" id="ref-link-section-d51120563e3147">25</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Thurlings, R. M. et al. Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients. Arthritis Rheum. 62, 3607–3614 (2010)." href="/articles/s41591-022-01789-0#ref-CR26" id="ref-link-section-d51120563e3150">26</a></sup>. In tocilizumab responders, in line with the prominent role of myeloid cells identified by histopathology, the myeloid cell cytokine module was upregulated together with PPAR signaling and metabolic pathways.</p><p>In contrast, nonresponse to both drugs was defined by &gt;1,000 genes and several shared pathways, including Hox, FGFs and ECM genes/modules. Critically, this shared nonresponse signature is linked to the fibroid pauci-immune pathotype characterized by scanty immune cell infiltrate with prevalence of stromal cells<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Lewis, M. J. et al. Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes. Cell Rep. 28, 2455–2470 (2019)." href="/articles/s41591-022-01789-0#ref-CR6" id="ref-link-section-d51120563e3157">6</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Humby, F. et al. Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients. Ann. Rheum. Dis. 78, 761–772 (2019)." href="/articles/s41591-022-01789-0#ref-CR7" id="ref-link-section-d51120563e3160">7</a></sup>, which we also reported as being associated with poor response to synthetic disease-modifying antirheumatic drugs (DMARDs)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Lliso-Ribera, G. et al. Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC). Ann. Rheum. Dis. 78, 1642–1652 (2019)." href="/articles/s41591-022-01789-0#ref-CR27" id="ref-link-section-d51120563e3164">27</a></sup> and TNF inhibitors<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Nerviani, A. et al. A pauci-immune synovial pathotype predicts inadequate response to TNFα-blockade in rheumatoid arthritis patients. Front. Immunol. 11, 845 (2020)." href="/articles/s41591-022-01789-0#ref-CR28" id="ref-link-section-d51120563e3168">28</a></sup>. This supports the concept that the fibroid pauci-immune phenotype represents a refractory endotype, since in R4RA double nonresponder patients conventional synthetic DMARDs (csDMARDs) and TNF inhibitors had already failed, as per trial entry criteria, thus displaying resistance to three biologic therapies targeting distinct immunological pathways (TNF, CD20<sup>+</sup> B cells and IL6R) and meeting the definition of multidrug resistant/refractory RA<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Buch, M. H. Defining refractory rheumatoid arthritis. Ann. Rheum. Dis. 77, 966–969 (2018)." href="/articles/s41591-022-01789-0#ref-CR2" id="ref-link-section-d51120563e3174">2</a></sup>.</p><p>Because recent studies using single-cell RNA-seq (scRNA-seq) on RA synovium identified specific fibroblast subsets with critical roles in RA pathogenesis<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Stephenson, W. et al. Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation. Nat. Commun. 9, 791 (2018)." href="/articles/s41591-022-01789-0#ref-CR13" id="ref-link-section-d51120563e3182">13</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Zhang, F. et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat. Immunol. 20, 928–942 (2019)." href="/articles/s41591-022-01789-0#ref-CR14" id="ref-link-section-d51120563e3185">14</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Croft, A. P. et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature 570, 246–251 (2019)." href="/articles/s41591-022-01789-0#ref-CR16" id="ref-link-section-d51120563e3188">16</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Mizoguchi, F. et al. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat. Commun. 9, 789 (2018)." href="/articles/s41591-022-01789-0#ref-CR29" id="ref-link-section-d51120563e3191">29</a></sup>, we applied modular analysis based on scRNA-seq fibroblast subsets<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Zhang, F. et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat. Immunol. 20, 928–942 (2019)." href="/articles/s41591-022-01789-0#ref-CR14" id="ref-link-section-d51120563e3195">14</a></sup> and orthogonal validation by multiplex immunofluorescence, and identified an association between DKK3<sup>+</sup> fibroblasts and refractoriness. <i>DKK3</i> encodes Dickkopf3, a negative regulator of beta-catenin that has been shown to promote aggressive behaviour in cancer-associated fibroblasts<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Ferrari, N. et al. Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts. Nat. Commun. 10, 130 (2019)." href="/articles/s41591-022-01789-0#ref-CR30" id="ref-link-section-d51120563e3204">30</a></sup>, although the exact function of DKK3<sup>+</sup> fibroblasts in RA remains to be established<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="Marsh, L. J., Kemble, S., Reis Nisa, P., Singh, R. &amp; Croft, A. P. Fibroblast pathology in inflammatory joint disease. Immunol. Rev. 302, 163–183 (2021)." href="/articles/s41591-022-01789-0#ref-CR31" id="ref-link-section-d51120563e3211">31</a></sup>. Furthermore, DSP revealed specific upregulation of genes in the sublining of refractory patients encoding for the fibroblast marker FAP, which has been linked with RA pathogenesis<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Croft, A. P. et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature 570, 246–251 (2019)." href="/articles/s41591-022-01789-0#ref-CR16" id="ref-link-section-d51120563e3215">16</a></sup>, while other markers consistently modulated across all regions included <i>CCL13</i> encoding for the monocyte-attracting chemokine MCP-4, which has been shown to activate synovial fibroblasts<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Iwamoto, T. et al. Monocyte chemoattractant protein-4 (MCP-4)/CCL13 is highly expressed in cartilage from patients with rheumatoid arthritis. Rheumatology (Oxford) 45, 421–424 (2006)." href="/articles/s41591-022-01789-0#ref-CR32" id="ref-link-section-d51120563e3222">32</a></sup>. Hence, stromal cells—and, in particular DKK3<sup>+</sup> fibroblast genes—may be a new drug target that helps overcome the complex problem of refractoriness in RA.</p><p>Genes linked with response included increased expression in the synovial aggregates encoding for CD24, a B cell marker associated with response to biologic treatment<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Salomon, S. et al. Th17 and CD24(hi)CD27(+) regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis. Arthritis Res. Ther. 19, 33 (2017)." href="/articles/s41591-022-01789-0#ref-CR33" id="ref-link-section-d51120563e3231">33</a></sup>. Also consistent with the capacity of biologic therapies to halt structural damage progression<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 34" title="Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann. Rheum. Dis. 79, 685–699 (2020)." href="/articles/s41591-022-01789-0#ref-CR34" id="ref-link-section-d51120563e3235">34</a></sup>, we identified increased expression of RANK transcripts (<i>TNFRSF11A</i>) in the lining/superficial sublining of responders, in line with the reported presence of osteoclast precursors in inflamed synovia<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Vandooren, B., Cantaert, T., Noordenbos, T., Tak, P. P. &amp; Baeten, D. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. Arthritis Rheum. 58, 718–729 (2008)." href="/articles/s41591-022-01789-0#ref-CR35" id="ref-link-section-d51120563e3242">35</a></sup>. Overall, these results suggest that the spatial organization of immune infiltrates is highly relevant for determinion of treatment response/resistance, although additional work is needed to dissect the contribution of specific markers in individual synovial regions and their association with therapy response/resistance.</p><p>The longitudinal analysis of matched pre-/post-treatment synovial biopsies enabled us to investigate drug effects on synovial pathology and gene expression. Rituximab reduced synovial CD20<sup>+</sup> B cells in both responders and nonresponders but, notably, a clinically relevant response required broader and deeper impacts on differentiated CD79a<sup>+</sup> plasmablasts and CD138<sup>+</sup> plasma cells over and above CD20<sup>+</sup> B cell depletion. These observations are in agreement with previous observational studies showing changes in plasma cells between responders and nonresponders to rituximab<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Kavanaugh, A. et al. Assessment of rituximab’s immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results. Ann. Rheum. Dis. 67, 402–408 (2008)." href="/articles/s41591-022-01789-0#ref-CR36" id="ref-link-section-d51120563e3257">36</a></sup>. However, another study showed variable depletion of B cells and plasma cells and an unclear association with treatment response<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 37" title="Ramwadhdoebe, T. H. et al. Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis. Rheumatology (Oxford) 58, 1075–1085 (2019)." href="/articles/s41591-022-01789-0#ref-CR37" id="ref-link-section-d51120563e3262">37</a></sup>, although the small sample size and biopsy analysis at different time points (4, 8, 12 and 16 weeks) make it difficult to draw conclusions. In our study, because repeated synovial biopsy was performed at 16 weeks following one cycle of rituximab (2× 1-g infusion), it is plausible that a repeated biopsy at the time of the second infusion at 6 months (not available in sufficient numbers to be informative) could have detected a wider/deeper effect on B cell lineages linked to clinical response.</p><p>Following tocilizumab therapy, nonresponders were characterized by a failure to reduce sublining macrophages, which is consistent with previous literature indicating macrophages as markers of treatment response<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Yanni, G., Whelan, A., Feighery, C. &amp; Bresnihan, B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann. Rheum. Dis. 53, 39–44 (1994)." href="/articles/s41591-022-01789-0#ref-CR20" id="ref-link-section-d51120563e3269">20</a></sup>.</p><p>To assess the relationship of gene expression changes and treatment response, we developed a pipeline for mixed-model analysis of RNA-seq data in repeat biopsies. This revealed patterns of change in gene expression not detectable by standard analytical pipelines, while interaction analysis allowed us to identify genes that were affected by each drug specifically. Biological differences in synovial gene expression following treatment with rituximab or tocilizumab were consistent with the cognate treatment targets: B cell depletion and IL-6 receptor blockade, but also revealed unexpected differences such as differential changes in metalloproteinases. Interaction analysis showed that rituximab responders had a greater decrease in genes encoding for serum amyloid proteins, Ig chains, the citrullination enzyme PADI2 and transcriptional regulator RORgamma. In tocilizumab responders, a greater reduction in pro-lymphoid follicle development genes was observed in keeping with the important role of IL-6 as a B cell growth factor driving in situ ectopic lymphoid structure development within inflamed tissues<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Hill, D. G., Ward, A., Nicholson, L. B. &amp; Jones, G. W. Emerging roles for IL-6 family cytokines as positive and negative regulators of ectopic lymphoid structures. Cytokine 146, 155650 (2021)." href="/articles/s41591-022-01789-0#ref-CR38" id="ref-link-section-d51120563e3276">38</a></sup>.</p><p>In translational terms, the importance of molecular studies is measured by their ability to enhance disease understanding, but also on their clinical impact<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Nouri, B., Nair, N. &amp; Barton, A. Predicting treatment response to IL6R blockers in rheumatoid arthritis. Rheumatology (Oxford) 59, 3603–3610 (2020)." href="/articles/s41591-022-01789-0#ref-CR39" id="ref-link-section-d51120563e3283">39</a></sup>. Thus, to determine the predictive value of deep molecular characterization in foretelling treatment response, we applied a number of machine learning methodologies resulting in the selection of models effective at predicting treatment response as tested by nested cross-validation (AUC for rituximab = 0.744, tocilizumab = 0.681, refractoriness = 0.686). The purpose of testing multiple models was to determine whether nonlinear algorithms (least-squares support vector machine (SVM), penalized discriminant analysis (PDA), mixture discriminant analysis (MDA), tree-based and so on) could outperform elastic net linear regression. In practice, for prediction of response to each drug individually, elastic net regression performed best. However, a GBM model was superior in predicting refractoriness, consistent with the notion that biological heterogeneity underlying refractoriness to multiple drugs might require a nonlinear algorithm for optimal prediction. Of relevance to future clinical practice, gene expression models were clearly superior to those built using clinical and histological data alone. Seropositivity, which has been weakly associated with response to rituximab<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Isaacs, J. D. et al. Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis. Ann. Rheum. Dis. 72, 329–336 (2013)." href="/articles/s41591-022-01789-0#ref-CR40" id="ref-link-section-d51120563e3287">40</a></sup> was not included in the final models.</p><p>A known limitation of this study is the relatively modest sample size of the training data for each predictive model. However, the study was powered purely for the primary outcome of the original clinical trial and numbers reflect the difficulty in conducting biopsy-driven randomized trials in RA. With the current sample size and case/biomarker ratio, statistical theory suggests that we are likely to be only part of the way up the learning curve<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="McKeigue, P. Sample size requirements for learning to classify with high-dimensional biomarker panels. Stat. Methods Med. Res. 28, 904–910 (2019)." href="/articles/s41591-022-01789-0#ref-CR41" id="ref-link-section-d51120563e3295">41</a></sup>. The AUCs derived in this study would still be relatively low for direct application to clinical use without further validation and improvement. Refining and reducing the number of genes in the models with validation in independent cohorts could improve the prediction models, as could incorporation of information from single-cell studies and enhanced deconvolution methods. Another limitation with regard to interpretation of the longitudinal results is that the second biopsy at 16 weeks was an optional procedure and, thus, at risk of selection bias. Although there were no major baseline differences, patients who underwent repeated biopsy had lower response rates, which is expected because responders would have been less likely to consent to a second biopsy.</p><p>In conclusion, this study provides insights from analysis of diseased tissue regarding the mechanisms driving treatment response heterogeneity in RA, and underscores the importance of integrating predictive molecular pathology signatures into clinical algorithms to optimize the usage of existing drugs. The identification of genes and cell types associated with multidrug resistance could aid the development of new drugs for refractory patients in whom current medications targeting classical immune pathways are not effective. We envisage that routine use of synovial biopsies could facilitate a patient-centered approach<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Pitzalis, C., Choy, E. H. S. &amp; Buch, M. H. Transforming clinical trials in rheumatology: towards patient-centric precision medicine. Nat. Rev. Rheumatol. 16, 590–599 (2020)." href="/articles/s41591-022-01789-0#ref-CR5" id="ref-link-section-d51120563e3302">5</a></sup> to the management of RA, thus moving away from the current trial-and-error drug prescribing towards an emergent era in which selection of the optimal drug is based on synovial biopsy gene signatures.</p></div></div></section><section data-title="Methods"><div class="c-article-section" id="Sec11-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec11">Methods</h2><div class="c-article-section__content" id="Sec11-content"><h3 class="c-article__sub-heading" id="Sec12">Patients and intervention</h3><p>A total of 164 patients aged 18 years or over, fulfilling the 2010 American College of Rheumatology/European Alliance of Associations for Rheumatology (EULAR) classification criteria for RA and who were eligible for treatment with rituximab therapy according to UK NICE guidelines—that is, failing or intolerant to csDMARD therapy and at least one biologic therapy (excluding trial IMPs), were recruited when fulfilling the trial inclusion/exclusion criteria (for the full study protocol and baseline patient characteristics see Humby et al.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Humby, F. et al. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. Lancet 397, 305–317 (2021)." href="/articles/s41591-022-01789-0#ref-CR9" id="ref-link-section-d51120563e3318">9</a></sup>). Briefly, patients underwent synovial biopsy of a clinically active joint at entry to the trial, performed according to the expertise of a local center as either an ultrasound-guided or arthroscopic procedure<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Kelly, S. et al. Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients. Ann. Rheum. Dis. 74, 611–617 (2015)." href="/articles/s41591-022-01789-0#ref-CR42" id="ref-link-section-d51120563e3322">42</a></sup> Following synovial biopsy, patients were randomized to receive rituximab as two 1,000-mg intravenous infusions 2 weeks apart or intravenous tocilizumab at a dose of 8 mg kg<sup>−1</sup> administered at 4-weekly intervals. Patients were followed up every 4 weeks throughout the 48-week trial treatment period, during which RA disease activity measurements and safety data were collected. An optional repeated synovial biopsy of the same joint sampled at baseline was performed at 16 weeks (Supplementary Tables <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM1">3</a> and <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM1">4</a>). The study protocol has been published online (<a href="http://www.r4ra-nihr.whri.qmul.ac.uk/docs/r4ra_protocol_version_9_30.10.2017_clean.pdf">http://www.r4ra-nihr.whri.qmul.ac.uk/docs/r4ra_protocol_version_9_30.10.2017_clean.pdf</a>) and was registered on the ISRCTN database (no. ISRCTN97443826) and with EudraCT (no. 2012-002535-28). Patient demographics are reported in the original trial publication<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Humby, F. et al. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. Lancet 397, 305–317 (2021)." href="/articles/s41591-022-01789-0#ref-CR9" id="ref-link-section-d51120563e3342">9</a></sup>. All patients provided written informed consent. Participants did not receive any compensation, except for reimbursement of travel expenses. The study was done in compliance with the Declaration of Helsinki, International Conference on Harmonization Guidelines for Good Clinical Practice and local country regulations. The protocol was approved by the institutional review board of each study center or relevant independent ethics committee (UK Medical Research and Ethics Committe, reference no. 12/WA/0307). The complete list of ethics committees to have approved the protocol is reported below.</p><p><b>UK ethics committee</b></p><ul class="u-list-style-bullet">
                  <li>
                    <p>Wales REC 3 (formerly REC for Wales)</p>
                  </li>
                </ul><p><b>Local ethics committees at EU sites</b></p><ul class="u-list-style-bullet">
                  <li>
                    <p>Comité d’Ethique Hospitalo-Facultaire</p>
                  </li>
                  <li>
                    <p>Comissão de Ética para a Investigação Clínica</p>
                  </li>
                  <li>
                    <p>Comitato Etico Interaziendale AOU ‘Maggiore della Carità’ di Novara, ASL BI, ASL NO, ASL VCO</p>
                  </li>
                  <li>
                    <p>Commissie Medische Ethiek UZ KU Leuven/Onderzoek</p>
                  </li>
                  <li>
                    <p>Comité Ético de Investigación Clínica del Hospital Clínic de Barcelona</p>
                  </li>
                  <li>
                    <p>Comitato Etico, Fondazione IRCCS Policlinico San Matteo</p>
                  </li>
                  <li>
                    <p>Regione Autonoma della Sardegna Azienda Ospedaliero Universitaria di Cagliari Comitato Etico Indipendente</p>
                  </li>
                </ul><p><b>Complete list of participating sites for data collection:</b></p><ul class="u-list-style-bullet">
                  <li>
                    <p>Mile End Hospital and Whipps Cross Hospital, Bart’s Health NHS Trust, London, UK</p>
                  </li>
                  <li>
                    <p>Cliniques Universitaires Saint Luc, Louvain, Belgium</p>
                  </li>
                  <li>
                    <p>Santa Maria Hospital, Lisbon, Portugal</p>
                  </li>
                  <li>
                    <p>Azienda ospedaliera Maggiore della Carità, Novara, Italy</p>
                  </li>
                  <li>
                    <p>University Hospital of Wales, Cardiff and Vale University Health Board, Cardiff, UK</p>
                  </li>
                  <li>
                    <p>Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK</p>
                  </li>
                  <li>
                    <p>Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK</p>
                  </li>
                  <li>
                    <p>Basildon University Hospital, Mid and South Essex NHS Foundation Trust (formerly Basildon and Thurrock University Hospital NHS Foundation Trust), Basildon, UK</p>
                  </li>
                  <li>
                    <p>Hospital Clínic de Barcelona, Barcelona, Spain</p>
                  </li>
                  <li>
                    <p>Southend University Hospital, Mid and South Essex NHS Foundation Trust (formerly Southend University Hospital NHS Foundation Trust), Southend, UK</p>
                  </li>
                  <li>
                    <p>Chapel Allerton Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK</p>
                  </li>
                  <li>
                    <p>Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy</p>
                  </li>
                  <li>
                    <p>Homerton University Hospital, Homerton University Hospital NHS Foundation Trust, London, UK</p>
                  </li>
                  <li>
                    <p>Nuffield Orthopaedic Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK</p>
                  </li>
                  <li>
                    <p>Aintree University Hospital, Aintree University Hospital NHS Foundation Trust, Liverpool, UK</p>
                  </li>
                  <li>
                    <p>Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK</p>
                  </li>
                  <li>
                    <p>Guy’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London, UK</p>
                  </li>
                  <li>
                    <p>Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy</p>
                  </li>
                  <li>
                    <p>Universitair Ziekenhuis Leuven, Leuven, Belgium</p>
                  </li>
                </ul><h3 class="c-article__sub-heading" id="Sec13">Response criteria and treatment switch</h3><p>The primary endpoint was defined as CDAI ≥ 50% improvement from baseline at 16 weeks<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Humby, F. et al. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. Lancet 397, 305–317 (2021)." href="/articles/s41591-022-01789-0#ref-CR9" id="ref-link-section-d51120563e3538">9</a></sup>. CDAI is calculated by totaling the number of tender joints (0–28), the number of swollen joints (0–28), patient global health assessment on a 0–10 visuoanalogic scale and the care provider global health assessment on a 0–10 visual analog scale.</p><p>As shown in Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM1">1</a>, CDAI 50% nonresponders at 16 weeks were switched to the alternative biologic agent and their response was assessed at 16 weeks following the switch, as determined by CDAI 50% improvement. Including crossover patients, a total of 108 patients were treated with rituximab and 117 with tocilizumab. Of those treated with rituximab, 43 were defined responders (40%) while 53 responded to tocilizumab (45%). Among all responders, 11 responded to rituximab following tocilizumab failure and were classified as exclusive responders to rituximab (pro-rituximab), while 13 responded to tocilizumab following rituximab failure and were thus classified as pro-tocilizumab. Patients in whom both drugs failed throughout the study were classified as multidrug resistant/refractory (<i>n</i> = 40).</p><h3 class="c-article__sub-heading" id="Sec14">Histological analysis</h3><p>A minimum of six synovial biopsies were processed in an Excelsior tissue processor before being paraffin-embedded en masse at Queen Mary University of London Core Pathology department. Tissue sections (3–5 µm thickness) were stained with hematoxylin and eosin and IHC markers CD20 (B cells), CD138 (plasma cells), CD21 (follicular dendritic cells) and CD68 (macrophages) in an automated Ventana Autostainer machine. CD79A (B cells) and CD3 (T cells) staining was performed in-house on deparaffinized tissue following antigen retrieval (30 min at 95 °C), followed by peroxidase- and protein-blocking steps. Primary antibodies (CD79A (clone JCB117, Dako), CD3 (clone F7.238, Dako), CD20 (clone L26, Dako), CD68 (clone KP1, Dako) and CD138 (clone MI15, Dako)) were used for 60 min at room temperature. Visualization of antibody binding was achieved by 30-min incubation with Dako EnVisionTM+ before completion by the addition of 3,3′-diaminobenzidine (DAB) + substrate chromogen for 10 s, followed by counterstaining with hematoxylin. Following IHC staining, sections underwent semiquantitative scoring (0–4), by a minimum of two assessors, to determine levels of CD20<sup>+</sup> and CD79a<sup>+</sup> B cells, CD3<sup>+</sup> T cells, CD138<sup>+</sup> plasma cells and CD68<sup>+</sup> lining (L) and sublining (SL) macrophages, adapted from a previously described score<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="Bugatti, S. et al. High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease. Rheumatology (Oxford) 53, 1886–1895 (2014)." href="/articles/s41591-022-01789-0#ref-CR43" id="ref-link-section-d51120563e3570">43</a></sup> and recently validated for CD20<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Rivellese, F. et al. B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure. Arthritis Rheumatol. 72, 714–725 (2020)." href="/articles/s41591-022-01789-0#ref-CR44" id="ref-link-section-d51120563e3574">44</a></sup>. Hematoxylin-and-eosin-stained slides also underwent evaluation to determine the level of synovitis according to the Krenn synovitis score (0–9)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Krenn, V. et al. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 49, 358–364 (2006)." href="/articles/s41591-022-01789-0#ref-CR45" id="ref-link-section-d51120563e3578">45</a></sup>. The sum of semiquantitative scores for Krenn synovitis score (0–9), CD20 (0–4), CD3 (0–4), CD138 (0–4) and CD68 (0–4) is reported as the immune score (0–25). Synovial biopsies were classified into synovial histological patterns, also known as pathotypes, according to the following criteria: (1) lymphomyeloid presence of grade 2–3 CD20<sup>+</sup> aggregates, CD20 ≥2 and/or CD138 ≥2; (2) diffuse-myeloid CD68SL ≥2, CD20 ≤1 and/or CD3 ≥1 and CD138 ≤2; and (3) pauci-immune-fibroid CD68SL &lt;2 and CD3, CD20 and CD138 &lt;1.</p><h3 class="c-article__sub-heading" id="Sec15">RNA-seq and molecular classification/analysis</h3><p>A minimum of six synovial samples per patient were immediately immersed in RNA-Later and RNA was extracted from tissue using one of two protocols: phenol/chloroform isolation and Zymo Direct-zol RNA MicroPrep–Total RNA/miRNA Extraction kit. In both methods, tissue was lysed in Trizol solution using a LabGen125 homogenizer. Briefly, for the phenol/chloroform extraction method, 1–10 mg of tissue was lysed and then sheared using a 21 G needle. The tissue lysate was then mixed vigorously with chloroform before centrifugation. The aqueous phase was removed and mixed with ice-cold isopropanol for 30 min. Following further centrifugation, the RNA pellet was washed in 70% ethanol before air-drying and resuspension in RNAse-free water. Samples extracted using Zymo Direct-zol Miniprep kits were processed as per the manufacturer’s instructions. Briefly, 1–10 mg of tissue lysate was run through the Zymo-Spin IC column. Columns were then washed using the appropriate kit wash buffers before RNA was eluted and resuspended in RNAse-free water. Quality control was carried out by quantifying samples via spectrophotometer readings on a Nanodrop ND2000C. RNA integrity was measured using Pico-chip technology on an Agilent 2100 Bioanalyzer to determine RNA integrity number. A total of 214 synovial tissue samples were available for RNA extraction and were subsequently sent for RNA-seq to Genewiz. RNA-seq libraries were prepared using the NEBNext Ultra RNA Library Prep kit for Illumina, following the manufacturer’s (NEB) instructions. Briefly, messenger RNAs were initially enriched with Oligo d(T) beads followed by limited PCR cycles. The sequencing library was validated on an Agilent TapeStation (Agilent Technologies) and quantified using a Qubit 2.0 Fluorometer (Invitrogen), as well as by quantitative PCR (KAPA Biosystems). The sequencing libraries were clustered on Illumina flowcells. Sequencing was performed on an Illumina HiSeq instrument according to the manufacturer’s instruction. Samples were sequenced using a 2 × 150-base-pair (BP) paired-end configuration.</p><h3 class="c-article__sub-heading" id="Sec16">RNA-seq data processing</h3><p>A total of 214 paired-end RNA-seq samples from 50 million reads of 150-bp length were trimmed to remove the Illumina adapters using bbduk from the BBMap package v.37.93, with default parameters. Transcripts were then quantified using Salmon<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. &amp; Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417–419 (2017)." href="/articles/s41591-022-01789-0#ref-CR46" id="ref-link-section-d51120563e3601">46</a></sup> v.0.13.1 and an index generated from the Gencode release 29 transcriptome following the standard operating procedure. Tximport v.1.13.10 was used to aggregate transcript-level expression data to genes, then counts were subjected to variance-stabilizing transformation (VST) using the DESeq2 v.1.25.9 package<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 47" title="Love, M. I., Huber, W. &amp; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014)." href="/articles/s41591-022-01789-0#ref-CR47" id="ref-link-section-d51120563e3605">47</a></sup>. Following RNA-seq quality control, 36 samples were excluded due to poor mapping or RNA quality. Using unsupervised PCA and plotting the first five eigenvectors in pairs, one outlier was identified and removed from further analysis. Thus RNA-seq data from 133 patients were available for subsequent analysis at baseline, and from 44 patients for the follow-up time point. Baseline characteristics of patients with available RNA-seq are shown in Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM1">5</a>. The first six PCs did not associate with demographics, treatment and its associated response or clinical disease features such as disease activity or anticyclic citrullinated protein antibody status (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig8">2a,c,d</a>).</p><p>Starting with length-scaled transcripts per million (TPM) counts derived using the R package tximport, Limma voom was used for normalization of data and calculation of weights for linear modeling<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Law, C. W., Chen, Y., Shi, W. &amp; Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014)." href="/articles/s41591-022-01789-0#ref-CR48" id="ref-link-section-d51120563e3618">48</a></sup>.</p><h3 class="c-article__sub-heading" id="Sec17">Cluster analysis</h3><p>For cluster analysis, after removal of low-expressed genes, VST data were filtered using a coefficient of variation cutoff of &gt;0.075 to select the 22,256 (of 56,809) most variable genes . These genes were used for cluster analysis of all baseline patients (<i>n</i> = 133) using the M3C algorithm<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="John, C. R. et al. M3C: Monte Carlo reference-based consensus clustering. Sci. Rep. 10, 1816 (2020)." href="/articles/s41591-022-01789-0#ref-CR11" id="ref-link-section-d51120563e3633">11</a></sup> with partitioning around medoids clustering and 1,000 iterations. The lowest penalized cluster stability Index was used to select the number of clusters. After cluster assignment, patients were split into treatment groups using Pearson’s distance metric and complete linkage method, and plotted using the ComplexHeatmap package (v.2.2.0) in R. An <i>χ</i><sup>2</sup> test was applied to test significance between clusters and response to treatment based on the trial primary outcome measure (CDAI 50%) and, additionally, EULAR C-reactive protein (CRP) response (EULAR response) as another commonly used criterion.</p><h3 class="c-article__sub-heading" id="Sec18">Differential expression and modular analysis of RNA-seq data</h3><p>Samples from all patients treated with either rituximab or tocilizumab throughout the trial were included in DEG analysis. This also comprised nonresponders who, as per trial protocol, were switched to the alternative medication at week 16, as shown in Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM1">1</a>. Neither responders nor nonresponders showed any significant differences in their baseline characteristics, including histological and molecular B cell status, gender or disease duration (Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM1">6</a>). Low-expressed genes were excluded from analysis, with the remaining 30,841 used for DEG analysis. This was based on negative binomial distribution via regression models of normalized count data using DESeq2, and a Wald test to compare variation between treatment response groups in synovium RNA-seq samples. Wald test-derived <i>P</i> values were FDR adjusted using Storey’s <i>q</i>-value, with a cutoff of <i>q</i> &lt; 0.05 used to define significantly DEGs (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM3">1</a>). Distributions of DEGs are illustrated in volcano plots, and DESeq2 outputs were used for further modular analysis with the Bioconductor package QuSAGE v.2.10.0. Gene modules from Li et al.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Li, S. et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. 15, 195–204 (2014)." href="/articles/s41591-022-01789-0#ref-CR12" id="ref-link-section-d51120563e3668">12</a></sup> and WGCNA modules were selected for gene set enrichment.</p><h3 class="c-article__sub-heading" id="Sec19">Deconvolution</h3><p>MCP-counter<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 10" title="Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17, 218 (2016)." href="/articles/s41591-022-01789-0#ref-CR10" id="ref-link-section-d51120563e3680">10</a></sup> was used to deconvolute synovial RNA-seq, with the package Immunedeconv. Following deconvolution, patients were classified into rich/poor according to the median value of the individual cell type (for example, B cell rich if above the median value of MCP B cells, poor if below). For the enrichment of four fibroblast subtypes (SC-F1: <i>CD34</i><sup>+</sup> <i>sublining</i>, SC-F2: <i>HLA</i><sup>+</sup> <i>sublining</i>, SC-F3: <i>DKK3</i><sup>+</sup> <i>sublining</i> and SC-F4: <i>CD55</i><sup>+</sup> <i>lining</i>), we used average expression of gene signatures obtained from differential gene expression analysis and known markers previously described by scRNA-seq<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Zhang, F. et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat. Immunol. 20, 928–942 (2019)." href="/articles/s41591-022-01789-0#ref-CR14" id="ref-link-section-d51120563e3714">14</a></sup>. Module scores for each subtype were calculated using the AddModuleScore function in the R package Seurat. The top five differentially expressed genes were considered subtype-specific gene sets and did not have genes in common. Wilcoxon testing was used for statistical assessment of module scores when comparing responders and nonresponders.</p><h3 class="c-article__sub-heading" id="Sec20">Crossover analysis of patients who underwent treatment switch</h3><p>The drug-crossover analysis was performed on baseline RNA-seq samples of patients who underwent treatment switch (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig3">3a</a>). RNA-seq counts of protein-coding genes (<i>n</i> = 19,508) were used to perform a likelihood ratio test (LRT) that was calculated in comparison to a reduced model with the DESeq2 R package. Three-dimensional volcano plots and radial plots were generated using the volcano3D (v.1.0.3) package in R (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig3">3c–e</a>). QuSAGE was applied using WGCNA-derived gene modules, and radial plots were created using the volcano3D package with a <i>P</i> value significance threshold of &lt;0.05 (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig3">3e</a>).</p><h3 class="c-article__sub-heading" id="Sec21">Multiplex immunofluorescence</h3><p>Immunofluorescence staining was performed on 3-µm, formalin-fixed, paraffin-embedded human sections obtained from synovial tissues of patients with RA. Tissue sections were deparaffinized in sequential changes of xylene and ethanol chambers before washing and placing in a preheated target retrieval solution (pH 6.0; Dako, no. S1699) in a pressure cooker for 15 min. Tissue sections were allowed to cool at room temperature (RT) before washing in Tris-buffered saline (TBS). Endogenous peroxidase and biotin activity were blocked with peroxidase (Dako, no. S2023) for 10 min at RT.</p><p>Antibody specifications used for immunofluorescence can be found in Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM1">7</a>. In brief, for CD90/CD45/DKK3 staining, protein block (Dako, no. X0909) was applied for 1 h, slides were stained with the first primary antibody (CD45; Dako, no. M0701, mouse IgG1), washed three times in TBS then incubated with Anti-Mouse Envision system horseradish peroxidase (HRP; Dako, no. K4001) for 30 min at RT. After three washes in TBS, the Cy5/Alx647-conjugated Tyramide reagent (1:100; Thermofisher, no. B40958) was applied for 3 min. After three washes in TBS, antibody stripping was performed by placing slides in preheated target retrieval solution (pH 6.0; Dako, no. S1699) in a pressure cooker for 15 min. This process was repeated for one of two additional primary antibodies: CD90 (1:240; Abcam, no. 133350, rabbit) or DKK3 (1:150; Sigma-Aldrich, no. HPA011868, rabbit), followed by Anti-Rabbit Envision system HRP (Dako, no. K4003) and Alx488-conjugated Tyramide reagent for CD90 (1:100; Thermofisher, no. B40953) or Alx555-conjugated Tyramide reagent for DKK3 (1:100; Thermofisher, no. B40955), with antibody stripping in between as described above.</p><p>DAPI (Thermofisher) nuclear counterstaining was applied for 10 min at RT and slides were then mounted with ProLong Gold Antifade reagent (Thermofisher).</p><p>Images were captured using a NanoZoomer S60 Digital slide scanner (Hamamatsu, no. C13210-01) at ×20 magnification at a resolution of 440 nm per pixel (DPI, no. 57727), with the following exposure times: CD45 alx647 Cy5, 16 ms; CD90 alx488 FITC, 32 ms; DKK3 alx555 TRITC, 24 ms; DAPI, 224 ms. Image analysis was performed using NDP.view 2 Software (Hamamatsu Photonics, no. U12388-01).</p><h3 class="c-article__sub-heading" id="Sec22">GeoMx DSP</h3><p>Formalin-fixed, paraffin-embedded synovial tissue from 12 patients with RA, before treatment with rituximab or tocilizumab, was profiled using the GeoMx DSP platform as previously described<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 49" title="Helmink, B. A. et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577, 549–555 (2020)." href="/articles/s41591-022-01789-0#ref-CR49" id="ref-link-section-d51120563e3770">49</a></sup>. Briefly, tissue morphology was visualized using fluorescent antibodies CD68-AF532 (clone KP1, Novus), CD20-DL594 (clone IGEL/773, Novus) and CD3-AF647 (clone UMAB54, Origene) and Syto13 (ThermoFisher).</p><p>For the NanoString GeoMx DSP WTA assay, slides were prepared following the automated Leica Bond RNA Slide Preparation Protocol (NanoString, no. MAN-10131-03). In situ hybridizations with the GeoMx Whole Transcriptome Atlas Panel (WTA, 18,677 genes) at 4-nM final concentration were done in Buffer R (NanoString). Morphology markers were prepared for four slides concurrently using Syto13 (DNA), CD20, CD3 and CD68 in Buffer W for a total volume of 125 μl per slide. Slides incubated with 125 μl of morphology marker solution at RT for 1 h, then washed in SSC and loaded onto the NanoString DSP instrument.</p><p>On the DSP instrument each slide was scanned with a ×20 objective at scan parameters 60 ms FITC/525 nm, 200 ms Cy3/568 nm, 250 ms Texas Red/615 nm and 300 ms Cy5/666 nm.</p><p>The resulting immunofluorescent images were used to select six freeform polygon-shaped ROIs containing approximately 200 nuclei in CD68<sup>+</sup> synovial tissue lining and superficial sublining, CD20<sup>–</sup>CD3<sup>–</sup> sublining and CD20<sup>+</sup>CD3<sup>+</sup> lymphocyte aggregates.</p><p>After approval of ROIs, GeoMx DSP photocleaved the ultraviolet (UV)-cleavable barcoded linker of bound RNA probes and collected individual segmented areas into separate wells in a 96-well collection plate.</p><p>The dataset included 72 ROIs from 12 patients (four refractory and eight responder) across the three ROI types. An NTC water well was used for quality control checks.</p><h3 class="c-article__sub-heading" id="Sec23">DSP analysis</h3><p>GeoMx WTA sequencing reads from NovaSeq6000 were compiled into FASTQ files corresponding to each ROI. FASTQ files were then converted to digital count conversion files using the NanoString GeoMx NGS DnD Pipeline. Out of 18,677 genes, 17,065 exceeded the lower level of quantitation (LOQ) in &gt;10% of ROIs; genes that did not exceed LOQ were excluded from the analysis. For normalization, counts were divided by sample-specific size factors determined by the median ratio of gene counts relative to geometric mean per gene. The DESeq2 R package was used for this preprocessing step.</p><h3 class="c-article__sub-heading" id="Sec24">Differential expression analysis</h3><p>We conducted differential expression analysis to compare responders and refractory patients using DESeq2<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 50" title="Bhattacharya, A. et al. An approach for normalization and quality control for NanoString RNA expression data. Brief. Bioinform. 22, bbaa163 (2021)." href="/articles/s41591-022-01789-0#ref-CR50" id="ref-link-section-d51120563e3816">50</a></sup>. This analysis was done for all ROIs simultaneously (responders, <i>n</i> = 48; refractory, <i>n</i> = 24) but separately for each location in the synovial layer: CD68<sup>+</sup> lining/superficial sublining (responders, <i>n</i> = 17; refractory, <i>n</i> = 8); CD20<sup>–</sup>CD3<sup>–</sup> deep sublining (responders, <i>n</i> = 21, refractory <i>n</i> = 12); and CD3<sup>+</sup>CD20<sup>+</sup> lymphoid aggregates (responders, <i>n</i> = 10; refractory, <i>n</i> = 4). Since samples were collected from different locations, in the analysis of all samples we included location as a covariate (~location + response) to eliminate its influence on gene expression. The <i>qvalue</i> R package implementing Storey’s <i>q</i>-value method was used to correct for multiple testing effects, and a cutoff of <i>q</i> &lt; 0.05 was used to define significantly DEGs.</p><h3 class="c-article__sub-heading" id="Sec25">Longitudinal mixed-effects model analysis</h3><p>Longitudinal analysis of RNA-seq on paired synovial biopsies was performed by fitting a negative binomial distribution GLMM for each gene. Because the most widely used mainstream differential gene expression analysis tools—edgeR, DESeq2<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 47" title="Love, M. I., Huber, W. &amp; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014)." href="/articles/s41591-022-01789-0#ref-CR47" id="ref-link-section-d51120563e3873">47</a></sup> and Limma voom<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Law, C. W., Chen, Y., Shi, W. &amp; Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014)." href="/articles/s41591-022-01789-0#ref-CR48" id="ref-link-section-d51120563e3877">48</a></sup>—are all unable to fit mixed-effects linear models, we developed the R package glmmSeq to fit negative binomial mixed-effects models at the individual gene level. glmmSeq uses the glmer function from the R package lme4 (v.1.1-25), with negative binomial family function from the MASS package (v.7.3-53). Models were fit using maximum-likelihood estimation by Laplace approximation and bound optimization by quadratic approximation. For analysis of the differential effects of the two trial medications over time, the following model was fitted for each gene individually:</p><div id="Equa" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\begin{array}{c}{{Y}}_{{{{\mathrm{ijg}}}}}\sim {{{\mathrm{NB}}}}\left( {\mu _{{{{\mathrm{ijg}}}}},\alpha _{{{\mathrm{g}}}}} \right)\\ {{{\mathrm{log}}}}\left( {\mu _{{\mathrm{ijg}}}} \right) = o_{{\mathrm{ij}}} + \beta _{{\mathrm{g}}0} + \beta _{{\mathrm{g}}1}{{{\mathrm{time}}}}_{{{{\mathrm{ij}}}}} + \beta _{{\mathrm{g}}2}{{{\mathrm{medication}}}}_{{{{{\mathrm{i}}}}}} + \beta _{{{{\mathrm{g}}}}3}{{{\mathrm{time}}}}_{{{{\mathrm{ij}}}}}{{{\mathrm{medication}}}}_{\mathrm{i}} + {{{{b}}}}_{{{{\mathrm{gi}}}}}\\ {{{{b}}}}_{{{{\mathrm{gi}}}}}\sim N\left( {0,\sigma _{{{{\mathrm{gb}}}}}^2} \right)\end{array}$$</span></div></div><p>where <i>Y</i><sub>ijg</sub> is the longitudinal raw count of gene g in individual I at timepoint j, <i>α</i><sub>g</sub> is the dispersion parameter for each gene, <i>o</i><sub>ij</sub> is an offset term scaled to the logarithm of the total library size for each sample, <i>b</i><sub>gi</sub> are random effects between individual patients, and N and NB are the functions for normal distribution and negative binomial distribution, respectively. TPM counts were used as input, and only individuals with paired samples were included (88 samples, 44 individuals). The dispersion parameter for the negative binomial distribution for each gene was calculated using the DESeq2 function estimateDispersions. To reduce the problem of inflated model coefficients relating to zero counts, genes of low expression were removed using the Limma (v.3.44.3) function filterByExpr and zero counts were adjusted to a pseudo-count of 0.125, equivalent to the ‘prior count’ approach of edgeR and Voom<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Law, C. W., Chen, Y., Shi, W. &amp; Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014)." href="/articles/s41591-022-01789-0#ref-CR48" id="ref-link-section-d51120563e4226">48</a></sup> whose internal defaults are 0.125 and 0.5, respectively. Statistical testing of the fitted model coefficients was performed using the Wald type 2 <i>χ</i><sup>2</sup> test from the car package (v.3.0-10). <i>P</i> values were FDR adjusted using Storey’s <i>q</i>-value, with a cutoff of FDR &lt; 0.05 considered significant for each term in the model (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM6">4</a>). Predictions were calculated for each fitted gene model based on the fitted linear model coefficients, and 95% CIs for the fixed effects of the fitted model were calculated from standard deviations of the predictions by extracting prediction variances as the diagonal from the variance–covariance matrix of the predictions <i>XVX</i>, where <i>X</i> represents the model matrix corresponding to the new data and <i>V</i> is the variance–covariance matrix of the model parameters. Similarly, for analysis of the difference between CDAI 50% responders and nonresponders following drug exposure for each medication, the following model was fitted for each drug cohort (58 samples, 29 individuals for rituximab; 30 samples, 15 individuals for tocilizumab):</p><div id="Equb" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$${{{\mathrm{log}}}}\left( {\mu _{{{{\mathrm{ijg}}}}}} \right) = o_{{{{\mathrm{ij}}}}} + \beta _{{{{\mathrm{g}}}}0} + \beta _{{{{\mathrm{g}}}}1}{{{\mathrm{time}}}}_{{{{\mathrm{ij}}}}} + \beta _{{{{\mathrm{g}}}}2}{{{\mathrm{response}}}}_{{{\mathrm{i}}}} + \beta _{{{{\mathrm{g}}}}3}{{{\mathrm{time}}}}_{{{{\mathrm{ij}}}}}{{{\mathrm{response}}}}_{{{\mathrm{i}}}} + {{{{b}}}}_{{{{\mathrm{gi}}}}}$$</span></div></div><p>The R package glmmSeq is downloadable via CRAN and the source code is also available, from <a href="https://github.com/KatrionaGoldmann/glmmSeq">https://github.com/KatrionaGoldmann/glmmSeq</a>. When compared against a Gaussian linear mixed-effects model on log count data, glmmSeq showed similar results with strong correlation between <i>P</i> values generated using either distribution (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM1">2a–c</a>). Q–Q plots suggested that the negative binomial mixed model showed greater power in identification of significant effects (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM1">2d–f</a>).</p><h3 class="c-article__sub-heading" id="Sec26">Longitudinal pathway analysis</h3><p>Genes showing a significant change in the analysis described in the previous section were used for GO/pathway enrichment analysis by means of the clueGO (v.2.5.5) Cytoscape plug-in. To allow an automated enrichment process, clueGO REST-enabled features were used in R using the following GO/pathway repositories: <i>BiologicalProcess-EBI-UniProt-GOA (11 February 2020)</i>, <i>CellularComponent-EBI-UniProt-GOA (11 February 2020)</i>, <i>ImmuneSystemProcess-EBI-UniProt-GOA (11 February 2020)</i>, <i>MolecularFunction-EBI-UniProt-GOA (11 February 2020)</i>, <i>KEGG (27 February 2019)</i> and <i>REACTOME (27 February 2019)</i>.</p><h3 class="c-article__sub-heading" id="Sec27">Building classifier models for prediction of rituximab and tocilizumab response and refractory status</h3><p>Baseline gene expression and clinical and histological data were used as features for machine learning models built to predict CDAI 50% response to either rituximab or tocilizumab treatment at the primary endpoint (16 weeks) or refractory status, defined as nonresponse to both drugs at the secondary endpoint (post-treatment crossover, 24 weeks). An overview of the pipeline is shown in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig6">6a</a>.</p><p>Although the R4RA study was not powered for machine learning, information theory demonstrates that sparse models developed from large biomarker panels in which only a small percentage of biomarkers have nonzero effects can still demonstrate evidence of prediction with relatively modest sample size, although the small sample sizes in our study mean that the predictive models are likely to be only part of the way up the learning curve<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="McKeigue, P. Sample size requirements for learning to classify with high-dimensional biomarker panels. Stat. Methods Med. Res. 28, 904–910 (2019)." href="/articles/s41591-022-01789-0#ref-CR41" id="ref-link-section-d51120563e4521">41</a></sup>. In the present study ~2% of the 1,500 biomarkers inputted into the modeling system have a nonzero effect. If the <i>C</i>-statistic of the optimal classifier is 0.83, a sample size equivalent to 0.05 events per variable (<i>n</i> = 83) would be required to learn a classifier that has expected information for discrimination equal to 25% of that obtained by the optimal classifier (equivalent to a <i>C</i>-statistic of 0.68) (see the online calculator, <a href="https://pmckeigue.shinyapps.io/sampsizeapp/">https://pmckeigue.shinyapps.io/sampsizeapp/</a>)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="McKeigue, P. Sample size requirements for learning to classify with high-dimensional biomarker panels. Stat. Methods Med. Res. 28, 904–910 (2019)." href="/articles/s41591-022-01789-0#ref-CR41" id="ref-link-section-d51120563e4542">41</a></sup>. The model feature space was created using either clinical and histological parameters or clinical data with gene expression. Gene expression data underwent VST and were subset to protein-coding genes (using gencode gene annotation v.29) with the highest expression variance (top 10%). Highly correlated genes (<i>r</i> &gt; 0.9) were removed using the <i>findCorrelation</i> function from the R package caret (v.6.0-86), leaving 1,438 genes. Clinical features included: baseline tender joint count (TJC), swollen joint count (SJC), age, gender, CDAI, erythrocyte sedimentation rate (ESR), CRP and disease activity score based on ESR and CRP (DAS28ESR and DAS28CRP, respectively). Histology features included CD3, CD68L, CD68SL, CD20 and CD138.</p><p>Following processing, data were split into 10 × 10 nested folds (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig6">6a (2)</a>). For models using gene expression features, filtering was performed using either RFE or univariate filtering from the <i>caret</i> package v.6.0. The number of features selected was chosen to maximize accuracy from 25, 30, 50 or 100. Model hyperparameters were tuned by inner tenfold cross-validation, with model accuracy determined in separate outer cross-validation folds to give an unbiased estimate of model accuracy.</p><p>Seven machine learning methodologies from the <i>caret</i> package were used to create the classifier models: elastic net (glmnet), random forest (RF), least-squares support vector machine (SVM) with radial basis function kernel (svmRadial), least-squares SVM with polynomial kernel (svmPoly), GBM, MDA and PDA. Models that failed to converge during training were excluded from evaluation. The purpose of testing multiple models was to determine whether nonlinear decision boundaries—as used by SVM, MDA, PDA and tree-based prediction algorithms such as GBM—could outperform penalized linear regression.</p><p>To evaluate model performance, receiver operating characteristic (ROC) curves were built using the <i>plotROC</i> R package v.2.2.1 to determine prediction accuracy in the outer fold test data and samples omitted for the inner fold. AUC was calculated to determine prediction performance. Tuning parameters for the final model were finalized as the mean over all ten outer folds. The final best model for each classification was fit to the entire dataset, exported and feature importance ranked.</p><h3 class="c-article__sub-heading" id="Sec28">Statistical analysis</h3><p>For cross-sectional comparisons of continuous variables between two groups the Mann–Whitney <i>U</i>-test was used, whereas the Wilcoxon signed-rank test was used to assess the difference between groups with longitudinal paired data. More specific analyses of RNA-seq count data are detailed above in each relevant section. R v.4.0.0, or later, was used for all formal testing analyses.</p><h3 class="c-article__sub-heading" id="Sec29">Reporting Summary</h3><p>Further information on research design is available in the <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM2">Nature Research Reporting Summary</a> linked to this article.</p></div></div></section>
                    
                </div>
            

            <div class="u-mt-32">
                <section data-title="Data availability"><div class="c-article-section" id="data-availability-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="data-availability">Data availability</h2><div class="c-article-section__content" id="data-availability-content">
              
              <p>The datasets generated during and/or analyzed during the current study are available on an interactive web interface that allows direct data exploration (<a href="https://r4ra.hpc.qmul.ac.uk/">https://r4ra.hpc.qmul.ac.uk/</a>). A searchable interface is available to examine relationships between individual synovial gene transcript levels and histological and clinical parameters, and clinical response at 16 weeks. In addition, interactive versions of Figs. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig3">3c</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig5">5b</a> and Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig11">5e,f</a> allow users to click on individual genes to see their expression and search for genes of interest. The website was constructed using R shiny server 1.5.16, with interactive plots generated with R plotly 4.9.3.</p>
              <p>The datasets can be downloaded from <a href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-11611">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-11611</a>.</p>
              <p>Other public datasets used for pathway analysis were sourced from the GO annotation (GOA) database (BiologicalProcess-EBI-UniProt-GOA (11 February 2020), CellularComponent-EBI-UniProt-GOA (11 February 2020), ImmuneSystemProcess-EBI-UniProt-GOA (11 February2020), MolecularFunction-EBI-UniProt-GOA (11 February 2020)), KEGG and Reactome.</p>
            </div></div></section><section data-title="Code availability"><div class="c-article-section" id="code-availability-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="code-availability">Code availability</h2><div class="c-article-section__content" id="code-availability-content">
              
              <p>Source code for all analyses written in R v.4.0.0 or later has been uploaded to Github and is available at <a href="https://github.com/EMR-bioinformatics/R4RA">https://github.com/EMR-bioinformatics/R4RA</a>. The R package glmmSeq is downloadable via CRAN, and the source code is available from <a href="https://github.com/KatrionaGoldmann/glmmSeq">https://github.com/KatrionaGoldmann/glmmSeq</a>. R objects for all classifiers are available in the supplementary material as Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01789-0#MOESM7">5</a>.</p>
            </div></div></section><div id="MagazineFulltextArticleBodySuffix"><section aria-labelledby="Bib1" data-title="References"><div class="c-article-section" id="Bib1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Bib1">References</h2><div class="c-article-section__content" id="Bib1-content"><div data-container-section="references"><ol class="c-article-references" data-track-component="outbound reference" data-track-context="references section"><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1."><p class="c-article-references__text" id="ref-CR1">Smolen, J. S. et al. Rheumatoid arthritis. <i>Nat. Rev. Dis. Prim.</i> <b>4</b>, 18001 (2018).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nrdp.2018.1" data-track-item_id="10.1038/nrdp.2018.1" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnrdp.2018.1" aria-label="Article reference 1" data-doi="10.1038/nrdp.2018.1">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29417936" aria-label="PubMed reference 1">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;title=Rheumatoid%20arthritis&amp;journal=Nat.%20Rev.%20Dis.%20Prim.&amp;doi=10.1038%2Fnrdp.2018.1&amp;volume=4&amp;publication_year=2018&amp;author=Smolen%2CJS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="2."><p class="c-article-references__text" id="ref-CR2">Buch, M. H. Defining refractory rheumatoid arthritis. <i>Ann. Rheum. Dis.</i> <b>77</b>, 966–969 (2018).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1136/annrheumdis-2017-212862" data-track-item_id="10.1136/annrheumdis-2017-212862" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1136%2Fannrheumdis-2017-212862" aria-label="Article reference 2" data-doi="10.1136/annrheumdis-2017-212862">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXislSitLY%3D" aria-label="CAS reference 2">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29588276" aria-label="PubMed reference 2">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;title=Defining%20refractory%20rheumatoid%20arthritis&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fannrheumdis-2017-212862&amp;volume=77&amp;pages=966-969&amp;publication_year=2018&amp;author=Buch%2CMH">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="3."><p class="c-article-references__text" id="ref-CR3">Borghaei, H. et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. <i>N. Engl. J. Med.</i> <b>373</b>, 1627–1639 (2015).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1056/NEJMoa1507643" data-track-item_id="10.1056/NEJMoa1507643" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1056%2FNEJMoa1507643" aria-label="Article reference 3" data-doi="10.1056/NEJMoa1507643">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XjsFyitL0%3D" aria-label="CAS reference 3">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26412456" aria-label="PubMed reference 3">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705936" aria-label="PubMed Central reference 3">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;title=Nivolumab%20versus%20docetaxel%20in%20advanced%20nonsquamous%20non-small-cell%20lung%20cancer&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa1507643&amp;volume=373&amp;pages=1627-1639&amp;publication_year=2015&amp;author=Borghaei%2CH">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="4."><p class="c-article-references__text" id="ref-CR4">Kawalec, P., Łopuch, S. &amp; Mikrut, A. Effectiveness of targeted therapy in patients with previously untreated metastatic breast cancer: a systematic review and meta-analysis. <i>Clin. Breast Cancer</i> <b>15</b>, 90–100 (2015).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.clbc.2014.10.006" data-track-item_id="10.1016/j.clbc.2014.10.006" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.clbc.2014.10.006" aria-label="Article reference 4" data-doi="10.1016/j.clbc.2014.10.006">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXhvFSgs7bP" aria-label="CAS reference 4">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25441421" aria-label="PubMed reference 4">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=Effectiveness%20of%20targeted%20therapy%20in%20patients%20with%20previously%20untreated%20metastatic%20breast%20cancer%3A%20a%20systematic%20review%20and%20meta-analysis&amp;journal=Clin.%20Breast%20Cancer&amp;doi=10.1016%2Fj.clbc.2014.10.006&amp;volume=15&amp;pages=90-100&amp;publication_year=2015&amp;author=Kawalec%2CP&amp;author=%C5%81opuch%2CS&amp;author=Mikrut%2CA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="5."><p class="c-article-references__text" id="ref-CR5">Pitzalis, C., Choy, E. H. S. &amp; Buch, M. H. Transforming clinical trials in rheumatology: towards patient-centric precision medicine. <i>Nat. Rev. Rheumatol.</i> <b>16</b>, 590–599 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41584-020-0491-4" data-track-item_id="10.1038/s41584-020-0491-4" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41584-020-0491-4" aria-label="Article reference 5" data-doi="10.1038/s41584-020-0491-4">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32887976" aria-label="PubMed reference 5">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;title=Transforming%20clinical%20trials%20in%20rheumatology%3A%20towards%20patient-centric%20precision%20medicine&amp;journal=Nat.%20Rev.%20Rheumatol.&amp;doi=10.1038%2Fs41584-020-0491-4&amp;volume=16&amp;pages=590-599&amp;publication_year=2020&amp;author=Pitzalis%2CC&amp;author=Choy%2CEHS&amp;author=Buch%2CMH">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="6."><p class="c-article-references__text" id="ref-CR6">Lewis, M. J. et al. Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes. <i>Cell Rep.</i> <b>28</b>, 2455–2470 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.celrep.2019.07.091" data-track-item_id="10.1016/j.celrep.2019.07.091" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.celrep.2019.07.091" aria-label="Article reference 6" data-doi="10.1016/j.celrep.2019.07.091">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXhs12jurzL" aria-label="CAS reference 6">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31461658" aria-label="PubMed reference 6">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718830" aria-label="PubMed Central reference 6">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=Molecular%20portraits%20of%20early%20rheumatoid%20arthritis%20identify%20clinical%20and%20treatment%20response%20phenotypes&amp;journal=Cell%20Rep.&amp;doi=10.1016%2Fj.celrep.2019.07.091&amp;volume=28&amp;pages=2455-2470&amp;publication_year=2019&amp;author=Lewis%2CMJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="7."><p class="c-article-references__text" id="ref-CR7">Humby, F. et al. Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients. <i>Ann. Rheum. Dis.</i> <b>78</b>, 761–772 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1136/annrheumdis-2018-214539" data-track-item_id="10.1136/annrheumdis-2018-214539" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1136%2Fannrheumdis-2018-214539" aria-label="Article reference 7" data-doi="10.1136/annrheumdis-2018-214539">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXisV2ms7bM" aria-label="CAS reference 7">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30878974" aria-label="PubMed reference 7">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=Synovial%20cellular%20and%20molecular%20signatures%20stratify%20clinical%20response%20to%20csDMARD%20therapy%20and%20predict%20radiographic%20progression%20in%20early%20rheumatoid%20arthritis%20patients&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fannrheumdis-2018-214539&amp;volume=78&amp;pages=761-772&amp;publication_year=2019&amp;author=Humby%2CF">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="8."><p class="c-article-references__text" id="ref-CR8">Giacomelli, R. et al. The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and experts’ consensus. <i>Autoimmun. Rev.</i> <b>20</b>, 102738 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.autrev.2020.102738" data-track-item_id="10.1016/j.autrev.2020.102738" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.autrev.2020.102738" aria-label="Article reference 8" data-doi="10.1016/j.autrev.2020.102738">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhvFakurk%3D" aria-label="CAS reference 8">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33326854" aria-label="PubMed reference 8">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20growing%20role%20of%20precision%20medicine%20for%20the%20treatment%20of%20autoimmune%20diseases%3B%20results%20of%20a%20systematic%20review%20of%20literature%20and%20experts%E2%80%99%20consensus&amp;journal=Autoimmun.%20Rev.&amp;doi=10.1016%2Fj.autrev.2020.102738&amp;volume=20&amp;publication_year=2021&amp;author=Giacomelli%2CR">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="9."><p class="c-article-references__text" id="ref-CR9">Humby, F. et al. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. <i>Lancet</i> <b>397</b>, 305–317 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0140-6736(20)32341-2" data-track-item_id="10.1016/S0140-6736(20)32341-2" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0140-6736%2820%2932341-2" aria-label="Article reference 9" data-doi="10.1016/S0140-6736(20)32341-2">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXltVyrtbw%3D" aria-label="CAS reference 9">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33485455" aria-label="PubMed reference 9">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829614" aria-label="PubMed Central reference 9">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;title=Rituximab%20versus%20tocilizumab%20in%20anti-TNF%20inadequate%20responder%20patients%20with%20rheumatoid%20arthritis%20%28R4RA%29%3A%2016-week%20outcomes%20of%20a%20stratified%2C%20biopsy-driven%2C%20multicentre%2C%20open-label%2C%20phase%204%20randomised%20controlled%20trial&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2820%2932341-2&amp;volume=397&amp;pages=305-317&amp;publication_year=2021&amp;author=Humby%2CF">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="10."><p class="c-article-references__text" id="ref-CR10">Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. <i>Genome Biol.</i> <b>17</b>, 218 (2016).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1186/s13059-016-1070-5" data-track-item_id="10.1186/s13059-016-1070-5" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s13059-016-1070-5" aria-label="Article reference 10" data-doi="10.1186/s13059-016-1070-5">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27765066" aria-label="PubMed reference 10">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073889" aria-label="PubMed Central reference 10">PubMed Central</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhvF2rt7fJ" aria-label="CAS reference 10">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;title=Estimating%20the%20population%20abundance%20of%20tissue-infiltrating%20immune%20and%20stromal%20cell%20populations%20using%20gene%20expression&amp;journal=Genome%20Biol.&amp;doi=10.1186%2Fs13059-016-1070-5&amp;volume=17&amp;publication_year=2016&amp;author=Becht%2CE">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="11."><p class="c-article-references__text" id="ref-CR11">John, C. R. et al. M3C: Monte Carlo reference-based consensus clustering. <i>Sci. Rep.</i> <b>10</b>, 1816 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41598-020-58766-1" data-track-item_id="10.1038/s41598-020-58766-1" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41598-020-58766-1" aria-label="Article reference 11" data-doi="10.1038/s41598-020-58766-1">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXkvVWqu7c%3D" aria-label="CAS reference 11">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32020004" aria-label="PubMed reference 11">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000518" aria-label="PubMed Central reference 11">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=M3C%3A%20Monte%20Carlo%20reference-based%20consensus%20clustering&amp;journal=Sci.%20Rep.&amp;doi=10.1038%2Fs41598-020-58766-1&amp;volume=10&amp;publication_year=2020&amp;author=John%2CCR">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="12."><p class="c-article-references__text" id="ref-CR12">Li, S. et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. <i>Nat. Immunol.</i> <b>15</b>, 195–204 (2014).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/ni.2789" data-track-item_id="10.1038/ni.2789" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fni.2789" aria-label="Article reference 12" data-doi="10.1038/ni.2789">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24336226" aria-label="PubMed reference 12">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXhvFent7%2FO" aria-label="CAS reference 12">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=Molecular%20signatures%20of%20antibody%20responses%20derived%20from%20a%20systems%20biology%20study%20of%20five%20human%20vaccines&amp;journal=Nat.%20Immunol.&amp;doi=10.1038%2Fni.2789&amp;volume=15&amp;pages=195-204&amp;publication_year=2014&amp;author=Li%2CS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="13."><p class="c-article-references__text" id="ref-CR13">Stephenson, W. et al. Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation. <i>Nat. Commun.</i> <b>9</b>, 791 (2018).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-017-02659-x" data-track-item_id="10.1038/s41467-017-02659-x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-017-02659-x" aria-label="Article reference 13" data-doi="10.1038/s41467-017-02659-x">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29476078" aria-label="PubMed reference 13">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824814" aria-label="PubMed Central reference 13">PubMed Central</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXhtFWkt7fE" aria-label="CAS reference 13">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;title=Single-cell%20RNA-seq%20of%20rheumatoid%20arthritis%20synovial%20tissue%20using%20low-cost%20microfluidic%20instrumentation&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-017-02659-x&amp;volume=9&amp;publication_year=2018&amp;author=Stephenson%2CW">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="14."><p class="c-article-references__text" id="ref-CR14">Zhang, F. et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. <i>Nat. Immunol.</i> <b>20</b>, 928–942 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41590-019-0378-1" data-track-item_id="10.1038/s41590-019-0378-1" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41590-019-0378-1" aria-label="Article reference 14" data-doi="10.1038/s41590-019-0378-1">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31061532" aria-label="PubMed reference 14">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602051" aria-label="PubMed Central reference 14">PubMed Central</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXovFemsLs%3D" aria-label="CAS reference 14">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;title=Defining%20inflammatory%20cell%20states%20in%20rheumatoid%20arthritis%20joint%20synovial%20tissues%20by%20integrating%20single-cell%20transcriptomics%20and%20mass%20cytometry&amp;journal=Nat.%20Immunol.&amp;doi=10.1038%2Fs41590-019-0378-1&amp;volume=20&amp;pages=928-942&amp;publication_year=2019&amp;author=Zhang%2CF">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="15."><p class="c-article-references__text" id="ref-CR15">Wei, K. et al. Notch signalling drives synovial fibroblast identity and arthritis pathology. <i>Nature</i> <b>582</b>, 259–264 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-020-2222-z" data-track-item_id="10.1038/s41586-020-2222-z" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-020-2222-z" aria-label="Article reference 15" data-doi="10.1038/s41586-020-2222-z">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXotVCiur4%3D" aria-label="CAS reference 15">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32499639" aria-label="PubMed reference 15">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841716" aria-label="PubMed Central reference 15">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;title=Notch%20signalling%20drives%20synovial%20fibroblast%20identity%20and%20arthritis%20pathology&amp;journal=Nature&amp;doi=10.1038%2Fs41586-020-2222-z&amp;volume=582&amp;pages=259-264&amp;publication_year=2020&amp;author=Wei%2CK">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="16."><p class="c-article-references__text" id="ref-CR16">Croft, A. P. et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. <i>Nature</i> <b>570</b>, 246–251 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-019-1263-7" data-track-item_id="10.1038/s41586-019-1263-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-019-1263-7" aria-label="Article reference 16" data-doi="10.1038/s41586-019-1263-7">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXhtVOgt7fL" aria-label="CAS reference 16">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31142839" aria-label="PubMed reference 16">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690841" aria-label="PubMed Central reference 16">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;title=Distinct%20fibroblast%20subsets%20drive%20inflammation%20and%20damage%20in%20arthritis&amp;journal=Nature&amp;doi=10.1038%2Fs41586-019-1263-7&amp;volume=570&amp;pages=246-251&amp;publication_year=2019&amp;author=Croft%2CAP">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="17."><p class="c-article-references__text" id="ref-CR17">Crozat, K. et al. Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8α<sup>+</sup> type. <i>J. Immunol.</i> <b>187</b>, 4411–4415 (2011).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.4049/jimmunol.1101717" data-track-item_id="10.4049/jimmunol.1101717" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.4049%2Fjimmunol.1101717" aria-label="Article reference 17" data-doi="10.4049/jimmunol.1101717">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXhtlChsbnP" aria-label="CAS reference 17">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21948982" aria-label="PubMed reference 17">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;title=Cutting%20edge%3A%20expression%20of%20XCR1%20defines%20mouse%20lymphoid-tissue%20resident%20and%20migratory%20dendritic%20cells%20of%20the%20CD8%CE%B1%2B%20type&amp;journal=J.%20Immunol.&amp;doi=10.4049%2Fjimmunol.1101717&amp;volume=187&amp;pages=4411-4415&amp;publication_year=2011&amp;author=Crozat%2CK">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="18."><p class="c-article-references__text" id="ref-CR18">Graham, S. A. et al. Prolectin, a glycan-binding receptor on dividing B cells in germinal centers. <i>J. Biol. Chem.</i> <b>284</b>, 18537–18544 (2009).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1074/jbc.M109.012807" data-track-item_id="10.1074/jbc.M109.012807" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1074%2Fjbc.M109.012807" aria-label="Article reference 18" data-doi="10.1074/jbc.M109.012807">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXnslegu7o%3D" aria-label="CAS reference 18">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19419970" aria-label="PubMed reference 18">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709368" aria-label="PubMed Central reference 18">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;title=Prolectin%2C%20a%20glycan-binding%20receptor%20on%20dividing%20B%20cells%20in%20germinal%20centers&amp;journal=J.%20Biol.%20Chem.&amp;doi=10.1074%2Fjbc.M109.012807&amp;volume=284&amp;pages=18537-18544&amp;publication_year=2009&amp;author=Graham%2CSA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="19."><p class="c-article-references__text" id="ref-CR19">Curran, A. M., Naik, P., Giles, J. T. &amp; Darrah, E. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets. <i>Nat. Rev. Rheumatol.</i> <b>16</b>, 301–315 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41584-020-0409-1" data-track-item_id="10.1038/s41584-020-0409-1" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41584-020-0409-1" aria-label="Article reference 19" data-doi="10.1038/s41584-020-0409-1">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXot1ajsrc%3D" aria-label="CAS reference 19">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32341463" aria-label="PubMed reference 19">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;title=PAD%20enzymes%20in%20rheumatoid%20arthritis%3A%20pathogenic%20effectors%20and%20autoimmune%20targets&amp;journal=Nat.%20Rev.%20Rheumatol.&amp;doi=10.1038%2Fs41584-020-0409-1&amp;volume=16&amp;pages=301-315&amp;publication_year=2020&amp;author=Curran%2CAM&amp;author=Naik%2CP&amp;author=Giles%2CJT&amp;author=Darrah%2CE">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="20."><p class="c-article-references__text" id="ref-CR20">Yanni, G., Whelan, A., Feighery, C. &amp; Bresnihan, B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. <i>Ann. Rheum. Dis.</i> <b>53</b>, 39–44 (1994).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1136/ard.53.1.39" data-track-item_id="10.1136/ard.53.1.39" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1136%2Fard.53.1.39" aria-label="Article reference 20" data-doi="10.1136/ard.53.1.39">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DyaK2c7ksFWrtw%3D%3D" aria-label="CAS reference 20">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8311554" aria-label="PubMed reference 20">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1005241" aria-label="PubMed Central reference 20">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;title=Synovial%20tissue%20macrophages%20and%20joint%20erosion%20in%20rheumatoid%20arthritis&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fard.53.1.39&amp;volume=53&amp;pages=39-44&amp;publication_year=1994&amp;author=Yanni%2CG&amp;author=Whelan%2CA&amp;author=Feighery%2CC&amp;author=Bresnihan%2CB">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="21."><p class="c-article-references__text" id="ref-CR21">Bresnihan, B. et al. Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers. <i>J. Rheumatol.</i> <b>36</b>, 1800–1802 (2009).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3899/jrheum.090348" data-track-item_id="10.3899/jrheum.090348" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3899%2Fjrheum.090348" aria-label="Article reference 21" data-doi="10.3899/jrheum.090348">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19671815" aria-label="PubMed reference 21">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;title=Synovial%20tissue%20sublining%20CD68%20expression%20is%20a%20biomarker%20of%20therapeutic%20response%20in%20rheumatoid%20arthritis%20clinical%20trials%3A%20consistency%20across%20centers&amp;journal=J.%20Rheumatol.&amp;doi=10.3899%2Fjrheum.090348&amp;volume=36&amp;pages=1800-1802&amp;publication_year=2009&amp;author=Bresnihan%2CB">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="22."><p class="c-article-references__text" id="ref-CR22">Teng, Y. K. et al. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment. <i>Arthritis Rheum.</i> <b>56</b>, 3909–3918 (2007).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/art.22967" data-track-item_id="10.1002/art.22967" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fart.22967" aria-label="Article reference 22" data-doi="10.1002/art.22967">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXnt1Olsw%3D%3D" aria-label="CAS reference 22">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18050222" aria-label="PubMed reference 22">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;title=Immunohistochemical%20analysis%20as%20a%20means%20to%20predict%20responsiveness%20to%20rituximab%20treatment&amp;journal=Arthritis%20Rheum.&amp;doi=10.1002%2Fart.22967&amp;volume=56&amp;pages=3909-3918&amp;publication_year=2007&amp;author=Teng%2CYK">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="23."><p class="c-article-references__text" id="ref-CR23">Hogan, V. E. et al. Pretreatment synovial transcriptional profile is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab. <i>Ann. Rheum. Dis.</i> <b>71</b>, 1888–1894 (2012).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1136/annrheumdis-2011-201115" data-track-item_id="10.1136/annrheumdis-2011-201115" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1136%2Fannrheumdis-2011-201115" aria-label="Article reference 23" data-doi="10.1136/annrheumdis-2011-201115">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XhvV2nsbfF" aria-label="CAS reference 23">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22736099" aria-label="PubMed reference 23">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;title=Pretreatment%20synovial%20transcriptional%20profile%20is%20associated%20with%20early%20and%20late%20clinical%20response%20in%20rheumatoid%20arthritis%20patients%20treated%20with%20rituximab&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fannrheumdis-2011-201115&amp;volume=71&amp;pages=1888-1894&amp;publication_year=2012&amp;author=Hogan%2CVE">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="24."><p class="c-article-references__text" id="ref-CR24">Choy, E. H. et al. Translating IL-6 biology into effective treatments. <i>Nat. Rev. Rheumatol.</i> <b>16</b>, 335–345 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41584-020-0419-z" data-track-item_id="10.1038/s41584-020-0419-z" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41584-020-0419-z" aria-label="Article reference 24" data-doi="10.1038/s41584-020-0419-z">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXot1aiu7c%3D" aria-label="CAS reference 24">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32327746" aria-label="PubMed reference 24">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;title=Translating%20IL-6%20biology%20into%20effective%20treatments&amp;journal=Nat.%20Rev.%20Rheumatol.&amp;doi=10.1038%2Fs41584-020-0419-z&amp;volume=16&amp;pages=335-345&amp;publication_year=2020&amp;author=Choy%2CEH">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="25."><p class="c-article-references__text" id="ref-CR25">Raterman, H. G. et al. The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients. <i>Arthritis Res. Ther.</i> <b>14</b>, R95 (2012).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1186/ar3819" data-track-item_id="10.1186/ar3819" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/ar3819" aria-label="Article reference 25" data-doi="10.1186/ar3819">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38Xot12qs7o%3D" aria-label="CAS reference 25">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22540992" aria-label="PubMed reference 25">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446469" aria-label="PubMed Central reference 25">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20interferon%20type%20I%20signature%20towards%20prediction%20of%20non-response%20to%20rituximab%20in%20rheumatoid%20arthritis%20patients&amp;journal=Arthritis%20Res.%20Ther.&amp;doi=10.1186%2Far3819&amp;volume=14&amp;publication_year=2012&amp;author=Raterman%2CHG">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="26."><p class="c-article-references__text" id="ref-CR26">Thurlings, R. M. et al. Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients. <i>Arthritis Rheum.</i> <b>62</b>, 3607–3614 (2010).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/art.27702" data-track-item_id="10.1002/art.27702" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fart.27702" aria-label="Article reference 26" data-doi="10.1002/art.27702">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXhs1antrvN" aria-label="CAS reference 26">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20722020" aria-label="PubMed reference 26">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;title=Relationship%20between%20the%20type%20I%20interferon%20signature%20and%20the%20response%20to%20rituximab%20in%20rheumatoid%20arthritis%20patients&amp;journal=Arthritis%20Rheum.&amp;doi=10.1002%2Fart.27702&amp;volume=62&amp;pages=3607-3614&amp;publication_year=2010&amp;author=Thurlings%2CRM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="27."><p class="c-article-references__text" id="ref-CR27">Lliso-Ribera, G. et al. Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC). <i>Ann. Rheum. Dis.</i> <b>78</b>, 1642–1652 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1136/annrheumdis-2019-215751" data-track-item_id="10.1136/annrheumdis-2019-215751" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1136%2Fannrheumdis-2019-215751" aria-label="Article reference 27" data-doi="10.1136/annrheumdis-2019-215751">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhtVSrsLzL" aria-label="CAS reference 27">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31582377" aria-label="PubMed reference 27">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;title=Synovial%20tissue%20signatures%20enhance%20clinical%20classification%20and%20prognostic%2Ftreatment%20response%20algorithms%20in%20early%20inflammatory%20arthritis%20and%20predict%20requirement%20for%20subsequent%20biological%20therapy%3A%20results%20from%20the%20pathobiology%20of%20early%20arthritis%20cohort%20%28PEAC%29&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fannrheumdis-2019-215751&amp;volume=78&amp;pages=1642-1652&amp;publication_year=2019&amp;author=Lliso-Ribera%2CG">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="28."><p class="c-article-references__text" id="ref-CR28">Nerviani, A. et al. A pauci-immune synovial pathotype predicts inadequate response to TNFα-blockade in rheumatoid arthritis patients. <i>Front. Immunol.</i> <b>11</b>, 845 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fimmu.2020.00845" data-track-item_id="10.3389/fimmu.2020.00845" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffimmu.2020.00845" aria-label="Article reference 28" data-doi="10.3389/fimmu.2020.00845">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXitVWgu7%2FK" aria-label="CAS reference 28">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32431716" aria-label="PubMed reference 28">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214807" aria-label="PubMed Central reference 28">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20pauci-immune%20synovial%20pathotype%20predicts%20inadequate%20response%20to%20TNF%CE%B1-blockade%20in%20rheumatoid%20arthritis%20patients&amp;journal=Front.%20Immunol.&amp;doi=10.3389%2Ffimmu.2020.00845&amp;volume=11&amp;publication_year=2020&amp;author=Nerviani%2CA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="29."><p class="c-article-references__text" id="ref-CR29">Mizoguchi, F. et al. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. <i>Nat. Commun.</i> <b>9</b>, 789 (2018).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-018-02892-y" data-track-item_id="10.1038/s41467-018-02892-y" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-018-02892-y" aria-label="Article reference 29" data-doi="10.1038/s41467-018-02892-y">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29476097" aria-label="PubMed reference 29">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824882" aria-label="PubMed Central reference 29">PubMed Central</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXhtFWkt7fN" aria-label="CAS reference 29">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;title=Functionally%20distinct%20disease-associated%20fibroblast%20subsets%20in%20rheumatoid%20arthritis&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-018-02892-y&amp;volume=9&amp;publication_year=2018&amp;author=Mizoguchi%2CF">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="30."><p class="c-article-references__text" id="ref-CR30">Ferrari, N. et al. Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts. <i>Nat. Commun.</i> <b>10</b>, 130 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-018-07987-0" data-track-item_id="10.1038/s41467-018-07987-0" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-018-07987-0" aria-label="Article reference 30" data-doi="10.1038/s41467-018-07987-0">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30631061" aria-label="PubMed reference 30">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328607" aria-label="PubMed Central reference 30">PubMed Central</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXmvFWju7c%3D" aria-label="CAS reference 30">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;title=Dickkopf-3%20links%20HSF1%20and%20YAP%2FTAZ%20signalling%20to%20control%20aggressive%20behaviours%20in%20cancer-associated%20fibroblasts&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-018-07987-0&amp;volume=10&amp;publication_year=2019&amp;author=Ferrari%2CN">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="31."><p class="c-article-references__text" id="ref-CR31">Marsh, L. J., Kemble, S., Reis Nisa, P., Singh, R. &amp; Croft, A. P. Fibroblast pathology in inflammatory joint disease. <i>Immunol. Rev.</i> <b>302</b>, 163–183 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/imr.12986" data-track-item_id="10.1111/imr.12986" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fimr.12986" aria-label="Article reference 31" data-doi="10.1111/imr.12986">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXht1GgsbzP" aria-label="CAS reference 31">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34096076" aria-label="PubMed reference 31">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;title=Fibroblast%20pathology%20in%20inflammatory%20joint%20disease&amp;journal=Immunol.%20Rev.&amp;doi=10.1111%2Fimr.12986&amp;volume=302&amp;pages=163-183&amp;publication_year=2021&amp;author=Marsh%2CLJ&amp;author=Kemble%2CS&amp;author=Reis%20Nisa%2CP&amp;author=Singh%2CR&amp;author=Croft%2CAP">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="32."><p class="c-article-references__text" id="ref-CR32">Iwamoto, T. et al. Monocyte chemoattractant protein-4 (MCP-4)/CCL13 is highly expressed in cartilage from patients with rheumatoid arthritis. <i>Rheumatology (Oxford)</i> <b>45</b>, 421–424 (2006).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/rheumatology/kei209" data-track-item_id="10.1093/rheumatology/kei209" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Frheumatology%2Fkei209" aria-label="Article reference 32" data-doi="10.1093/rheumatology/kei209">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD28Xis1Gltrc%3D" aria-label="CAS reference 32">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;title=Monocyte%20chemoattractant%20protein-4%20%28MCP-4%29%2FCCL13%20is%20highly%20expressed%20in%20cartilage%20from%20patients%20with%20rheumatoid%20arthritis&amp;journal=Rheumatology%20%28Oxford%29&amp;doi=10.1093%2Frheumatology%2Fkei209&amp;volume=45&amp;pages=421-424&amp;publication_year=2006&amp;author=Iwamoto%2CT">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="33."><p class="c-article-references__text" id="ref-CR33">Salomon, S. et al. Th17 and CD24(hi)CD27(<sup>+</sup>) regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis. <i>Arthritis Res. Ther.</i> <b>19</b>, 33 (2017).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1186/s13075-017-1244-x" data-track-item_id="10.1186/s13075-017-1244-x" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s13075-017-1244-x" aria-label="Article reference 33" data-doi="10.1186/s13075-017-1244-x">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28183330" aria-label="PubMed reference 33">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301325" aria-label="PubMed Central reference 33">PubMed Central</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXjt1Srs7w%3D" aria-label="CAS reference 33">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;title=Th17%20and%20CD24%28hi%29CD27%28%2B%29%20regulatory%20B%20lymphocytes%20are%20biomarkers%20of%20response%20to%20biologics%20in%20rheumatoid%20arthritis&amp;journal=Arthritis%20Res.%20Ther.&amp;doi=10.1186%2Fs13075-017-1244-x&amp;volume=19&amp;publication_year=2017&amp;author=Salomon%2CS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="34."><p class="c-article-references__text" id="ref-CR34">Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. <i>Ann. Rheum. Dis.</i> <b>79</b>, 685–699 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1136/annrheumdis-2019-216655" data-track-item_id="10.1136/annrheumdis-2019-216655" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1136%2Fannrheumdis-2019-216655" aria-label="Article reference 34" data-doi="10.1136/annrheumdis-2019-216655">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhvFemtLrE" aria-label="CAS reference 34">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31969328" aria-label="PubMed reference 34">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;title=EULAR%20recommendations%20for%20the%20management%20of%20rheumatoid%20arthritis%20with%20synthetic%20and%20biological%20disease-modifying%20antirheumatic%20drugs%3A%202019%20update&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fannrheumdis-2019-216655&amp;volume=79&amp;pages=685-699&amp;publication_year=2020&amp;author=Smolen%2CJS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="35."><p class="c-article-references__text" id="ref-CR35">Vandooren, B., Cantaert, T., Noordenbos, T., Tak, P. P. &amp; Baeten, D. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. <i>Arthritis Rheum.</i> <b>58</b>, 718–729 (2008).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/art.23290" data-track-item_id="10.1002/art.23290" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fart.23290" aria-label="Article reference 35" data-doi="10.1002/art.23290">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXjslWqurk%3D" aria-label="CAS reference 35">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18311801" aria-label="PubMed reference 35">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 35" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20abundant%20synovial%20expression%20of%20the%20RANK%2FRANKL%2FOsteoprotegerin%20system%20in%20peripheral%20spondylarthritis%20is%20partially%20disconnected%20from%20inflammation&amp;journal=Arthritis%20Rheum.&amp;doi=10.1002%2Fart.23290&amp;volume=58&amp;pages=718-729&amp;publication_year=2008&amp;author=Vandooren%2CB&amp;author=Cantaert%2CT&amp;author=Noordenbos%2CT&amp;author=Tak%2CPP&amp;author=Baeten%2CD">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="36."><p class="c-article-references__text" id="ref-CR36">Kavanaugh, A. et al. Assessment of rituximab’s immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results. <i>Ann. Rheum. Dis.</i> <b>67</b>, 402–408 (2008).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1136/ard.2007.074229" data-track-item_id="10.1136/ard.2007.074229" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1136%2Fard.2007.074229" aria-label="Article reference 36" data-doi="10.1136/ard.2007.074229">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXjs1ejsLs%3D" aria-label="CAS reference 36">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17644541" aria-label="PubMed reference 36">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;title=Assessment%20of%20rituximab%E2%80%99s%20immunomodulatory%20synovial%20effects%20%28ARISE%20trial%29.%201%3A%20clinical%20and%20synovial%20biomarker%20results&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fard.2007.074229&amp;volume=67&amp;pages=402-408&amp;publication_year=2008&amp;author=Kavanaugh%2CA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="37."><p class="c-article-references__text" id="ref-CR37">Ramwadhdoebe, T. H. et al. Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis. <i>Rheumatology (Oxford)</i> <b>58</b>, 1075–1085 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/rheumatology/key428" data-track-item_id="10.1093/rheumatology/key428" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Frheumatology%2Fkey428" aria-label="Article reference 37" data-doi="10.1093/rheumatology/key428">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXht1aisbvO" aria-label="CAS reference 37">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 37" href="http://scholar.google.com/scholar_lookup?&amp;title=Effect%20of%20rituximab%20treatment%20on%20T%20and%20B%20cell%20subsets%20in%20lymph%20node%20biopsies%20of%20patients%20with%20rheumatoid%20arthritis&amp;journal=Rheumatology%20%28Oxford%29&amp;doi=10.1093%2Frheumatology%2Fkey428&amp;volume=58&amp;pages=1075-1085&amp;publication_year=2019&amp;author=Ramwadhdoebe%2CTH">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="38."><p class="c-article-references__text" id="ref-CR38">Hill, D. G., Ward, A., Nicholson, L. B. &amp; Jones, G. W. Emerging roles for IL-6 family cytokines as positive and negative regulators of ectopic lymphoid structures. <i>Cytokine</i> <b>146</b>, 155650 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cyto.2021.155650" data-track-item_id="10.1016/j.cyto.2021.155650" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cyto.2021.155650" aria-label="Article reference 38" data-doi="10.1016/j.cyto.2021.155650">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhs1yntb7J" aria-label="CAS reference 38">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34343865" aria-label="PubMed reference 38">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 38" href="http://scholar.google.com/scholar_lookup?&amp;title=Emerging%20roles%20for%20IL-6%20family%20cytokines%20as%20positive%20and%20negative%20regulators%20of%20ectopic%20lymphoid%20structures&amp;journal=Cytokine&amp;doi=10.1016%2Fj.cyto.2021.155650&amp;volume=146&amp;publication_year=2021&amp;author=Hill%2CDG&amp;author=Ward%2CA&amp;author=Nicholson%2CLB&amp;author=Jones%2CGW">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="39."><p class="c-article-references__text" id="ref-CR39">Nouri, B., Nair, N. &amp; Barton, A. Predicting treatment response to IL6R blockers in rheumatoid arthritis. <i>Rheumatology (Oxford)</i> <b>59</b>, 3603–3610 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/rheumatology/keaa529" data-track-item_id="10.1093/rheumatology/keaa529" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Frheumatology%2Fkeaa529" aria-label="Article reference 39" data-doi="10.1093/rheumatology/keaa529">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXmvVCitb0%3D" aria-label="CAS reference 39">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 39" href="http://scholar.google.com/scholar_lookup?&amp;title=Predicting%20treatment%20response%20to%20IL6R%20blockers%20in%20rheumatoid%20arthritis&amp;journal=Rheumatology%20%28Oxford%29&amp;doi=10.1093%2Frheumatology%2Fkeaa529&amp;volume=59&amp;pages=3603-3610&amp;publication_year=2020&amp;author=Nouri%2CB&amp;author=Nair%2CN&amp;author=Barton%2CA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="40."><p class="c-article-references__text" id="ref-CR40">Isaacs, J. D. et al. Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis. <i>Ann. Rheum. Dis.</i> <b>72</b>, 329–336 (2013).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1136/annrheumdis-2011-201117" data-track-item_id="10.1136/annrheumdis-2011-201117" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1136%2Fannrheumdis-2011-201117" aria-label="Article reference 40" data-doi="10.1136/annrheumdis-2011-201117">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXjvFOjtbk%3D" aria-label="CAS reference 40">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22689315" aria-label="PubMed reference 40">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 40" href="http://scholar.google.com/scholar_lookup?&amp;title=Effect%20of%20baseline%20rheumatoid%20factor%20and%20anticitrullinated%20peptide%20antibody%20serotype%20on%20rituximab%20clinical%20response%3A%20a%20meta-analysis&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fannrheumdis-2011-201117&amp;volume=72&amp;pages=329-336&amp;publication_year=2013&amp;author=Isaacs%2CJD">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="41."><p class="c-article-references__text" id="ref-CR41">McKeigue, P. Sample size requirements for learning to classify with high-dimensional biomarker panels. <i>Stat. Methods Med. Res.</i> <b>28</b>, 904–910 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1177/0962280217738807" data-track-item_id="10.1177/0962280217738807" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1177%2F0962280217738807" aria-label="Article reference 41" data-doi="10.1177/0962280217738807">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29179643" aria-label="PubMed reference 41">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;title=Sample%20size%20requirements%20for%20learning%20to%20classify%20with%20high-dimensional%20biomarker%20panels&amp;journal=Stat.%20Methods%20Med.%20Res.&amp;doi=10.1177%2F0962280217738807&amp;volume=28&amp;pages=904-910&amp;publication_year=2019&amp;author=McKeigue%2CP">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="42."><p class="c-article-references__text" id="ref-CR42">Kelly, S. et al. Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients. <i>Ann. Rheum. Dis.</i> <b>74</b>, 611–617 (2015).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1136/annrheumdis-2013-204603" data-track-item_id="10.1136/annrheumdis-2013-204603" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1136%2Fannrheumdis-2013-204603" aria-label="Article reference 42" data-doi="10.1136/annrheumdis-2013-204603">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DC%2BC2c3mtleqtQ%3D%3D" aria-label="CAS reference 42">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24336336" aria-label="PubMed reference 42">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;title=Ultrasound-guided%20synovial%20biopsy%3A%20a%20safe%2C%20well-tolerated%20and%20reliable%20technique%20for%20obtaining%20high-quality%20synovial%20tissue%20from%20both%20large%20and%20small%20joints%20in%20early%20arthritis%20patients&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fannrheumdis-2013-204603&amp;volume=74&amp;pages=611-617&amp;publication_year=2015&amp;author=Kelly%2CS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="43."><p class="c-article-references__text" id="ref-CR43">Bugatti, S. et al. High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease. <i>Rheumatology (Oxford)</i> <b>53</b>, 1886–1895 (2014).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/rheumatology/keu163" data-track-item_id="10.1093/rheumatology/keu163" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Frheumatology%2Fkeu163" aria-label="Article reference 43" data-doi="10.1093/rheumatology/keu163">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXns1ehsLs%3D" aria-label="CAS reference 43">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;title=High%20expression%20levels%20of%20the%20B%20cell%20chemoattractant%20CXCL13%20in%20rheumatoid%20synovium%20are%20a%20marker%20of%20severe%20disease&amp;journal=Rheumatology%20%28Oxford%29&amp;doi=10.1093%2Frheumatology%2Fkeu163&amp;volume=53&amp;pages=1886-1895&amp;publication_year=2014&amp;author=Bugatti%2CS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="44."><p class="c-article-references__text" id="ref-CR44">Rivellese, F. et al. B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure. <i>Arthritis Rheumatol.</i> <b>72</b>, 714–725 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/art.41184" data-track-item_id="10.1002/art.41184" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fart.41184" aria-label="Article reference 44" data-doi="10.1002/art.41184">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXnvVOju7c%3D" aria-label="CAS reference 44">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31785084" aria-label="PubMed reference 44">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217046" aria-label="PubMed Central reference 44">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 44" href="http://scholar.google.com/scholar_lookup?&amp;title=B%20cell%20synovitis%20and%20clinical%20phenotypes%20in%20rheumatoid%20arthritis%3A%20relationship%20to%20disease%20stages%20and%20drug%20exposure&amp;journal=Arthritis%20Rheumatol.&amp;doi=10.1002%2Fart.41184&amp;volume=72&amp;pages=714-725&amp;publication_year=2020&amp;author=Rivellese%2CF">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="45."><p class="c-article-references__text" id="ref-CR45">Krenn, V. et al. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. <i>Histopathology</i> <b>49</b>, 358–364 (2006).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/j.1365-2559.2006.02508.x" data-track-item_id="10.1111/j.1365-2559.2006.02508.x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fj.1365-2559.2006.02508.x" aria-label="Article reference 45" data-doi="10.1111/j.1365-2559.2006.02508.x">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DC%2BD28rlsVSksg%3D%3D" aria-label="CAS reference 45">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16978198" aria-label="PubMed reference 45">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 45" href="http://scholar.google.com/scholar_lookup?&amp;title=Synovitis%20score%3A%20discrimination%20between%20chronic%20low-grade%20and%20high-grade%20synovitis&amp;journal=Histopathology&amp;doi=10.1111%2Fj.1365-2559.2006.02508.x&amp;volume=49&amp;pages=358-364&amp;publication_year=2006&amp;author=Krenn%2CV">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="46."><p class="c-article-references__text" id="ref-CR46">Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. &amp; Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. <i>Nat. Methods</i> <b>14</b>, 417–419 (2017).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nmeth.4197" data-track-item_id="10.1038/nmeth.4197" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnmeth.4197" aria-label="Article reference 46" data-doi="10.1038/nmeth.4197">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXltVWgtL8%3D" aria-label="CAS reference 46">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28263959" aria-label="PubMed reference 46">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600148" aria-label="PubMed Central reference 46">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 46" href="http://scholar.google.com/scholar_lookup?&amp;title=Salmon%20provides%20fast%20and%20bias-aware%20quantification%20of%20transcript%20expression&amp;journal=Nat.%20Methods&amp;doi=10.1038%2Fnmeth.4197&amp;volume=14&amp;pages=417-419&amp;publication_year=2017&amp;author=Patro%2CR&amp;author=Duggal%2CG&amp;author=Love%2CMI&amp;author=Irizarry%2CRA&amp;author=Kingsford%2CC">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="47."><p class="c-article-references__text" id="ref-CR47">Love, M. I., Huber, W. &amp; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. <i>Genome Biol.</i> <b>15</b>, 550 (2014).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1186/s13059-014-0550-8" data-track-item_id="10.1186/s13059-014-0550-8" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s13059-014-0550-8" aria-label="Article reference 47" data-doi="10.1186/s13059-014-0550-8">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25516281" aria-label="PubMed reference 47">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302049" aria-label="PubMed Central reference 47">PubMed Central</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXjtVCrsL8%3D" aria-label="CAS reference 47">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 47" href="http://scholar.google.com/scholar_lookup?&amp;title=Moderated%20estimation%20of%20fold%20change%20and%20dispersion%20for%20RNA-seq%20data%20with%20DESeq2&amp;journal=Genome%20Biol.&amp;doi=10.1186%2Fs13059-014-0550-8&amp;volume=15&amp;publication_year=2014&amp;author=Love%2CMI&amp;author=Huber%2CW&amp;author=Anders%2CS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="48."><p class="c-article-references__text" id="ref-CR48">Law, C. W., Chen, Y., Shi, W. &amp; Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. <i>Genome Biol.</i> <b>15</b>, R29 (2014).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1186/gb-2014-15-2-r29" data-track-item_id="10.1186/gb-2014-15-2-r29" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/gb-2014-15-2-r29" aria-label="Article reference 48" data-doi="10.1186/gb-2014-15-2-r29">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24485249" aria-label="PubMed reference 48">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053721" aria-label="PubMed Central reference 48">PubMed Central</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXjsVeltbw%3D" aria-label="CAS reference 48">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 48" href="http://scholar.google.com/scholar_lookup?&amp;title=voom%3A%20Precision%20weights%20unlock%20linear%20model%20analysis%20tools%20for%20RNA-seq%20read%20counts&amp;journal=Genome%20Biol.&amp;doi=10.1186%2Fgb-2014-15-2-r29&amp;volume=15&amp;publication_year=2014&amp;author=Law%2CCW&amp;author=Chen%2CY&amp;author=Shi%2CW&amp;author=Smyth%2CGK">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="49."><p class="c-article-references__text" id="ref-CR49">Helmink, B. A. et al. B cells and tertiary lymphoid structures promote immunotherapy response. <i>Nature</i> <b>577</b>, 549–555 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-019-1922-8" data-track-item_id="10.1038/s41586-019-1922-8" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-019-1922-8" aria-label="Article reference 49" data-doi="10.1038/s41586-019-1922-8">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXis1Sitrk%3D" aria-label="CAS reference 49">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31942075" aria-label="PubMed reference 49">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762581" aria-label="PubMed Central reference 49">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 49" href="http://scholar.google.com/scholar_lookup?&amp;title=B%20cells%20and%20tertiary%20lymphoid%20structures%20promote%20immunotherapy%20response&amp;journal=Nature&amp;doi=10.1038%2Fs41586-019-1922-8&amp;volume=577&amp;pages=549-555&amp;publication_year=2020&amp;author=Helmink%2CBA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="50."><p class="c-article-references__text" id="ref-CR50">Bhattacharya, A. et al. An approach for normalization and quality control for NanoString RNA expression data. <i>Brief. Bioinform.</i> <b>22</b>, bbaa163 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/bib/bbaa163" data-track-item_id="10.1093/bib/bbaa163" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Fbib%2Fbbaa163" aria-label="Article reference 50" data-doi="10.1093/bib/bbaa163">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32789507" aria-label="PubMed reference 50">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXisFeqtLnF" aria-label="CAS reference 50">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 50" href="http://scholar.google.com/scholar_lookup?&amp;title=An%20approach%20for%20normalization%20and%20quality%20control%20for%20NanoString%20RNA%20expression%20data&amp;journal=Brief.%20Bioinform.&amp;doi=10.1093%2Fbib%2Fbbaa163&amp;volume=22&amp;publication_year=2021&amp;author=Bhattacharya%2CA">
                    Google Scholar</a>&nbsp;
                </p></li></ol><p class="c-article-references__download u-hide-print"><a data-track="click" data-track-action="download citation references" data-track-label="link" rel="nofollow" href="https://citation-needed.springer.com/v2/references/10.1038/s41591-022-01789-0?format=refman&amp;flavour=references">Download references<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-download-medium"></use></svg></a></p></div></div></div></section></div><section data-title="Acknowledgements"><div class="c-article-section" id="Ack1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Ack1">Acknowledgements</h2><div class="c-article-section__content" id="Ack1-content"><p>We thank all patients participating in the trial for their generous contribution of time, patience and willingness to consent to a minimally invasive procedure that they would not have had as part of their routine care; and the Patient Advisory Group, represented by Z. Ide, for their continuous support in evaluation of trial documentation and the linked research, as well as in dissemination of the importance of precision medicine among patients and through patient organizations (including the National Rheumatoid Arthritis Society).The R4RA trial was funded by the Efficacy and Mechanism Evaluation (EME) Programme, a partnership between the Medical Research Council (MRC) and the National Institute for Health and Care Research (NIHR) (grant no. 11/100/76). This study was further supported by NIHR (grant 131575) and MRC (MR/V012509/1). We would also like to thank the NIHR for supporting F.R.’s fellowship (no. TRF-2018-11-ST2-002), and Versus Arthritis for providing infrastructure support through the Experimental Arthritis Treatment Centre (grant no. 20022) and for supporting A.N.’s clinical lectureship (grant no. 21890). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, MRC, Versus Arthritis or the Department of Health. We thank A. Spiliopoulou (Edinburgh University) for statistical advice and discussions. Some of the illustrations were created using Servier medical art (smart.servier.com) under Creative Commons Attribution 3.0 Unported License.</p></div></div></section><section aria-labelledby="author-information" data-title="Author information"><div class="c-article-section" id="author-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="author-information">Author information</h2><div class="c-article-section__content" id="author-information-content"><span class="c-article-author-information__subtitle u-visually-hidden" id="author-notes">Author notes</span><ol class="c-article-author-information__list"><li class="c-article-author-information__item" id="na1"><p>These authors contributed equally Felice Rivellese, Anna E.A. Surace.</p></li><li class="c-article-author-information__item" id="na2"><p>Deceased: Christopher R. John.</p></li><li class="c-article-author-information__item" id="na3"><p>These authors jointly supervised this work Myles J. Lewis, Costantino Pitzalis.</p></li></ol><h3 class="c-article__sub-heading" id="affiliations">Authors and Affiliations</h3><ol class="c-article-author-affiliation__list"><li id="Aff1"><p class="c-article-author-affiliation__address">Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK</p><p class="c-article-author-affiliation__authors-list">Felice Rivellese,&nbsp;Anna E. A. Surace,&nbsp;Katriona Goldmann,&nbsp;Elisabetta Sciacca,&nbsp;Cankut Çubuk,&nbsp;Giovanni Giorli,&nbsp;Christopher R. John,&nbsp;Alessandra Nerviani,&nbsp;Liliane Fossati-Jimack,&nbsp;Georgina Thorborn,&nbsp;Manzoor Ahmed,&nbsp;Edoardo Prediletto,&nbsp;Frances Humby,&nbsp;Michele Bombardieri,&nbsp;Myles J. Lewis,&nbsp;Costantino Pitzalis,&nbsp;Felice Rivellese,&nbsp;Giovanni Giorli,&nbsp;Alessandra Nerviani,&nbsp;Liliane Fossati-Jimack,&nbsp;Georgina Thorborn,&nbsp;Frances Humby,&nbsp;Michele Bombardieri,&nbsp;Myles J. Lewis,&nbsp;Louise Warren,&nbsp;Joanna Peel,&nbsp;Rebecca Hands,&nbsp;Gaye Hadfield&nbsp;&amp;&nbsp;Costantino Pitzalis</p></li><li id="Aff2"><p class="c-article-author-affiliation__address">Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK</p><p class="c-article-author-affiliation__authors-list">Felice Rivellese,&nbsp;Anna E. A. Surace,&nbsp;Katriona Goldmann,&nbsp;Elisabetta Sciacca,&nbsp;Cankut Çubuk,&nbsp;Giovanni Giorli,&nbsp;Christopher R. John,&nbsp;Michael R. Barnes,&nbsp;Myles J. Lewis,&nbsp;Felice Rivellese,&nbsp;Giovanni Giorli,&nbsp;Myles J. Lewis&nbsp;&amp;&nbsp;Stephen Kelly</p></li><li id="Aff3"><p class="c-article-author-affiliation__address">NanoString Technologies Inc., Seattle, WA, USA</p><p class="c-article-author-affiliation__authors-list">Sarah E. Church,&nbsp;Briana M. Hudson&nbsp;&amp;&nbsp;Sarah E. Warren</p></li><li id="Aff4"><p class="c-article-author-affiliation__address">Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK</p><p class="c-article-author-affiliation__authors-list">Paul M. McKeigue</p></li><li id="Aff5"><p class="c-article-author-affiliation__address">Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium</p><p class="c-article-author-affiliation__authors-list">Patrick Durez&nbsp;&amp;&nbsp;Bernard Lauwerys</p></li><li id="Aff6"><p class="c-article-author-affiliation__address">Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium</p><p class="c-article-author-affiliation__authors-list">Patrick Durez&nbsp;&amp;&nbsp;Bernard Lauwerys</p></li><li id="Aff7"><p class="c-article-author-affiliation__address">Centre for Musculoskeletal Research, Division of Musculoskeletal &amp; Dermatological Sciences, The University of Manchester, Manchester, UK</p><p class="c-article-author-affiliation__authors-list">Maya H. Buch</p></li><li id="Aff8"><p class="c-article-author-affiliation__address">NIHR Manchester Biomedical Research Centre, Manchester, UK</p><p class="c-article-author-affiliation__authors-list">Maya H. Buch</p></li><li id="Aff9"><p class="c-article-author-affiliation__address">Department of Cellular Pathology, Barts Health NHS Trust, London, UK</p><p class="c-article-author-affiliation__authors-list">Hasan Rizvi</p></li><li id="Aff10"><p class="c-article-author-affiliation__address">Institute of Health Sciences Education, Queen Mary University of London, London, UK</p><p class="c-article-author-affiliation__authors-list">Hasan Rizvi</p></li><li id="Aff11"><p class="c-article-author-affiliation__address">Department of Rheumatology, Kings College Hospital NHS Foundation Trust, London, UK</p><p class="c-article-author-affiliation__authors-list">Arti Mahto</p></li><li id="Aff12"><p class="c-article-author-affiliation__address">Department of Rheumatology, Fondazione I.R.C.C.S. Policlinico San Matteo, University of Pavia, Pavia, Italy</p><p class="c-article-author-affiliation__authors-list">Carlomaurizio Montecucco&nbsp;&amp;&nbsp;Serena Bugatti</p></li><li id="Aff13"><p class="c-article-author-affiliation__address">Rheumatology Department, Guy’s and St Thomas’ NHS Foundation Trust, London, UK</p><p class="c-article-author-affiliation__authors-list">Nora Ng</p></li><li id="Aff14"><p class="c-article-author-affiliation__address">The Kellgren Centre for Rheumatology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK</p><p class="c-article-author-affiliation__authors-list">Pauline Ho</p></li><li id="Aff15"><p class="c-article-author-affiliation__address">Rheumatology Department, Hospital De Santa Maria Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal</p><p class="c-article-author-affiliation__authors-list">Vasco C. Romão</p></li><li id="Aff16"><p class="c-article-author-affiliation__address">Rheumatology Research Unit, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal</p><p class="c-article-author-affiliation__authors-list">Vasco C. Romão&nbsp;&amp;&nbsp;João Eurico Cabral da Fonseca</p></li><li id="Aff17"><p class="c-article-author-affiliation__address">Skeletal Biology and Engineering Research Centre, Department of Development and Regeneration, KU Leuven, Leuven, Belgium</p><p class="c-article-author-affiliation__authors-list">Patrick Verschueren</p></li><li id="Aff18"><p class="c-article-author-affiliation__address">Division of Rheumatology, University Hospital Leuven, Leuven, Belgium</p><p class="c-article-author-affiliation__authors-list">Patrick Verschueren</p></li><li id="Aff19"><p class="c-article-author-affiliation__address">Department of Rheumatology, University of Eastern Piedmont and Maggiore della Carita Hospital, Novara, Italy</p><p class="c-article-author-affiliation__authors-list">Pier Paolo Sainaghi&nbsp;&amp;&nbsp;Mattia Bellan</p></li><li id="Aff20"><p class="c-article-author-affiliation__address">Rheumatology Department, Basildon Hospital, Basildon, UK</p><p class="c-article-author-affiliation__authors-list">Nagui Gendi</p></li><li id="Aff21"><p class="c-article-author-affiliation__address">Rheumatology Department, Mid &amp; South Essex University Hospitals NHS Foundation Trust, Southend University Hospital, Westcliff-on-Sea, UK</p><p class="c-article-author-affiliation__authors-list">Bhaskar Dasgupta</p></li><li id="Aff22"><p class="c-article-author-affiliation__address">Rheumatology Unit, Department of Medicine and Public Health, AOU and University of Cagliari, Monserrato, Italy</p><p class="c-article-author-affiliation__authors-list">Alberto Cauli&nbsp;&amp;&nbsp;Mattia Congia</p></li><li id="Aff23"><p class="c-article-author-affiliation__address">Department of Rheumatology, Homerton University Hospital, London, UK</p><p class="c-article-author-affiliation__authors-list">Piero Reynolds</p></li><li id="Aff24"><p class="c-article-author-affiliation__address">Rheumatology Department, Hospital Clínic de Barcelona, Barcelona, Spain</p><p class="c-article-author-affiliation__authors-list">Juan D. Cañete,&nbsp;Julio Ramirez&nbsp;&amp;&nbsp;Raquel Celis</p></li><li id="Aff25"><p class="c-article-author-affiliation__address">Institut d’Investigacions Biomèdiques August Pí I Sunyer, Barcelona, Spain</p><p class="c-article-author-affiliation__authors-list">Juan D. Cañete</p></li><li id="Aff26"><p class="c-article-author-affiliation__address">Academic Rheumatology Unit, Aintree University Hospital, Liverpool, UK</p><p class="c-article-author-affiliation__authors-list">Robert Moots</p></li><li id="Aff27"><p class="c-article-author-affiliation__address">Faculty of Health, Social Care and Medicine, Edge Hill University, Ormskirk, UK</p><p class="c-article-author-affiliation__authors-list">Robert Moots</p></li><li id="Aff28"><p class="c-article-author-affiliation__address">Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, UK</p><p class="c-article-author-affiliation__authors-list">Peter C. Taylor</p></li><li id="Aff29"><p class="c-article-author-affiliation__address">NIHR Clinical Research Facility, University Hospital Southampton, Southampton, UK</p><p class="c-article-author-affiliation__authors-list">Chris J. Edwards</p></li><li id="Aff30"><p class="c-article-author-affiliation__address">Faculty of Medicine, University of Southampton, Southampton, UK</p><p class="c-article-author-affiliation__authors-list">Chris J. Edwards</p></li><li id="Aff31"><p class="c-article-author-affiliation__address">Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK</p><p class="c-article-author-affiliation__authors-list">John Isaacs&nbsp;&amp;&nbsp;Arthur Pratt</p></li><li id="Aff32"><p class="c-article-author-affiliation__address">Musculoskeletal Unit, Newcastle upon Tyne hospitals NHS Foundation Trust, Newcastle upon Tyne, UK</p><p class="c-article-author-affiliation__authors-list">John Isaacs&nbsp;&amp;&nbsp;Arthur Pratt</p></li><li id="Aff33"><p class="c-article-author-affiliation__address">King’s Clinical Trials Unit, Kings College London, London, UK</p><p class="c-article-author-affiliation__authors-list">Peter Sasieni</p></li><li id="Aff34"><p class="c-article-author-affiliation__address">CREATE Centre, Cardiff University, Cardiff, UK</p><p class="c-article-author-affiliation__authors-list">Ernest Choy</p></li><li id="Aff35"><p class="c-article-author-affiliation__address">Department of Rheumatology, University Hospital of Wales, Cardiff, UK</p><p class="c-article-author-affiliation__authors-list">Ernest Choy</p></li><li id="Aff36"><p class="c-article-author-affiliation__address">Brighton and Sussex Medical School, University of Sussex, Brighton, UK</p><p class="c-article-author-affiliation__authors-list">Charlotte Thompson</p></li><li id="Aff37"><p class="c-article-author-affiliation__address">Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK</p><p class="c-article-author-affiliation__authors-list">Christopher Holroyd</p></li><li id="Aff38"><p class="c-article-author-affiliation__address">Cancer Research UK &amp; UCL Cancer Trials Centre, University College London, London, UK</p><p class="c-article-author-affiliation__authors-list">Laura White</p></li></ol><div class="u-js-hide u-hide-print" data-test="author-info"><span class="c-article__sub-heading">Authors</span><ol class="c-article-authors-search u-list-reset"><li id="auth-Felice-Rivellese-Aff1-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Felice Rivellese</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Felice%20Rivellese" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Felice%20Rivellese" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Felice%20Rivellese%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Anna_E__A_-Surace-Aff1-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Anna E. A. Surace</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Anna%20E.%20A.%20Surace" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Anna%20E.%20A.%20Surace" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Anna%20E.%20A.%20Surace%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Katriona-Goldmann-Aff1-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Katriona Goldmann</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Katriona%20Goldmann" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Katriona%20Goldmann" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Katriona%20Goldmann%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Elisabetta-Sciacca-Aff1-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Elisabetta Sciacca</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Elisabetta%20Sciacca" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Elisabetta%20Sciacca" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Elisabetta%20Sciacca%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Cankut-_ubuk-Aff1-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Cankut Çubuk</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Cankut%20%C3%87ubuk" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Cankut%20%C3%87ubuk" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Cankut%20%C3%87ubuk%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Giovanni-Giorli-Aff1-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Giovanni Giorli</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Giovanni%20Giorli" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Giovanni%20Giorli" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Giovanni%20Giorli%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Christopher_R_-John-Aff1-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Christopher R. John</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Christopher%20R.%20John" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Christopher%20R.%20John" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Christopher%20R.%20John%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Alessandra-Nerviani-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Alessandra Nerviani</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Alessandra%20Nerviani" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Alessandra%20Nerviani" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Alessandra%20Nerviani%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Liliane-Fossati_Jimack-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Liliane Fossati-Jimack</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Liliane%20Fossati-Jimack" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Liliane%20Fossati-Jimack" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Liliane%20Fossati-Jimack%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Georgina-Thorborn-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Georgina Thorborn</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Georgina%20Thorborn" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Georgina%20Thorborn" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Georgina%20Thorborn%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Manzoor-Ahmed-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Manzoor Ahmed</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Manzoor%20Ahmed" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Manzoor%20Ahmed" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Manzoor%20Ahmed%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Edoardo-Prediletto-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Edoardo Prediletto</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Edoardo%20Prediletto" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Edoardo%20Prediletto" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Edoardo%20Prediletto%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Sarah_E_-Church-Aff3"><span class="c-article-authors-search__title u-h3 js-search-name">Sarah E. Church</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Sarah%20E.%20Church" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Sarah%20E.%20Church" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Sarah%20E.%20Church%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Briana_M_-Hudson-Aff3"><span class="c-article-authors-search__title u-h3 js-search-name">Briana M. Hudson</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Briana%20M.%20Hudson" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Briana%20M.%20Hudson" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Briana%20M.%20Hudson%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Sarah_E_-Warren-Aff3"><span class="c-article-authors-search__title u-h3 js-search-name">Sarah E. Warren</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Sarah%20E.%20Warren" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Sarah%20E.%20Warren" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Sarah%20E.%20Warren%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Paul_M_-McKeigue-Aff4"><span class="c-article-authors-search__title u-h3 js-search-name">Paul M. McKeigue</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Paul%20M.%20McKeigue" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Paul%20M.%20McKeigue" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Paul%20M.%20McKeigue%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Frances-Humby-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Frances Humby</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Frances%20Humby" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Frances%20Humby" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Frances%20Humby%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Michele-Bombardieri-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Michele Bombardieri</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Michele%20Bombardieri" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Michele%20Bombardieri" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Michele%20Bombardieri%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Michael_R_-Barnes-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Michael R. Barnes</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Michael%20R.%20Barnes" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Michael%20R.%20Barnes" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Michael%20R.%20Barnes%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Myles_J_-Lewis-Aff1-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Myles J. Lewis</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Myles%20J.%20Lewis" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Myles%20J.%20Lewis" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Myles%20J.%20Lewis%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Costantino-Pitzalis-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Costantino Pitzalis</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Costantino%20Pitzalis" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Costantino%20Pitzalis" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Costantino%20Pitzalis%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li></ol></div><h3 class="c-article__sub-heading" id="groups">Consortia</h3><div class="c-article-author-institutional-author" id="group-1"><h3 class="c-article-author-institutional-author__name u-h3">the R4RA collaborative group</h3><ul class="c-article-author-institutional-author__author-list"><li class="c-article-author-institutional-author__author-name">Felice Rivellese</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Giovanni Giorli</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Alessandra Nerviani</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Liliane Fossati-Jimack</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Georgina Thorborn</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Frances Humby</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Michele Bombardieri</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Myles J. Lewis</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Patrick Durez</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Maya H. Buch</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Hasan Rizvi</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Arti Mahto</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Carlomaurizio Montecucco</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Bernard Lauwerys</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Nora Ng</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Pauline Ho</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Vasco C. Romão</li><li class="c-article-author-institutional-author__author-name">,&nbsp;João Eurico Cabral da Fonseca</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Patrick Verschueren</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Stephen Kelly</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Pier Paolo Sainaghi</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Nagui Gendi</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Bhaskar Dasgupta</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Alberto Cauli</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Piero Reynolds</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Juan D. Cañete</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Julio Ramirez</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Raquel Celis</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Robert Moots</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Peter C. Taylor</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Chris J. Edwards</li><li class="c-article-author-institutional-author__author-name">,&nbsp;John Isaacs</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Peter Sasieni</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Ernest Choy</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Charlotte Thompson</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Serena Bugatti</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Mattia Bellan</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Mattia Congia</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Christopher Holroyd</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Arthur Pratt</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Laura White</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Louise Warren</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Joanna Peel</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Rebecca Hands</li><li class="c-article-author-institutional-author__author-name">,&nbsp;Gaye Hadfield</li><li class="c-article-author-institutional-author__author-name">&nbsp;&amp;&nbsp;Costantino Pitzalis</li></ul></div><h3 class="c-article__sub-heading" id="contributions">Contributions</h3><p>C.P. conceived the trial, sought funding and assumes overall responsibility for the trial and all reported data. F.R., A.E.A.S., K.G., E.S., G.G., C.C., C.R.J., M.R.B. and M.J.L. performed data analysis. K.G., C.C. and M.J.L. performed machine learning analysis. P.M.M. contributed to the revision of machine learning. L.F.J., G.T., A.N., F.R. and F.H. were responsible for collection and processing of samples. B.M.H., S.E.C. and S.E.W. ran the GeoMx spatial profiling analysis and advised on data analysis. A.M. and E.P. performed multiplex immunofluorescence staining. F.H., M.B., M.J.L. and C.P. oversaw the clinical trial. M.J.L. and C.P. supervised the analysis. F.R., A.E.A.S., K.G., E.S., G.G., M.J.L. and C.P. wrote the initial draft of the manuscript and the revised version. All authors contributed to discussion and interpretation of the results, critically reviewed the manuscript and approved the final version for submission.</p><h3 class="c-article__sub-heading" id="corresponding-author">Corresponding authors</h3><p id="corresponding-author-list">Correspondence to
                <a id="corresp-c1" href="mailto:myles.lewis@qmul.ac.uk">Myles J. Lewis</a> or <a id="corresp-c2" href="mailto:c.pitzalis@qmul.ac.uk">Costantino Pitzalis</a>.</p></div></div></section><section data-title="Ethics declarations"><div class="c-article-section" id="ethics-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="ethics">Ethics declarations</h2><div class="c-article-section__content" id="ethics-content">
              
                <h3 class="c-article__sub-heading" id="FPar4">Competing interests</h3>
                <p>S.E.C., B.M.H. and S.E.W. are employees and stockholders of NanoString Technologies, Inc. C.P. and M.J.L. are inventors on a patent application (no. GB 2100821.4), submitted by Queen Mary University of London, that covers methods used to select treatments in RA. All other authors declare no competing interests.</p>
              
            </div></div></section><section data-title="Peer review"><div class="c-article-section" id="peer-review-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="peer-review">Peer review</h2><div class="c-article-section__content" id="peer-review-content">
              
              
                <h3 class="c-article__sub-heading" id="FPar3">Peer review information</h3>
                <p><i>Nature Medicine</i> thanks Gerhard Kronke, Rong Lu and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Saheli Sadanand was the primary editor on this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.</p>
              
            </div></div></section><section data-title="Additional information"><div class="c-article-section" id="additional-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="additional-information">Additional information</h2><div class="c-article-section__content" id="additional-information-content"><p><b>Publisher’s note</b> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section data-title="Extended data"><div class="c-article-section" id="Sec31-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec31">Extended data</h2><div class="c-article-section__content" id="Sec31-content"><div data-test="supplementary-info"><div id="figshareContainer" class="c-article-figshare-container" data-test="figshare-container"></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig7"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 1 histological analyses." href="/articles/s41591-022-01789-0/figures/7" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig7_ESM.jpg">Extended Data Fig. 1 Histological analyses.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p><b>a</b>, Atlas of semi-quantitative synovial IHC scores for immune cells. <b>b</b>, Distribution of semiquantitative scores at baseline in all patients, individually shown in the y axis. The total on the x axis represents the sum of the individual scores (Immune score). <b>c</b>, Baseline semi-quantitative IHC scores, Krenn synovitis score (‘Synovial score’) and total Immune score in patients stratified according to 16 weeks CDAI50% response to rituximab (top) and tocilizumab (bottom). Two-sided Mann Whitney test. ns= p value &gt;0.05. n = 161 patients. Boxplots showing median with first and third quartiles.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig8"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 2 unsupervised principal compon" href="/articles/s41591-022-01789-0/figures/8" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig8_ESM.jpg">Extended Data Fig. 2 Unsupervised Principal Component Analysis shows association primarily with cell types present and consequently also pathotype.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p><b>a</b>, Clinical features and their degree of association with Principal Components (PC) 1–10 with coloring indicating the –log(p) (left) and FDR corrected –log(q) value (right). RF, Rheumatoid Factor; CCP, anti-Cyclic Citrullinated Protein; CRP, C-Reactive Protein; ESR, Erythrocyte Sedimentation Rate; SJC, Swollen Joint Counts; TJC, Tender Joint Count. <b>b</b>, PC 1 and 3 gene expression variance with coloring by (b) pathotypes showing fibroid (blue), lymphoid (red), myeloid (pink) and ungraded (grey) patients. Ellipses indicate 80% confidence interval. <b>c and d</b>, PC1 and 2 colored by response to treatment. Patients allocated to treatment group rituximab are displayed in c and to tocilizumab in d, with non response colored in red, response to RTX in blue and response to TOC in gold. Ellipses shown for all PCs represent the 80% confidence interval. <b>e</b>, Differential expression of genes important for B-cells (MS4A1, CD79A, CD79B, PIK3CA, BTK and SYK) and Weighted Gene Correlation Network Analysis (WGCNA) cell modules (B-cells, M1 macrophage cytokine signalling, Fibroblast 2a THY1+) in Rituximab treated patients (n = 68), according to the consensus clusters shown in (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig2">2a</a>). Boxplots show median with upper and lower hinges and whiskers extending to highest and lowest point, but at most 1.5x the interquartile range. p-values stated for Kruskal-Wallis test. <b>f</b>, IL-6 related genes (IL6R, IL6, IL6ST, JAK1, JAK2 and STAT3) and WGCNA cell modules expression in tocilizumab (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01789-0#Fig2">2b</a>) treated patients (n = 65) based on consensus clusters. Boxplots as above. <b>g</b>, Boxplots showing median with upper and lower hinges for semiquantitative histological scores of CD3, CD20, CD68L, CD68SL, CD138 and CD79a for all patients (n = 133) split into consensuscluster 1 and consensuscluster 2. Kruskal-Wallis test p-values are shown.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig9"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 3 influence of immune cells on " href="/articles/s41591-022-01789-0/figures/9" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig9_ESM.jpg">Extended Data Fig. 3 Influence of immune cells on consensusclusters.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p><b>a-d</b>, Volcano plots showing differential gene expression analysis using DESeq2 comparing consensuscluster 1 and 2 of patients treated with rituximab (left) or tocilizumab (right). While <b>a</b> and <b>b</b> were analyzed without covariates, <b>c</b> and <b>d</b> were adjusted for principal component (PC1). Comparison between groups were tested for significance using Wald test and multiple testing was corrected for with Storey’s q value (q &lt; 0.05 = significant, shown in blue). Positive log2fold changes represent upregulation in consensuscluster 2, negative log2fold changes represents upregulation in consensuscluster 1. <b>e</b>, Correlation plot highlighting relation between PC1, histology markers and genes involved in the mode of action of RTX and TOC. Positive correlation is shown in blue while red would indicate negative correlation. For all correlations without significance, the p-value is shown. <b>f,g</b>, Volcano plots of DEGs using DESeq2 comparing CDAI50% responders versus non responders to rituximab (f) and tocilizumab (g) after adjustment for principal component 1. Comparison between groups using Wald test and correcting for multiple testing Storey’s q value (q &lt; 0.05 = significant, shown in blue). Positive values represent upregulation in responders and negative values downregulation compared to non-responders.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig10"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 4 immunofluorescence of dkk3 + " href="/articles/s41591-022-01789-0/figures/10" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig10_ESM.jpg">Extended Data Fig. 4 Immunofluorescence of DKK3 + fibroblasts.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>DKK3 + fibroblasts in refractory (left) and responder (right) patients (representative image out of 3 refractory and 3 responders). Immunofluorescence with DNA in blue, CD45 in red, CD90 in green and DKK3 in yellow. Lines at 0.250 mm in the overview (top panels) and 0.05 mm in the higher magnification (bottom panels).</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig11"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 5 longitudinal analysis of pair" href="/articles/s41591-022-01789-0/figures/11" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig11_ESM.jpg">Extended Data Fig. 5 Longitudinal analysis of paired pre- and post-treatment synovial biopsies.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p><b>a</b>, Schema showing an overview of longitudinal analysis of matched pre and post-treatment synovial biopsies, with number of samples for each medication (in brackets samples with available RNA-Seq). <b>b</b>, Semi-quantitative scores at baseline and 16 weeks in patients stratified according to treatment with rituximab (n = 41) or tocilizumab (n = 24). Mean ± SEM. Exact p values from two-sided analysis of covariance testing the difference in the changes from baseline between treatments, with treatment as factor and baseline score as covariate. <b>c</b>, MCP-counter scores in baseline and 16 weeks samples. Scatterplots showing individual samples and boxplots showing median and first and third quartiles, whiskers extending to the highest and lowest values no further than 1.5*interquartile range. Two-sided Wilcoxon signed-rank test (paired), comparing baseline and 16 weeks, adjusted for multiple testing by false discovery rate. n = 29 for rituximab and n = 15 for tocilizumab. <b>d</b>, Semi-quantitative scores of synovial immune cells at baseline and 16 weeks in patients treated with rituximab (n = 41) and tocilizumab (n = 24), stratified by CDAI50% response (NR = non responders, R = responders). Boxplots showing median and first and third quartiles. p values shown when &lt;0.05, two sided Wilcoxon signed-rank test (paired) comparing baseline and 16 weeks, adjusted for multiple testing by false discovery rate. <b>e,f</b>, Longitudinal negative binomial mixed effects model on Rituximab (n = 29) and (f) Tocilizumab (n = 15) treated patients showing differential gene expression between responders and non-responders categorised by CDAI 50% response. Blue genes show greater absolute gene expression change in rituximab responders, yellow genes show greater absolute gene expression change in tocilizumab responders, while red genes showed greater absolute gene expression change in non-responders. <b>g,h</b> Scatter plots of representative genes with coloured points showing regression line of fitted negative binomial mixed effects model with error bars showing 95% confidence intervals (fixed effects) from analyses in e &amp; f respectively. Grey points and lines show raw paired count data. n = 29 for rituximab and n = 15 for tocilizumab.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig12"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 6 venn diagram showing overlap " href="/articles/s41591-022-01789-0/figures/12" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig12_ESM.jpg">Extended Data Fig. 6 Venn diagram showing overlap in genes between machine learning models and comparison with models built using only clinical and histological variables.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p><b>a</b>, Venn diagram showing the overlap in genes selected as features in optimal predictive models for prediction of rituximab and tocilizumab response at week 16 and refractory state (failure to respond to both rituximab and tocilizumab). <b>b</b>, Grid of plots showing the optimal predictive models for different treatment when using clinical and histological variables only. From top to bottom plots show: ROC curves for the best model on the test data (from outer-fold) set; ROC curves on the left-out (from inner-fold) set; and the variable importance when fit to the whole data set.</p></div></div><div class="c-article-supplementary__item" data-test="supp-item"><div class="c-article-table" data-test="inline-table" data-container-section="table" id="table-1"><figure><figcaption class="c-article-table__figcaption"><b id="Tab1" data-test="table-caption">Extended Data Table 1 Synovial histological analysis stratified according to treatment at baseline and 16 weeks</b></figcaption><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="table-link" data-track="click" data-track-action="view table" data-track-label="button" rel="nofollow" href="/articles/s41591-022-01789-0/tables/1" aria-label="Full size table 1"><span>Full size table</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div></div><div class="c-article-supplementary__item" data-test="supp-item"><div class="c-article-table" data-test="inline-table" data-container-section="table" id="table-2"><figure><figcaption class="c-article-table__figcaption"><b id="Tab2" data-test="table-caption">Extended Data Table 2 Genes included in prediction models</b></figcaption><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="table-link" data-track="click" data-track-action="view table" data-track-label="button" rel="nofollow" href="/articles/s41591-022-01789-0/tables/2" aria-label="Full size table 2"><span>Full size table</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div></div></div></div></div></section><section data-title="Supplementary information"><div class="c-article-section" id="Sec32-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec32">Supplementary information</h2><div class="c-article-section__content" id="Sec32-content"><div data-test="supplementary-info"><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM1"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="supplementary information" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_MOESM1_ESM.pdf" data-supp-info-image="">Supplementary Information</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Supplementary Figs. 1 and 2, Tables 1–7 and a list of R4RA collaborative group members.</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM2"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="reporting summary" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_MOESM2_ESM.pdf" data-supp-info-image="">Reporting Summary</a></h3></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM3"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="supplementary data 1" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_MOESM3_ESM.xls" data-supp-info-image="">Supplementary Data 1</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Synovial biopsy DEGs in rituximab and tocilizumab responders compared with nonresponders.</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM4"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="supplementary data 2" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_MOESM4_ESM.xlsx" data-supp-info-image="">Supplementary Data 2</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Three-way DEG analysis of patients who were pro-rituximab, pro-tocilizumab or refractory.</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM5"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="supplementary data 3" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_MOESM5_ESM.xlsx" data-supp-info-image="">Supplementary Data 3</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Modular analysis of patients who were pro-rituximab, pro-tocilizumab or refractory.</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM6"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="supplementary data 4" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_MOESM6_ESM.xlsx" data-supp-info-image="">Supplementary Data 4</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Longitudinal mixed-model gene expression analysis.</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM7"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="supplementary data 5" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_MOESM7_ESM.zip" data-supp-info-image="">Supplementary Data 5</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>R objects for optimal prediction models for rituximab (glmnet), tocilizumab (glmnet) and refractory state (GBM), including feature space data for ten dummy samples and R script outlining model interrogation and use for future predictions.</p></div></div></div></div></div></section><section data-title="Rights and permissions"><div class="c-article-section" id="rightslink-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="rightslink">Rights and permissions</h2><div class="c-article-section__content" id="rightslink-content">
                <p><b>Open Access</b>  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <a href="http://creativecommons.org/licenses/by/4.0/" rel="license">http://creativecommons.org/licenses/by/4.0/</a>.</p>
              <p class="c-article-rights"><a data-track="click" data-track-action="view rights and permissions" data-track-label="link" href="https://s100.copyright.com/AppDispatchServlet?title=Rituximab%20versus%20tocilizumab%20in%20rheumatoid%20arthritis%3A%20synovial%20biopsy-based%20biomarker%20analysis%20of%20the%20phase%204%20R4RA%20randomized%20trial&amp;author=Felice%20Rivellese%20Felice%20Rivellese%20et%20al&amp;contentID=10.1038%2Fs41591-022-01789-0&amp;copyright=Crown&amp;publication=1078-8956&amp;publicationDate=2022-05-19&amp;publisherName=SpringerNature&amp;orderBeanReset=true&amp;oa=CC%20BY">Reprints and permissions</a></p></div></div></section><section aria-labelledby="article-info" data-title="About this article"><div class="c-article-section" id="article-info-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="article-info">About this article</h2><div class="c-article-section__content" id="article-info-content"><div class="c-bibliographic-information"><div class="u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border"><a data-crossmark="10.1038/s41591-022-01789-0" target="_blank" rel="noopener" href="https://crossmark.crossref.org/dialog/?doi=10.1038/s41591-022-01789-0" data-track="click" data-track-action="Click Crossmark" data-track-label="link" data-test="crossmark"><img loading="lazy" width="57" height="81" alt="Check for updates. Verify currency and authenticity via CrossMark" src="data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>"></a></div><div class="c-bibliographic-information__column"><h3 class="c-article__sub-heading" id="citeas">Cite this article</h3><p class="c-bibliographic-information__citation">Rivellese, F., Surace, A.E.A., Goldmann, K. <i>et al.</i> Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial.
                    <i>Nat Med</i> <b>28</b>, 1256–1268 (2022). https://doi.org/10.1038/s41591-022-01789-0</p><p class="c-bibliographic-information__download-citation u-hide-print"><a data-test="citation-link" data-track="click" data-track-action="download article citation" data-track-label="link" data-track-external="" rel="nofollow" href="https://citation-needed.springer.com/v2/references/10.1038/s41591-022-01789-0?format=refman&amp;flavour=citation">Download citation<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-download-medium"></use></svg></a></p><ul class="c-bibliographic-information__list" data-test="publication-history"><li class="c-bibliographic-information__list-item"><p>Received<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2021-04-28">28 April 2021</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Accepted<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2022-03-21">21 March 2022</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Published<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2022-05-19">19 May 2022</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Issue Date<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2022-06">June 2022</time></span></p></li><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--full-width"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide">: </span><span class="c-bibliographic-information__value">https://doi.org/10.1038/s41591-022-01789-0</span></p></li></ul><div data-component="share-box"><div class="c-article-share-box u-display-block"><h3 class="c-article__sub-heading">Share this article</h3><p class="c-article-share-box__description">Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" type="button" id="get-share-url" data-track="click" data-track-label="button" data-track-external="" data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none" hidden=""><p class="js-c-article-share-box__no-sharelink-info c-article-share-box__no-sharelink-info">Sorry, a shareable link is not currently available for this article.</p></div><div class="js-share-url-container u-display-none" hidden=""><p class="js-share-url c-article-share-box__only-read-input" id="share-url" data-track="click" data-track-label="button" data-track-action="select share url"></p><button class="js-copy-share-url c-article-share-box__button--link-like" type="button" id="copy-share-url" data-track="click" data-track-label="button" data-track-action="copy share url" data-track-external="">Copy to clipboard</button></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
                            Provided by the Springer Nature SharedIt content-sharing initiative
                        </p></div></div><div data-component="article-info-list">
        <h3 class="c-article__sub-heading">Subjects</h3>
        <ul class="c-article-subject-list">
            <li class="c-article-subject-list__subject"><a href="/subjects/machine-learning" data-track="click" data-track-action="view subject" data-track-label="link">Machine learning</a></li><li class="c-article-subject-list__subject"><a href="/subjects/predictive-markers" data-track="click" data-track-action="view subject" data-track-label="link">Predictive markers</a></li><li class="c-article-subject-list__subject"><a href="/subjects/predictive-medicine" data-track="click" data-track-action="view subject" data-track-label="link">Predictive medicine</a></li><li class="c-article-subject-list__subject"><a href="/subjects/randomized-controlled-trials" data-track="click" data-track-action="view subject" data-track-label="link">Randomized controlled trials</a></li><li class="c-article-subject-list__subject"><a href="/subjects/rheumatoid-arthritis" data-track="click" data-track-action="view subject" data-track-label="link">Rheumatoid arthritis</a></li>
        </ul>
    </div></div></div></div></div></section>
            </div>

            
        <section>
            <div class="c-article-section js-article-section" id="further-reading-section" data-test="further-reading-section">
                <h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="further-reading">This article is cited by</h2>
                <div class="c-article-section__content js-collapsible-section" id="further-reading-content">
                    <ul class="c-article-further-reading__list" id="further-reading-list">
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Spatial transcriptomics in autoimmune rheumatic disease: potential clinical applications and perspectives" href="https://doi.org/10.1186/s41232-025-00369-2">
                                        Spatial transcriptomics in autoimmune rheumatic disease: potential clinical applications and perspectives
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Atsuko Tsujii Miyamoto</li><li>Hiroshi Shimagami</li><li>Masayuki Nishide</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Inflammation and Regeneration</i> (2025)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Molecular and cellular dynamics of the developing human neocortex" href="https://doi.org/10.1038/s41586-024-08351-7">
                                        Molecular and cellular dynamics of the developing human neocortex
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Li Wang</li><li>Cheng Wang</li><li>Arnold R. Kriegstein</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Nature</i> (2025)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Comprehensive RNA-seq analysis of benign prostatic hyperplasia (BPH) in rats exposed to testosterone and estradiol" href="https://doi.org/10.1038/s41598-025-87205-2">
                                        Comprehensive RNA-seq analysis of benign prostatic hyperplasia (BPH) in rats exposed to testosterone and estradiol
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Xiao-Hu Tang</li><li>Zhi-Yan Liu</li><li>Guang-Heng Luo</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Scientific Reports</i> (2025)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Artificial intelligence to predict treatment response in rheumatoid arthritis and spondyloarthritis: a scoping review" href="https://doi.org/10.1007/s00296-025-05825-3">
                                        Artificial intelligence to predict treatment response in rheumatoid arthritis and spondyloarthritis: a scoping review
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Diego Benavent</li><li>Loreto Carmona</li><li>Antonio Gómez-Centeno</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Rheumatology International</i> (2025)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort" href="https://doi.org/10.1186/s13075-024-03392-9">
                                        Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Piero Ruscitti</li><li>Damiano Currado</li><li>Roberto Giacomelli</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Arthritis Research &amp; Therapy</i> (2024)</p>
                            </li>
                        
                    </ul>
                </div>
            </div>
        </section>
    

        </div>
</article>
</main>

<aside class="c-article-extras u-hide-print" aria-label="Article navigation" data-component-reading-companion="" data-container-type="reading-companion" data-track-component="reading companion">
    <div class="js-context-bar-sticky-point-desktop" data-track-context="reading companion">
        

        
            
                
                    
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41591-022-01789-0.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external="" download="">
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"></use></svg>
            </a>
        </div>
    

                
            
        
    </div>

    
        
    

    
    
        <div class="c-article-associated-content__container">
            <section>
                <h2 class="c-article-associated-content__title u-mb-24">Associated content</h2>
                
                    
                    
                        <div class="u-full-height u-mb-24">
                            
    <article class="u-full-height c-card c-card--flush">
        <div class="c-card__layout u-full-height">
            <div class="c-card__body">
                <h3 class="c-card__title">
                    <a href="https://www.nature.com/articles/s41591-022-01857-5" class="c-card__link u-link-inherit" data-track="click" data-track-action="view article" data-track-category="associated content" data-track-label="news_and_views">Inching closer to precision treatment for rheumatoid arthritis</a>
                </h3>
                
<ul data-test="author-list" class="app-author-list app-author-list--compact">
    <li>Laura T. Donlin</li>
</ul>

                
    <div class="c-card__section c-meta">
        
            <span class="c-meta__item">Nature Medicine</span>
        
        <span class="c-meta__item" data-test="article.type"><span class="c-meta__type">News &amp; Views</span></span>
        
        
            <time class="c-meta__item" datetime="2022-06-09">09 Jun 2022</time>
        
    </div>

            </div>
        </div>
    </article>


                        </div>
                    
                
            </section>
        </div>
        <script>
            window.dataLayer = window.dataLayer || [];
            window.dataLayer[0] = window.dataLayer[0] || {};
            window.dataLayer[0].content = window.dataLayer[0].content || {};
            window.dataLayer[0].content.associatedContentTypes = "news_and_views";
            
        </script>
    

    

    <div class="c-reading-companion">
        <div class="c-reading-companion__sticky" data-component="reading-companion-sticky" data-test="reading-companion-sticky" style="top: 40px;">
            <ul class="c-reading-companion__tabs" role="tablist"><li role="presentation"><button data-tab-target="sections" role="tab" id="tab-sections" aria-controls="tabpanel-sections" aria-selected="true" class="c-reading-companion__tab c-reading-companion__tab--active" data-track="click" data-track-action="sections tab" data-track-label="tab">Sections</button></li><li role="presentation"><button data-tab-target="figures" role="tab" id="tab-figures" aria-controls="tabpanel-figures" aria-selected="false" tabindex="-1" class="c-reading-companion__tab" data-track="click" data-track-action="figures tab" data-track-label="tab">Figures</button></li><li role="presentation"><button data-tab-target="references" role="tab" id="tab-references" aria-controls="tabpanel-references" aria-selected="false" tabindex="-1" class="c-reading-companion__tab" data-track="click" data-track-action="references tab" data-track-label="tab">References</button></li></ul><div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id="tabpanel-sections" aria-labelledby="tab-sections" role="tabpanel"><div class="c-reading-companion__scroll-pane" style="max-height: none;"><ul class="c-reading-companion__sections-list"><li id="rc-sec-Abs1" class="c-reading-companion__section-item"><a href="#Abs1" data-track="click" data-track-action="section anchor" data-track-label="link:Abstract">Abstract</a></li><li id="rc-sec-Sec1" class="c-reading-companion__section-item"><a href="#Sec1" data-track="click" data-track-action="section anchor" data-track-label="link:Main">Main</a></li><li id="rc-sec-Sec2" class="c-reading-companion__section-item"><a href="#Sec2" data-track="click" data-track-action="section anchor" data-track-label="link:Results">Results</a></li><li id="rc-sec-Sec10" class="c-reading-companion__section-item"><a href="#Sec10" data-track="click" data-track-action="section anchor" data-track-label="link:Discussion">Discussion</a></li><li id="rc-sec-Sec11" class="c-reading-companion__section-item"><a href="#Sec11" data-track="click" data-track-action="section anchor" data-track-label="link:Methods">Methods</a></li><li id="rc-sec-data-availability" class="c-reading-companion__section-item"><a href="#data-availability" data-track="click" data-track-action="section anchor" data-track-label="link:Data availability">Data availability</a></li><li id="rc-sec-code-availability" class="c-reading-companion__section-item"><a href="#code-availability" data-track="click" data-track-action="section anchor" data-track-label="link:Code availability">Code availability</a></li><li id="rc-sec-Bib1" class="c-reading-companion__section-item"><a href="#Bib1" data-track="click" data-track-action="section anchor" data-track-label="link:References">References</a></li><li id="rc-sec-Ack1" class="c-reading-companion__section-item"><a href="#Ack1" data-track="click" data-track-action="section anchor" data-track-label="link:Acknowledgements">Acknowledgements</a></li><li id="rc-sec-author-information" class="c-reading-companion__section-item"><a href="#author-information" data-track="click" data-track-action="section anchor" data-track-label="link:Author information">Author information</a></li><li id="rc-sec-ethics" class="c-reading-companion__section-item"><a href="#ethics" data-track="click" data-track-action="section anchor" data-track-label="link:Ethics declarations">Ethics declarations</a></li><li id="rc-sec-peer-review" class="c-reading-companion__section-item"><a href="#peer-review" data-track="click" data-track-action="section anchor" data-track-label="link:Peer review">Peer review</a></li><li id="rc-sec-additional-information" class="c-reading-companion__section-item"><a href="#additional-information" data-track="click" data-track-action="section anchor" data-track-label="link:Additional information">Additional information</a></li><li id="rc-sec-Sec31" class="c-reading-companion__section-item"><a href="#Sec31" data-track="click" data-track-action="section anchor" data-track-label="link:Extended data">Extended data</a></li><li id="rc-sec-Sec32" class="c-reading-companion__section-item"><a href="#Sec32" data-track="click" data-track-action="section anchor" data-track-label="link:Supplementary information">Supplementary information</a></li><li id="rc-sec-rightslink" class="c-reading-companion__section-item"><a href="#rightslink" data-track="click" data-track-action="section anchor" data-track-label="link:Rights and permissions">Rights and permissions</a></li><li id="rc-sec-article-info" class="c-reading-companion__section-item"><a href="#article-info" data-track="click" data-track-action="section anchor" data-track-label="link:About this article">About this article</a></li><li id="rc-sec-further-reading" class="c-reading-companion__section-item"><a href="#further-reading" data-track="click" data-track-action="section anchor" data-track-label="link:This article is cited by">This article is cited by</a></li></ul></div>
                <div class="u-lazy-ad-wrapper u-mt-16 u-show" data-component-mpu="" style="display: none !important;">
                    <div class="c-ad c-ad--300x250">
                        <div class="c-ad__inner">
                            <p class="c-ad__label">Advertisement</p>
                            
    <div id="div-gpt-ad-right-2" class="div-gpt-ad advert medium-rectangle js-ad text-center hide-print grade-c-hide" data-ad-type="right" data-test="right-ad" data-pa11y-ignore="" data-gpt="" data-gpt-unitpath="/285/medicine.nature.com/article" data-gpt-sizes="300x250" data-gpt-targeting="type=article;pos=right;artid=s41591-022-01789-0;doi=10.1038/s41591-022-01789-0;subjmeta=114,1305,1670,2413,2423,2779,308,498,53,631,692,699,777;kwrd=Machine+learning,Predictive+markers,Predictive+medicine,Randomized+controlled+trials,Rheumatoid+arthritis">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/medicine.nature.com/article&amp;sz=300x250&amp;c=693625307&amp;t=pos%3Dright%26type%3Darticle%26artid%3Ds41591-022-01789-0%26doi%3D10.1038/s41591-022-01789-0%26subjmeta%3D114,1305,1670,2413,2423,2779,308,498,53,631,692,699,777%26kwrd%3DMachine+learning,Predictive+markers,Predictive+medicine,Randomized+controlled+trials,Rheumatoid+arthritis">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/medicine.nature.com/article&amp;sz=300x250&amp;c=693625307&amp;t=pos%3Dright%26type%3Darticle%26artid%3Ds41591-022-01789-0%26doi%3D10.1038/s41591-022-01789-0%26subjmeta%3D114,1305,1670,2413,2423,2779,308,498,53,631,692,699,777%26kwrd%3DMachine+learning,Predictive+markers,Predictive+medicine,Randomized+controlled+trials,Rheumatoid+arthritis"
                     alt="Advertisement"
                     width="300"
                     height="250"></a>
        </noscript>
    </div>

                        </div>
                    </div>
                </div>
            </div>
            <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width" id="tabpanel-figures" aria-labelledby="tab-figures" role="tabpanel"><div class="c-reading-companion__scroll-pane"><ul class="c-reading-companion__figures-list"><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig1">Fig. 1: Synovial histological markers at baseline associate with response to rituximab and tocilizumab.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig1_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig1_HTML.png" alt="figure 1" aria-describedby="rc-Fig1"></picture><p class="c-reading-companion__figure-links"><a href="#Fig1" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01789-0/figures/1" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig2">Fig. 2: Molecular signatures of response and nonresponse to rituximab and tocilizumab.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig2_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig2_HTML.png" alt="figure 2" aria-describedby="rc-Fig2"></picture><p class="c-reading-companion__figure-links"><a href="#Fig2" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01789-0/figures/2" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig3">Fig. 3: Identification of multidrug nonresponse (refractory) signature.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig3_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig3_HTML.png" alt="figure 3" aria-describedby="rc-Fig3"></picture><p class="c-reading-companion__figure-links"><a href="#Fig3" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01789-0/figures/3" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig4">Fig. 4: DSP of refractory RA.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig4_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig4_HTML.png" alt="figure 4" aria-describedby="rc-Fig4"></picture><p class="c-reading-companion__figure-links"><a href="#Fig4" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01789-0/figures/4" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig5">Fig. 5: Histological and molecular analysis of paired pre- and post-treatment synovial biopsies.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig5_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig5_HTML.png" alt="figure 5" aria-describedby="rc-Fig5"></picture><p class="c-reading-companion__figure-links"><a href="#Fig5" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01789-0/figures/5" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig6">Fig. 6: Predictive models using nested ten-by-ten-fold cross-validation for response to rituximab and tocilizumab.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig6_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig6_HTML.png" alt="figure 6" aria-describedby="rc-Fig6"></picture><p class="c-reading-companion__figure-links"><a href="#Fig6" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01789-0/figures/6" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig7">Extended Data Fig. 1 Histological analyses.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig7_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig7_ESM.jpg" alt="extended data figure 7" aria-describedby="rc-Fig7"></picture><p class="c-reading-companion__figure-links"><a href="#Fig7" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01789-0/figures/7" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig8">Extended Data Fig. 2 Unsupervised Principal Component Analysis shows association primarily with cell types present and consequently also pathotype.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig8_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig8_ESM.jpg" alt="extended data figure 8" aria-describedby="rc-Fig8"></picture><p class="c-reading-companion__figure-links"><a href="#Fig8" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01789-0/figures/8" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig9">Extended Data Fig. 3 Influence of immune cells on consensusclusters.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig9_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig9_ESM.jpg" alt="extended data figure 9" aria-describedby="rc-Fig9"></picture><p class="c-reading-companion__figure-links"><a href="#Fig9" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01789-0/figures/9" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig10">Extended Data Fig. 4 Immunofluorescence of DKK3 + fibroblasts.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig10_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig10_ESM.jpg" alt="extended data figure 10" aria-describedby="rc-Fig10"></picture><p class="c-reading-companion__figure-links"><a href="#Fig10" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01789-0/figures/10" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig11">Extended Data Fig. 5 Longitudinal analysis of paired pre- and post-treatment synovial biopsies.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig11_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig11_ESM.jpg" alt="extended data figure 11" aria-describedby="rc-Fig11"></picture><p class="c-reading-companion__figure-links"><a href="#Fig11" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01789-0/figures/11" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig12">Extended Data Fig. 6 Venn diagram showing overlap in genes between machine learning models and comparison with models built using only clinical and histological variables.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig12_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig12_ESM.jpg" alt="extended data figure 12" aria-describedby="rc-Fig12"></picture><p class="c-reading-companion__figure-links"><a href="#Fig12" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01789-0/figures/12" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li></ul></div></div>
            <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width" id="tabpanel-references" aria-labelledby="tab-references" role="tabpanel"><div class="c-reading-companion__scroll-pane"><ol class="c-reading-companion__references-list c-reading-companion__references-list--numeric" data-track-context="article references sidebar"><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR1">Smolen, J. S. et al. Rheumatoid arthritis. <i>Nat. Rev. Dis. Prim.</i> <b>4</b>, 18001 (2018).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fnrdp.2018.1" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/nrdp.2018.1" data-track-item_id="10.1038/nrdp.2018.1">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29417936" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Rheumatoid%20arthritis&amp;journal=Nat.%20Rev.%20Dis.%20Prim.&amp;doi=10.1038%2Fnrdp.2018.1&amp;volume=4&amp;publication_year=2018&amp;author=Smolen%2CJS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR2">Buch, M. H. Defining refractory rheumatoid arthritis. <i>Ann. Rheum. Dis.</i> <b>77</b>, 966–969 (2018).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1136%2Fannrheumdis-2017-212862" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1136/annrheumdis-2017-212862" data-track-item_id="10.1136/annrheumdis-2017-212862">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXislSitLY%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29588276" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Defining%20refractory%20rheumatoid%20arthritis&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fannrheumdis-2017-212862&amp;volume=77&amp;pages=966-969&amp;publication_year=2018&amp;author=Buch%2CMH" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR3">Borghaei, H. et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. <i>N. Engl. J. Med.</i> <b>373</b>, 1627–1639 (2015).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1056%2FNEJMoa1507643" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1056/NEJMoa1507643" data-track-item_id="10.1056/NEJMoa1507643">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC28XjsFyitL0%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26412456" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705936" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Nivolumab%20versus%20docetaxel%20in%20advanced%20nonsquamous%20non-small-cell%20lung%20cancer&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa1507643&amp;volume=373&amp;pages=1627-1639&amp;publication_year=2015&amp;author=Borghaei%2CH" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR4">Kawalec, P., Łopuch, S. &amp; Mikrut, A. Effectiveness of targeted therapy in patients with previously untreated metastatic breast cancer: a systematic review and meta-analysis. <i>Clin. Breast Cancer</i> <b>15</b>, 90–100 (2015).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.clbc.2014.10.006" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.clbc.2014.10.006" data-track-item_id="10.1016/j.clbc.2014.10.006">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXhvFSgs7bP" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25441421" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Effectiveness%20of%20targeted%20therapy%20in%20patients%20with%20previously%20untreated%20metastatic%20breast%20cancer%3A%20a%20systematic%20review%20and%20meta-analysis&amp;journal=Clin.%20Breast%20Cancer&amp;doi=10.1016%2Fj.clbc.2014.10.006&amp;volume=15&amp;pages=90-100&amp;publication_year=2015&amp;author=Kawalec%2CP&amp;author=%C5%81opuch%2CS&amp;author=Mikrut%2CA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR5">Pitzalis, C., Choy, E. H. S. &amp; Buch, M. H. Transforming clinical trials in rheumatology: towards patient-centric precision medicine. <i>Nat. Rev. Rheumatol.</i> <b>16</b>, 590–599 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41584-020-0491-4" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41584-020-0491-4" data-track-item_id="10.1038/s41584-020-0491-4">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32887976" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Transforming%20clinical%20trials%20in%20rheumatology%3A%20towards%20patient-centric%20precision%20medicine&amp;journal=Nat.%20Rev.%20Rheumatol.&amp;doi=10.1038%2Fs41584-020-0491-4&amp;volume=16&amp;pages=590-599&amp;publication_year=2020&amp;author=Pitzalis%2CC&amp;author=Choy%2CEHS&amp;author=Buch%2CMH" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR6">Lewis, M. J. et al. Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes. <i>Cell Rep.</i> <b>28</b>, 2455–2470 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.celrep.2019.07.091" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.celrep.2019.07.091" data-track-item_id="10.1016/j.celrep.2019.07.091">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXhs12jurzL" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31461658" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718830" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Molecular%20portraits%20of%20early%20rheumatoid%20arthritis%20identify%20clinical%20and%20treatment%20response%20phenotypes&amp;journal=Cell%20Rep.&amp;doi=10.1016%2Fj.celrep.2019.07.091&amp;volume=28&amp;pages=2455-2470&amp;publication_year=2019&amp;author=Lewis%2CMJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR7">Humby, F. et al. Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients. <i>Ann. Rheum. Dis.</i> <b>78</b>, 761–772 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1136%2Fannrheumdis-2018-214539" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1136/annrheumdis-2018-214539" data-track-item_id="10.1136/annrheumdis-2018-214539">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXisV2ms7bM" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30878974" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Synovial%20cellular%20and%20molecular%20signatures%20stratify%20clinical%20response%20to%20csDMARD%20therapy%20and%20predict%20radiographic%20progression%20in%20early%20rheumatoid%20arthritis%20patients&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fannrheumdis-2018-214539&amp;volume=78&amp;pages=761-772&amp;publication_year=2019&amp;author=Humby%2CF" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR8">Giacomelli, R. et al. The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and experts’ consensus. <i>Autoimmun. Rev.</i> <b>20</b>, 102738 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.autrev.2020.102738" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.autrev.2020.102738" data-track-item_id="10.1016/j.autrev.2020.102738">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhvFakurk%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33326854" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=The%20growing%20role%20of%20precision%20medicine%20for%20the%20treatment%20of%20autoimmune%20diseases%3B%20results%20of%20a%20systematic%20review%20of%20literature%20and%20experts%E2%80%99%20consensus&amp;journal=Autoimmun.%20Rev.&amp;doi=10.1016%2Fj.autrev.2020.102738&amp;volume=20&amp;publication_year=2021&amp;author=Giacomelli%2CR" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR9">Humby, F. et al. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. <i>Lancet</i> <b>397</b>, 305–317 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS0140-6736%2820%2932341-2" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S0140-6736(20)32341-2" data-track-item_id="10.1016/S0140-6736(20)32341-2">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXltVyrtbw%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33485455" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829614" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Rituximab%20versus%20tocilizumab%20in%20anti-TNF%20inadequate%20responder%20patients%20with%20rheumatoid%20arthritis%20%28R4RA%29%3A%2016-week%20outcomes%20of%20a%20stratified%2C%20biopsy-driven%2C%20multicentre%2C%20open-label%2C%20phase%204%20randomised%20controlled%20trial&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2820%2932341-2&amp;volume=397&amp;pages=305-317&amp;publication_year=2021&amp;author=Humby%2CF" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR10">Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. <i>Genome Biol.</i> <b>17</b>, 218 (2016).</p><p class="c-reading-companion__reference-links"><a href="https://link.springer.com/doi/10.1186/s13059-016-1070-5" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1186/s13059-016-1070-5" data-track-item_id="10.1186/s13059-016-1070-5">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27765066" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073889" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXhvF2rt7fJ" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Estimating%20the%20population%20abundance%20of%20tissue-infiltrating%20immune%20and%20stromal%20cell%20populations%20using%20gene%20expression&amp;journal=Genome%20Biol.&amp;doi=10.1186%2Fs13059-016-1070-5&amp;volume=17&amp;publication_year=2016&amp;author=Becht%2CE" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR11">John, C. R. et al. M3C: Monte Carlo reference-based consensus clustering. <i>Sci. Rep.</i> <b>10</b>, 1816 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41598-020-58766-1" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41598-020-58766-1" data-track-item_id="10.1038/s41598-020-58766-1">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXkvVWqu7c%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32020004" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000518" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=M3C%3A%20Monte%20Carlo%20reference-based%20consensus%20clustering&amp;journal=Sci.%20Rep.&amp;doi=10.1038%2Fs41598-020-58766-1&amp;volume=10&amp;publication_year=2020&amp;author=John%2CCR" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR12">Li, S. et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. <i>Nat. Immunol.</i> <b>15</b>, 195–204 (2014).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fni.2789" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/ni.2789" data-track-item_id="10.1038/ni.2789">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24336226" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3sXhvFent7%2FO" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Molecular%20signatures%20of%20antibody%20responses%20derived%20from%20a%20systems%20biology%20study%20of%20five%20human%20vaccines&amp;journal=Nat.%20Immunol.&amp;doi=10.1038%2Fni.2789&amp;volume=15&amp;pages=195-204&amp;publication_year=2014&amp;author=Li%2CS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR13">Stephenson, W. et al. Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation. <i>Nat. Commun.</i> <b>9</b>, 791 (2018).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41467-017-02659-x" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41467-017-02659-x" data-track-item_id="10.1038/s41467-017-02659-x">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29476078" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824814" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXhtFWkt7fE" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Single-cell%20RNA-seq%20of%20rheumatoid%20arthritis%20synovial%20tissue%20using%20low-cost%20microfluidic%20instrumentation&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-017-02659-x&amp;volume=9&amp;publication_year=2018&amp;author=Stephenson%2CW" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR14">Zhang, F. et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. <i>Nat. Immunol.</i> <b>20</b>, 928–942 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41590-019-0378-1" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41590-019-0378-1" data-track-item_id="10.1038/s41590-019-0378-1">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31061532" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602051" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXovFemsLs%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Defining%20inflammatory%20cell%20states%20in%20rheumatoid%20arthritis%20joint%20synovial%20tissues%20by%20integrating%20single-cell%20transcriptomics%20and%20mass%20cytometry&amp;journal=Nat.%20Immunol.&amp;doi=10.1038%2Fs41590-019-0378-1&amp;volume=20&amp;pages=928-942&amp;publication_year=2019&amp;author=Zhang%2CF" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR15">Wei, K. et al. Notch signalling drives synovial fibroblast identity and arthritis pathology. <i>Nature</i> <b>582</b>, 259–264 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41586-020-2222-z" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41586-020-2222-z" data-track-item_id="10.1038/s41586-020-2222-z">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXotVCiur4%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32499639" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841716" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Notch%20signalling%20drives%20synovial%20fibroblast%20identity%20and%20arthritis%20pathology&amp;journal=Nature&amp;doi=10.1038%2Fs41586-020-2222-z&amp;volume=582&amp;pages=259-264&amp;publication_year=2020&amp;author=Wei%2CK" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR16">Croft, A. P. et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. <i>Nature</i> <b>570</b>, 246–251 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41586-019-1263-7" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41586-019-1263-7" data-track-item_id="10.1038/s41586-019-1263-7">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXhtVOgt7fL" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31142839" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690841" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Distinct%20fibroblast%20subsets%20drive%20inflammation%20and%20damage%20in%20arthritis&amp;journal=Nature&amp;doi=10.1038%2Fs41586-019-1263-7&amp;volume=570&amp;pages=246-251&amp;publication_year=2019&amp;author=Croft%2CAP" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR17">Crozat, K. et al. Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8α<sup>+</sup> type. <i>J. Immunol.</i> <b>187</b>, 4411–4415 (2011).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.4049%2Fjimmunol.1101717" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.4049/jimmunol.1101717" data-track-item_id="10.4049/jimmunol.1101717">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3MXhtlChsbnP" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21948982" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Cutting%20edge%3A%20expression%20of%20XCR1%20defines%20mouse%20lymphoid-tissue%20resident%20and%20migratory%20dendritic%20cells%20of%20the%20CD8%CE%B1%2B%20type&amp;journal=J.%20Immunol.&amp;doi=10.4049%2Fjimmunol.1101717&amp;volume=187&amp;pages=4411-4415&amp;publication_year=2011&amp;author=Crozat%2CK" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR18">Graham, S. A. et al. Prolectin, a glycan-binding receptor on dividing B cells in germinal centers. <i>J. Biol. Chem.</i> <b>284</b>, 18537–18544 (2009).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1074%2Fjbc.M109.012807" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1074/jbc.M109.012807" data-track-item_id="10.1074/jbc.M109.012807">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD1MXnslegu7o%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19419970" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709368" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Prolectin%2C%20a%20glycan-binding%20receptor%20on%20dividing%20B%20cells%20in%20germinal%20centers&amp;journal=J.%20Biol.%20Chem.&amp;doi=10.1074%2Fjbc.M109.012807&amp;volume=284&amp;pages=18537-18544&amp;publication_year=2009&amp;author=Graham%2CSA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR19">Curran, A. M., Naik, P., Giles, J. T. &amp; Darrah, E. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets. <i>Nat. Rev. Rheumatol.</i> <b>16</b>, 301–315 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41584-020-0409-1" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41584-020-0409-1" data-track-item_id="10.1038/s41584-020-0409-1">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXot1ajsrc%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32341463" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=PAD%20enzymes%20in%20rheumatoid%20arthritis%3A%20pathogenic%20effectors%20and%20autoimmune%20targets&amp;journal=Nat.%20Rev.%20Rheumatol.&amp;doi=10.1038%2Fs41584-020-0409-1&amp;volume=16&amp;pages=301-315&amp;publication_year=2020&amp;author=Curran%2CAM&amp;author=Naik%2CP&amp;author=Giles%2CJT&amp;author=Darrah%2CE" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR20">Yanni, G., Whelan, A., Feighery, C. &amp; Bresnihan, B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. <i>Ann. Rheum. Dis.</i> <b>53</b>, 39–44 (1994).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1136%2Fard.53.1.39" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1136/ard.53.1.39" data-track-item_id="10.1136/ard.53.1.39">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:STN:280:DyaK2c7ksFWrtw%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8311554" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1005241" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Synovial%20tissue%20macrophages%20and%20joint%20erosion%20in%20rheumatoid%20arthritis&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fard.53.1.39&amp;volume=53&amp;pages=39-44&amp;publication_year=1994&amp;author=Yanni%2CG&amp;author=Whelan%2CA&amp;author=Feighery%2CC&amp;author=Bresnihan%2CB" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR21">Bresnihan, B. et al. Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers. <i>J. Rheumatol.</i> <b>36</b>, 1800–1802 (2009).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.3899%2Fjrheum.090348" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.3899/jrheum.090348" data-track-item_id="10.3899/jrheum.090348">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19671815" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Synovial%20tissue%20sublining%20CD68%20expression%20is%20a%20biomarker%20of%20therapeutic%20response%20in%20rheumatoid%20arthritis%20clinical%20trials%3A%20consistency%20across%20centers&amp;journal=J.%20Rheumatol.&amp;doi=10.3899%2Fjrheum.090348&amp;volume=36&amp;pages=1800-1802&amp;publication_year=2009&amp;author=Bresnihan%2CB" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR22">Teng, Y. K. et al. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment. <i>Arthritis Rheum.</i> <b>56</b>, 3909–3918 (2007).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1002%2Fart.22967" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1002/art.22967" data-track-item_id="10.1002/art.22967">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD1cXnt1Olsw%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18050222" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Immunohistochemical%20analysis%20as%20a%20means%20to%20predict%20responsiveness%20to%20rituximab%20treatment&amp;journal=Arthritis%20Rheum.&amp;doi=10.1002%2Fart.22967&amp;volume=56&amp;pages=3909-3918&amp;publication_year=2007&amp;author=Teng%2CYK" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR23">Hogan, V. E. et al. Pretreatment synovial transcriptional profile is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab. <i>Ann. Rheum. Dis.</i> <b>71</b>, 1888–1894 (2012).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1136%2Fannrheumdis-2011-201115" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1136/annrheumdis-2011-201115" data-track-item_id="10.1136/annrheumdis-2011-201115">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC38XhvV2nsbfF" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22736099" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Pretreatment%20synovial%20transcriptional%20profile%20is%20associated%20with%20early%20and%20late%20clinical%20response%20in%20rheumatoid%20arthritis%20patients%20treated%20with%20rituximab&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fannrheumdis-2011-201115&amp;volume=71&amp;pages=1888-1894&amp;publication_year=2012&amp;author=Hogan%2CVE" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR24">Choy, E. H. et al. Translating IL-6 biology into effective treatments. <i>Nat. Rev. Rheumatol.</i> <b>16</b>, 335–345 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41584-020-0419-z" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41584-020-0419-z" data-track-item_id="10.1038/s41584-020-0419-z">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXot1aiu7c%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32327746" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Translating%20IL-6%20biology%20into%20effective%20treatments&amp;journal=Nat.%20Rev.%20Rheumatol.&amp;doi=10.1038%2Fs41584-020-0419-z&amp;volume=16&amp;pages=335-345&amp;publication_year=2020&amp;author=Choy%2CEH" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR25">Raterman, H. G. et al. The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients. <i>Arthritis Res. Ther.</i> <b>14</b>, R95 (2012).</p><p class="c-reading-companion__reference-links"><a href="https://link.springer.com/doi/10.1186/ar3819" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1186/ar3819" data-track-item_id="10.1186/ar3819">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC38Xot12qs7o%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22540992" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446469" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=The%20interferon%20type%20I%20signature%20towards%20prediction%20of%20non-response%20to%20rituximab%20in%20rheumatoid%20arthritis%20patients&amp;journal=Arthritis%20Res.%20Ther.&amp;doi=10.1186%2Far3819&amp;volume=14&amp;publication_year=2012&amp;author=Raterman%2CHG" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR26">Thurlings, R. M. et al. Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients. <i>Arthritis Rheum.</i> <b>62</b>, 3607–3614 (2010).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1002%2Fart.27702" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1002/art.27702" data-track-item_id="10.1002/art.27702">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3cXhs1antrvN" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20722020" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Relationship%20between%20the%20type%20I%20interferon%20signature%20and%20the%20response%20to%20rituximab%20in%20rheumatoid%20arthritis%20patients&amp;journal=Arthritis%20Rheum.&amp;doi=10.1002%2Fart.27702&amp;volume=62&amp;pages=3607-3614&amp;publication_year=2010&amp;author=Thurlings%2CRM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR27">Lliso-Ribera, G. et al. Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC). <i>Ann. Rheum. Dis.</i> <b>78</b>, 1642–1652 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1136%2Fannrheumdis-2019-215751" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1136/annrheumdis-2019-215751" data-track-item_id="10.1136/annrheumdis-2019-215751">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhtVSrsLzL" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31582377" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Synovial%20tissue%20signatures%20enhance%20clinical%20classification%20and%20prognostic%2Ftreatment%20response%20algorithms%20in%20early%20inflammatory%20arthritis%20and%20predict%20requirement%20for%20subsequent%20biological%20therapy%3A%20results%20from%20the%20pathobiology%20of%20early%20arthritis%20cohort%20%28PEAC%29&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fannrheumdis-2019-215751&amp;volume=78&amp;pages=1642-1652&amp;publication_year=2019&amp;author=Lliso-Ribera%2CG" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR28">Nerviani, A. et al. A pauci-immune synovial pathotype predicts inadequate response to TNFα-blockade in rheumatoid arthritis patients. <i>Front. Immunol.</i> <b>11</b>, 845 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.3389%2Ffimmu.2020.00845" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.3389/fimmu.2020.00845" data-track-item_id="10.3389/fimmu.2020.00845">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXitVWgu7%2FK" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32431716" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214807" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=A%20pauci-immune%20synovial%20pathotype%20predicts%20inadequate%20response%20to%20TNF%CE%B1-blockade%20in%20rheumatoid%20arthritis%20patients&amp;journal=Front.%20Immunol.&amp;doi=10.3389%2Ffimmu.2020.00845&amp;volume=11&amp;publication_year=2020&amp;author=Nerviani%2CA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR29">Mizoguchi, F. et al. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. <i>Nat. Commun.</i> <b>9</b>, 789 (2018).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41467-018-02892-y" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41467-018-02892-y" data-track-item_id="10.1038/s41467-018-02892-y">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29476097" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824882" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXhtFWkt7fN" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Functionally%20distinct%20disease-associated%20fibroblast%20subsets%20in%20rheumatoid%20arthritis&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-018-02892-y&amp;volume=9&amp;publication_year=2018&amp;author=Mizoguchi%2CF" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR30">Ferrari, N. et al. Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts. <i>Nat. Commun.</i> <b>10</b>, 130 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41467-018-07987-0" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41467-018-07987-0" data-track-item_id="10.1038/s41467-018-07987-0">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30631061" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328607" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXmvFWju7c%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Dickkopf-3%20links%20HSF1%20and%20YAP%2FTAZ%20signalling%20to%20control%20aggressive%20behaviours%20in%20cancer-associated%20fibroblasts&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-018-07987-0&amp;volume=10&amp;publication_year=2019&amp;author=Ferrari%2CN" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR31">Marsh, L. J., Kemble, S., Reis Nisa, P., Singh, R. &amp; Croft, A. P. Fibroblast pathology in inflammatory joint disease. <i>Immunol. Rev.</i> <b>302</b>, 163–183 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1111%2Fimr.12986" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1111/imr.12986" data-track-item_id="10.1111/imr.12986">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXht1GgsbzP" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34096076" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Fibroblast%20pathology%20in%20inflammatory%20joint%20disease&amp;journal=Immunol.%20Rev.&amp;doi=10.1111%2Fimr.12986&amp;volume=302&amp;pages=163-183&amp;publication_year=2021&amp;author=Marsh%2CLJ&amp;author=Kemble%2CS&amp;author=Reis%20Nisa%2CP&amp;author=Singh%2CR&amp;author=Croft%2CAP" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR32">Iwamoto, T. et al. Monocyte chemoattractant protein-4 (MCP-4)/CCL13 is highly expressed in cartilage from patients with rheumatoid arthritis. <i>Rheumatology (Oxford)</i> <b>45</b>, 421–424 (2006).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1093%2Frheumatology%2Fkei209" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1093/rheumatology/kei209" data-track-item_id="10.1093/rheumatology/kei209">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD28Xis1Gltrc%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Monocyte%20chemoattractant%20protein-4%20%28MCP-4%29%2FCCL13%20is%20highly%20expressed%20in%20cartilage%20from%20patients%20with%20rheumatoid%20arthritis&amp;journal=Rheumatology%20%28Oxford%29&amp;doi=10.1093%2Frheumatology%2Fkei209&amp;volume=45&amp;pages=421-424&amp;publication_year=2006&amp;author=Iwamoto%2CT" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR33">Salomon, S. et al. Th17 and CD24(hi)CD27(<sup>+</sup>) regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis. <i>Arthritis Res. Ther.</i> <b>19</b>, 33 (2017).</p><p class="c-reading-companion__reference-links"><a href="https://link.springer.com/doi/10.1186/s13075-017-1244-x" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1186/s13075-017-1244-x" data-track-item_id="10.1186/s13075-017-1244-x">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28183330" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301325" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXjt1Srs7w%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Th17%20and%20CD24%28hi%29CD27%28%2B%29%20regulatory%20B%20lymphocytes%20are%20biomarkers%20of%20response%20to%20biologics%20in%20rheumatoid%20arthritis&amp;journal=Arthritis%20Res.%20Ther.&amp;doi=10.1186%2Fs13075-017-1244-x&amp;volume=19&amp;publication_year=2017&amp;author=Salomon%2CS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR34">Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. <i>Ann. Rheum. Dis.</i> <b>79</b>, 685–699 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1136%2Fannrheumdis-2019-216655" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1136/annrheumdis-2019-216655" data-track-item_id="10.1136/annrheumdis-2019-216655">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhvFemtLrE" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31969328" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=EULAR%20recommendations%20for%20the%20management%20of%20rheumatoid%20arthritis%20with%20synthetic%20and%20biological%20disease-modifying%20antirheumatic%20drugs%3A%202019%20update&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fannrheumdis-2019-216655&amp;volume=79&amp;pages=685-699&amp;publication_year=2020&amp;author=Smolen%2CJS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR35">Vandooren, B., Cantaert, T., Noordenbos, T., Tak, P. P. &amp; Baeten, D. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. <i>Arthritis Rheum.</i> <b>58</b>, 718–729 (2008).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1002%2Fart.23290" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1002/art.23290" data-track-item_id="10.1002/art.23290">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD1cXjslWqurk%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18311801" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=The%20abundant%20synovial%20expression%20of%20the%20RANK%2FRANKL%2FOsteoprotegerin%20system%20in%20peripheral%20spondylarthritis%20is%20partially%20disconnected%20from%20inflammation&amp;journal=Arthritis%20Rheum.&amp;doi=10.1002%2Fart.23290&amp;volume=58&amp;pages=718-729&amp;publication_year=2008&amp;author=Vandooren%2CB&amp;author=Cantaert%2CT&amp;author=Noordenbos%2CT&amp;author=Tak%2CPP&amp;author=Baeten%2CD" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR36">Kavanaugh, A. et al. Assessment of rituximab’s immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results. <i>Ann. Rheum. Dis.</i> <b>67</b>, 402–408 (2008).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1136%2Fard.2007.074229" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1136/ard.2007.074229" data-track-item_id="10.1136/ard.2007.074229">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD1cXjs1ejsLs%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17644541" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Assessment%20of%20rituximab%E2%80%99s%20immunomodulatory%20synovial%20effects%20%28ARISE%20trial%29.%201%3A%20clinical%20and%20synovial%20biomarker%20results&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fard.2007.074229&amp;volume=67&amp;pages=402-408&amp;publication_year=2008&amp;author=Kavanaugh%2CA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR37">Ramwadhdoebe, T. H. et al. Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis. <i>Rheumatology (Oxford)</i> <b>58</b>, 1075–1085 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1093%2Frheumatology%2Fkey428" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1093/rheumatology/key428" data-track-item_id="10.1093/rheumatology/key428">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXht1aisbvO" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Effect%20of%20rituximab%20treatment%20on%20T%20and%20B%20cell%20subsets%20in%20lymph%20node%20biopsies%20of%20patients%20with%20rheumatoid%20arthritis&amp;journal=Rheumatology%20%28Oxford%29&amp;doi=10.1093%2Frheumatology%2Fkey428&amp;volume=58&amp;pages=1075-1085&amp;publication_year=2019&amp;author=Ramwadhdoebe%2CTH" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR38">Hill, D. G., Ward, A., Nicholson, L. B. &amp; Jones, G. W. Emerging roles for IL-6 family cytokines as positive and negative regulators of ectopic lymphoid structures. <i>Cytokine</i> <b>146</b>, 155650 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.cyto.2021.155650" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.cyto.2021.155650" data-track-item_id="10.1016/j.cyto.2021.155650">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhs1yntb7J" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34343865" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Emerging%20roles%20for%20IL-6%20family%20cytokines%20as%20positive%20and%20negative%20regulators%20of%20ectopic%20lymphoid%20structures&amp;journal=Cytokine&amp;doi=10.1016%2Fj.cyto.2021.155650&amp;volume=146&amp;publication_year=2021&amp;author=Hill%2CDG&amp;author=Ward%2CA&amp;author=Nicholson%2CLB&amp;author=Jones%2CGW" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR39">Nouri, B., Nair, N. &amp; Barton, A. Predicting treatment response to IL6R blockers in rheumatoid arthritis. <i>Rheumatology (Oxford)</i> <b>59</b>, 3603–3610 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1093%2Frheumatology%2Fkeaa529" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1093/rheumatology/keaa529" data-track-item_id="10.1093/rheumatology/keaa529">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXmvVCitb0%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Predicting%20treatment%20response%20to%20IL6R%20blockers%20in%20rheumatoid%20arthritis&amp;journal=Rheumatology%20%28Oxford%29&amp;doi=10.1093%2Frheumatology%2Fkeaa529&amp;volume=59&amp;pages=3603-3610&amp;publication_year=2020&amp;author=Nouri%2CB&amp;author=Nair%2CN&amp;author=Barton%2CA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR40">Isaacs, J. D. et al. Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis. <i>Ann. Rheum. Dis.</i> <b>72</b>, 329–336 (2013).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1136%2Fannrheumdis-2011-201117" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1136/annrheumdis-2011-201117" data-track-item_id="10.1136/annrheumdis-2011-201117">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3sXjvFOjtbk%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22689315" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Effect%20of%20baseline%20rheumatoid%20factor%20and%20anticitrullinated%20peptide%20antibody%20serotype%20on%20rituximab%20clinical%20response%3A%20a%20meta-analysis&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fannrheumdis-2011-201117&amp;volume=72&amp;pages=329-336&amp;publication_year=2013&amp;author=Isaacs%2CJD" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR41">McKeigue, P. Sample size requirements for learning to classify with high-dimensional biomarker panels. <i>Stat. Methods Med. Res.</i> <b>28</b>, 904–910 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1177%2F0962280217738807" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1177/0962280217738807" data-track-item_id="10.1177/0962280217738807">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29179643" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Sample%20size%20requirements%20for%20learning%20to%20classify%20with%20high-dimensional%20biomarker%20panels&amp;journal=Stat.%20Methods%20Med.%20Res.&amp;doi=10.1177%2F0962280217738807&amp;volume=28&amp;pages=904-910&amp;publication_year=2019&amp;author=McKeigue%2CP" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR42">Kelly, S. et al. Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients. <i>Ann. Rheum. Dis.</i> <b>74</b>, 611–617 (2015).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1136%2Fannrheumdis-2013-204603" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1136/annrheumdis-2013-204603" data-track-item_id="10.1136/annrheumdis-2013-204603">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:STN:280:DC%2BC2c3mtleqtQ%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24336336" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Ultrasound-guided%20synovial%20biopsy%3A%20a%20safe%2C%20well-tolerated%20and%20reliable%20technique%20for%20obtaining%20high-quality%20synovial%20tissue%20from%20both%20large%20and%20small%20joints%20in%20early%20arthritis%20patients&amp;journal=Ann.%20Rheum.%20Dis.&amp;doi=10.1136%2Fannrheumdis-2013-204603&amp;volume=74&amp;pages=611-617&amp;publication_year=2015&amp;author=Kelly%2CS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR43">Bugatti, S. et al. High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease. <i>Rheumatology (Oxford)</i> <b>53</b>, 1886–1895 (2014).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1093%2Frheumatology%2Fkeu163" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1093/rheumatology/keu163" data-track-item_id="10.1093/rheumatology/keu163">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXns1ehsLs%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=High%20expression%20levels%20of%20the%20B%20cell%20chemoattractant%20CXCL13%20in%20rheumatoid%20synovium%20are%20a%20marker%20of%20severe%20disease&amp;journal=Rheumatology%20%28Oxford%29&amp;doi=10.1093%2Frheumatology%2Fkeu163&amp;volume=53&amp;pages=1886-1895&amp;publication_year=2014&amp;author=Bugatti%2CS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR44">Rivellese, F. et al. B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure. <i>Arthritis Rheumatol.</i> <b>72</b>, 714–725 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1002%2Fart.41184" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1002/art.41184" data-track-item_id="10.1002/art.41184">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXnvVOju7c%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31785084" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217046" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=B%20cell%20synovitis%20and%20clinical%20phenotypes%20in%20rheumatoid%20arthritis%3A%20relationship%20to%20disease%20stages%20and%20drug%20exposure&amp;journal=Arthritis%20Rheumatol.&amp;doi=10.1002%2Fart.41184&amp;volume=72&amp;pages=714-725&amp;publication_year=2020&amp;author=Rivellese%2CF" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR45">Krenn, V. et al. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. <i>Histopathology</i> <b>49</b>, 358–364 (2006).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1111%2Fj.1365-2559.2006.02508.x" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1111/j.1365-2559.2006.02508.x" data-track-item_id="10.1111/j.1365-2559.2006.02508.x">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:STN:280:DC%2BD28rlsVSksg%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16978198" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Synovitis%20score%3A%20discrimination%20between%20chronic%20low-grade%20and%20high-grade%20synovitis&amp;journal=Histopathology&amp;doi=10.1111%2Fj.1365-2559.2006.02508.x&amp;volume=49&amp;pages=358-364&amp;publication_year=2006&amp;author=Krenn%2CV" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR46">Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. &amp; Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. <i>Nat. Methods</i> <b>14</b>, 417–419 (2017).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fnmeth.4197" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/nmeth.4197" data-track-item_id="10.1038/nmeth.4197">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXltVWgtL8%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28263959" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600148" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Salmon%20provides%20fast%20and%20bias-aware%20quantification%20of%20transcript%20expression&amp;journal=Nat.%20Methods&amp;doi=10.1038%2Fnmeth.4197&amp;volume=14&amp;pages=417-419&amp;publication_year=2017&amp;author=Patro%2CR&amp;author=Duggal%2CG&amp;author=Love%2CMI&amp;author=Irizarry%2CRA&amp;author=Kingsford%2CC" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR47">Love, M. I., Huber, W. &amp; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. <i>Genome Biol.</i> <b>15</b>, 550 (2014).</p><p class="c-reading-companion__reference-links"><a href="https://link.springer.com/doi/10.1186/s13059-014-0550-8" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1186/s13059-014-0550-8" data-track-item_id="10.1186/s13059-014-0550-8">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25516281" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302049" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2MXjtVCrsL8%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Moderated%20estimation%20of%20fold%20change%20and%20dispersion%20for%20RNA-seq%20data%20with%20DESeq2&amp;journal=Genome%20Biol.&amp;doi=10.1186%2Fs13059-014-0550-8&amp;volume=15&amp;publication_year=2014&amp;author=Love%2CMI&amp;author=Huber%2CW&amp;author=Anders%2CS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR48">Law, C. W., Chen, Y., Shi, W. &amp; Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. <i>Genome Biol.</i> <b>15</b>, R29 (2014).</p><p class="c-reading-companion__reference-links"><a href="https://link.springer.com/doi/10.1186/gb-2014-15-2-r29" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1186/gb-2014-15-2-r29" data-track-item_id="10.1186/gb-2014-15-2-r29">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24485249" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053721" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2MXjsVeltbw%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=voom%3A%20Precision%20weights%20unlock%20linear%20model%20analysis%20tools%20for%20RNA-seq%20read%20counts&amp;journal=Genome%20Biol.&amp;doi=10.1186%2Fgb-2014-15-2-r29&amp;volume=15&amp;publication_year=2014&amp;author=Law%2CCW&amp;author=Chen%2CY&amp;author=Shi%2CW&amp;author=Smyth%2CGK" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR49">Helmink, B. A. et al. B cells and tertiary lymphoid structures promote immunotherapy response. <i>Nature</i> <b>577</b>, 549–555 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41586-019-1922-8" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41586-019-1922-8" data-track-item_id="10.1038/s41586-019-1922-8">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXis1Sitrk%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31942075" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762581" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=B%20cells%20and%20tertiary%20lymphoid%20structures%20promote%20immunotherapy%20response&amp;journal=Nature&amp;doi=10.1038%2Fs41586-019-1922-8&amp;volume=577&amp;pages=549-555&amp;publication_year=2020&amp;author=Helmink%2CBA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR50">Bhattacharya, A. et al. An approach for normalization and quality control for NanoString RNA expression data. <i>Brief. Bioinform.</i> <b>22</b>, bbaa163 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1093%2Fbib%2Fbbaa163" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1093/bib/bbaa163" data-track-item_id="10.1093/bib/bbaa163">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32789507" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXisFeqtLnF" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=An%20approach%20for%20normalization%20and%20quality%20control%20for%20NanoString%20RNA%20expression%20data&amp;journal=Brief.%20Bioinform.&amp;doi=10.1093%2Fbib%2Fbbaa163&amp;volume=22&amp;publication_year=2021&amp;author=Bhattacharya%2CA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li></ol></div></div>
        </div>
    </div>
</aside>
</div>


    
        
    
    
        
            
        

        
            
        
    
    <script>
        window.dataLayer = window.dataLayer || [];
        window.dataLayer.push({
            page: {
                content: {
                    fundingWidget: "true",
                        }
                    }
                });
    </script>




<footer class="composite-layer" itemscope="" itemtype="http://schema.org/Periodical">
        <meta itemprop="publisher" content="Springer Nature">
        

        <div class="u-mt-16 u-mb-16">
    <div class="u-container">
        <div class="u-display-flex u-flex-wrap u-justify-content-space-between">
            

            <div class="c-meta u-ma-0 u-flex-shrink">
                <p class="c-meta__item c-meta__type u-mt-0">
                    <span itemprop="name">
                        Nature Medicine
                    </span>
                    (<i itemprop="alternateName">Nat Med</i>)
                </p>
                
    
        <p class="c-meta__item u-mt-0">
            <abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop="issn">1546-170X</span> (online)
        </p>
    

                
    
        <p class="c-meta__item u-mt-0">
            <abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop="issn">1078-8956</span> (print)
        </p>
    

            </div>
        </div>
    </div>
</div>

    <div class="c-footer">
        <div class="u-hide-print" data-track-component="footer">
    <h2 class="u-visually-hidden">nature.com sitemap</h2>
    <div class="c-footer__container">
        <div class="c-footer__grid c-footer__group--separator">
            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">About Nature Portfolio</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/npg_/company_info/index.html" data-track="click" data-track-action="about us" data-track-label="link">About us</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/npg_/press_room/press_releases.html" data-track="click" data-track-action="press releases" data-track-label="link">Press releases</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://press.nature.com/" data-track="click" data-track-action="press office" data-track-label="link">Press office</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://support.nature.com/support/home" data-track="click" data-track-action="contact us" data-track-label="link">Contact us</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Discover content</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/siteindex" data-track="click" data-track-action="journals a-z" data-track-label="link">Journals A-Z</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/subjects" data-track="click" data-track-action="article by subject" data-track-label="link">Articles by subject</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.protocols.io/" data-track="click" data-track-action="protocols.io" data-track-label="link">protocols.io</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.natureindex.com/" data-track="click" data-track-action="nature index" data-track-label="link">Nature Index</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Publishing policies</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/authors/editorial_policies" data-track="click" data-track-action="Nature portfolio policies" data-track-label="link">Nature portfolio policies</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nature-research/open-access" data-track="click" data-track-action="open access" data-track-label="link">Open access</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Author &amp; Researcher services</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/reprints" data-track="click" data-track-action="reprints and permissions" data-track-label="link">Reprints &amp; permissions</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/authors/research-data" data-track="click" data-track-action="data research service" data-track-label="link">Research data</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://authorservices.springernature.com/language-editing/" data-track="click" data-track-action="language editing" data-track-label="link">Language editing</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://authorservices.springernature.com/scientific-editing/" data-track="click" data-track-action="scientific editing" data-track-label="link">Scientific editing</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://masterclasses.nature.com/" data-track="click" data-track-action="nature masterclasses" data-track-label="link">Nature Masterclasses</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://solutions.springernature.com/" data-track="click" data-track-action="research solutions" data-track-label="link">Research Solutions</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Libraries &amp; institutions</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/librarians/tools-services" data-track="click" data-track-action="librarian service and tools" data-track-label="link">Librarian service &amp; tools</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/librarians/manage-your-account/librarianportal" data-track="click" data-track-action="librarian portal" data-track-label="link">Librarian portal</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/openresearch/about-open-access/information-for-institutions" data-track="click" data-track-action="open research" data-track-label="link">Open research</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/librarians/recommend-to-your-library" data-track="click" data-track-action="Recommend to library" data-track-label="link">Recommend to library</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Advertising &amp; partnerships</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/product/digital-advertising/" data-track="click" data-track-action="advertising" data-track-label="link">Advertising</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/" data-track="click" data-track-action="partnerships and services" data-track-label="link">Partnerships &amp; Services</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/media-kits/" data-track="click" data-track-action="media kits" data-track-label="link">Media kits</a>
                    </li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/product/branded-content-native-advertising/" data-track-action="branded content" data-track-label="link">Branded
                        content</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Professional development</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/naturecareers/" data-track="click" data-track-action="nature careers" data-track-label="link">Nature Careers</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://conferences.nature.com" data-track="click" data-track-action="nature conferences" data-track-label="link">Nature<span class="u-visually-hidden"> </span>
                        Conferences</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Regional websites</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/natafrica" data-track="click" data-track-action="nature africa" data-track-label="link">Nature Africa</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="http://www.naturechina.com" data-track="click" data-track-action="nature china" data-track-label="link">Nature China</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nindia" data-track="click" data-track-action="nature india" data-track-label="link">Nature India</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/natitaly" data-track="click" data-track-action="nature Italy" data-track-label="link">Nature Italy</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.natureasia.com/ja-jp" data-track="click" data-track-action="nature japan" data-track-label="link">Nature Japan</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nmiddleeast" data-track="click" data-track-action="nature middle east" data-track-label="link">Nature Middle East</a></li>
                </ul>
            </div>

        </div>
    </div>
    <div class="c-footer__container">
        <ul class="c-footer__links">
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/privacy" data-track="click" data-track-action="privacy policy" data-track-label="link">Privacy
                Policy</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/cookies" data-track="click" data-track-action="use of cookies" data-track-label="link">Use
                of cookies</a></li>
            <li class="c-footer__item">
                <button class="optanon-toggle-display c-footer__link" onclick="javascript:;" data-cc-action="preferences" data-track="click" data-track-action="manage cookies" data-track-label="link">Your privacy choices/Manage cookies
                </button>
            </li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/legal-notice" data-track="click" data-track-action="legal notice" data-track-label="link">Legal
                notice</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/accessibility-statement" data-track="click" data-track-action="accessibility statement" data-track-label="link">Accessibility
                statement</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/terms-and-conditions" data-track="click" data-track-action="terms and conditions" data-track-label="link">Terms &amp; Conditions</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/ccpa" data-track="click" data-track-action="california privacy statement" data-track-label="link">Your US state privacy rights</a></li>
            
        </ul>
    </div>
</div>


        <div class="c-footer__container">
    <a href="https://www.springernature.com/" class="c-footer__link">
        <img src="/static/images/logos/sn-logo-white-ea63208b81.svg" alt="Springer Nature" loading="lazy" width="200" height="20">
    </a>
    <p class="c-footer__legal" data-test="copyright">© 2025 Springer Nature Limited</p>
</div>

    </div>
    <div class="u-visually-hidden" aria-hidden="true">
    
    <!--?xml version="1.0" encoding="UTF-8"?--><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><defs><path id="a" d="M0 .74h56.72v55.24H0z"></path></defs><symbol id="icon-access" viewBox="0 0 18 18"><path d="m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z" fill-rule="evenodd"></path></symbol><symbol id="icon-account" viewBox="0 0 18 18"><path d="m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"></path></symbol><symbol id="icon-alert" viewBox="0 0 18 18"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-broad" viewBox="0 0 16 16"><path d="m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 14 15)"></path></symbol><symbol id="icon-arrow-down" viewBox="0 0 16 16"><path d="m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-left" viewBox="0 0 16 16"><path d="m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-right" viewBox="0 0 16 16"><path d="m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-sub" viewBox="0 0 16 16"><path d="m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-up" viewBox="0 0 16 16"><path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule="evenodd"></path></symbol><symbol id="icon-article" viewBox="0 0 18 18"><path d="m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z" fill-rule="evenodd"></path></symbol><symbol id="icon-audio" viewBox="0 0 18 18"><path d="m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z" fill-rule="evenodd"></path></symbol><symbol id="icon-block" viewBox="0 0 24 24"><path d="m0 0h24v24h-24z" fill-rule="evenodd"></path></symbol><symbol id="icon-book" viewBox="0 0 18 18"><path d="m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-broad" viewBox="0 0 24 24"><path d="m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 20.182742 24.805206)"></path></symbol><symbol id="icon-calendar" viewBox="0 0 18 18"><path d="m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z" fill-rule="evenodd"></path></symbol><symbol id="icon-cart" viewBox="0 0 18 18"><path d="m5 14c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm10 0c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm-10 1c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1 1-.4477153 1-1-.44771525-1-1-1zm10 0c-.5522847 0-1 .4477153-1 1s.4477153 1 1 1 1-.4477153 1-1-.4477153-1-1-1zm-12.82032249-15c.47691417 0 .88746157.33678127.98070211.80449199l.23823144 1.19501025 13.36277974.00045554c.5522847.00001882.9999659.44774934.9999659 1.00004222 0 .07084994-.0075361.14150708-.022474.2107727l-1.2908094 5.98534344c-.1007861.46742419-.5432548.80388386-1.0571651.80388386h-10.24805106c-.59173366 0-1.07142857.4477153-1.07142857 1 0 .5128358.41361449.9355072.94647737.9932723l.1249512.0067277h10.35933776c.2749512 0 .4979349.2228539.4979349.4978051 0 .2749417-.2227336.4978951-.4976753.4980063l-10.35959736.0041886c-1.18346732 0-2.14285714-.8954305-2.14285714-2 0-.6625717.34520317-1.24989198.87690425-1.61383592l-1.63768102-8.19004794c-.01312273-.06561364-.01950005-.131011-.0196107-.19547395l-1.71961253-.00064219c-.27614237 0-.5-.22385762-.5-.5 0-.27614237.22385763-.5.5-.5zm14.53193359 2.99950224h-13.11300004l1.20580469 6.02530174c.11024034-.0163252.22327998-.02480398.33844139-.02480398h10.27064786z"></path></symbol><symbol id="icon-chevron-less" viewBox="0 0 10 10"><path d="m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 -1 -1 0 9 9)"></path></symbol><symbol id="icon-chevron-more" viewBox="0 0 10 10"><path d="m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"></path></symbol><symbol id="icon-chevron-right" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id="icon-circle-fill" viewBox="0 0 16 16"><path d="m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"></path></symbol><symbol id="icon-circle" viewBox="0 0 16 16"><path d="m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"></path></symbol><symbol id="icon-citation" viewBox="0 0 18 18"><path d="m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-close" viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"></path></symbol><symbol id="icon-collections" viewBox="0 0 18 18"><path d="m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-compare" viewBox="0 0 18 18"><path d="m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z" fill-rule="evenodd"></path></symbol><symbol id="icon-download-file" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z" fill-rule="evenodd"></path></symbol><symbol id="icon-download" viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"></path></symbol><symbol id="icon-editors" viewBox="0 0 18 18"><path d="m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z" fill-rule="evenodd"></path></symbol><symbol id="icon-email" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z" fill-rule="evenodd"></path></symbol><symbol id="icon-error" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill-rule="evenodd"></path></symbol><symbol id="icon-ethics" viewBox="0 0 18 18"><path d="m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z" fill-rule="evenodd"></path></symbol><symbol id="icon-expand"><path d="M7.498 11.918a.997.997 0 0 0-.003-1.411.995.995 0 0 0-1.412-.003l-4.102 4.102v-3.51A1 1 0 0 0 .98 10.09.992.992 0 0 0 0 11.092V17c0 .554.448 1.002 1.002 1.002h5.907c.554 0 1.002-.45 1.002-1.003 0-.539-.45-.978-1.006-.978h-3.51zm3.005-5.835a.997.997 0 0 0 .003 1.412.995.995 0 0 0 1.411.003l4.103-4.103v3.51a1 1 0 0 0 1.001 1.006A.992.992 0 0 0 18 6.91V1.002A1 1 0 0 0 17 0h-5.907a1.003 1.003 0 0 0-1.002 1.003c0 .539.45.978 1.006.978h3.51z" fill-rule="evenodd"></path></symbol><symbol id="icon-explore" viewBox="0 0 18 18"><path d="m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z" fill-rule="evenodd"></path></symbol><symbol id="icon-filter" viewBox="0 0 16 16"><path d="m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z"></path></symbol><symbol id="icon-home" viewBox="0 0 18 18"><path d="m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z" fill-rule="evenodd"></path></symbol><symbol id="icon-image" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-info" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"></path></symbol><symbol id="icon-institution" viewBox="0 0 18 18"><path d="m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z" fill-rule="evenodd"></path></symbol><symbol id="icon-location" viewBox="0 0 18 18"><path d="m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z" fill-rule="evenodd"></path></symbol><symbol id="icon-minus" viewBox="0 0 16 16"><path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-newsletter" viewBox="0 0 18 18"><path d="m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z" fill-rule="evenodd"></path></symbol><symbol id="icon-orcid" viewBox="0 0 18 18"><path d="m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z" fill-rule="evenodd"></path></symbol><symbol id="icon-plus" viewBox="0 0 16 16"><path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-print" viewBox="0 0 18 18"><path d="m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z" fill-rule="evenodd"></path></symbol><symbol id="icon-search" viewBox="0 0 22 22"><path d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z" fill-rule="evenodd"></path></symbol><symbol id="icon-social-facebook" viewBox="0 0 24 24"><path d="m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z" fill-rule="evenodd"></path></symbol><symbol id="icon-social-twitter" viewBox="0 0 24 24"><path d="m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z" fill-rule="evenodd"></path></symbol><symbol id="icon-social-youtube" viewBox="0 0 24 24"><path d="m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z" fill-rule="evenodd"></path></symbol><symbol id="icon-subject-medicine" viewBox="0 0 18 18"><path d="m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-success" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z" fill-rule="evenodd"></path></symbol><symbol id="icon-table" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z" fill-rule="evenodd"></path></symbol><symbol id="icon-tick-circle" viewBox="0 0 24 24"><path d="m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z" fill-rule="evenodd"></path></symbol><symbol id="icon-tick" viewBox="0 0 16 16"><path d="m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z" fill-rule="evenodd"></path></symbol><symbol id="icon-update" viewBox="0 0 18 18"><path d="m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z" fill-rule="evenodd"></path></symbol><symbol id="icon-upload" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z" fill-rule="evenodd"></path></symbol><symbol id="icon-video" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z" fill-rule="evenodd"></path></symbol><symbol id="icon-warning" viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"></path></symbol><symbol id="icon-checklist-banner" viewBox="0 0 56.69 56.69"><path style="fill:none" d="M0 0h56.69v56.69H0z"></path><clipPath id="b"><use xlink:href="#a" style="overflow:visible"></use></clipPath><path d="M21.14 34.46c0-6.77 5.48-12.26 12.24-12.26s12.24 5.49 12.24 12.26-5.48 12.26-12.24 12.26c-6.76-.01-12.24-5.49-12.24-12.26zm19.33 10.66 10.23 9.22s1.21 1.09 2.3-.12l2.09-2.32s1.09-1.21-.12-2.3l-10.23-9.22m-19.29-5.92c0-4.38 3.55-7.94 7.93-7.94s7.93 3.55 7.93 7.94c0 4.38-3.55 7.94-7.93 7.94-4.38-.01-7.93-3.56-7.93-7.94zm17.58 12.99 4.14-4.81" style="clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round"></path><path d="M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5m14.42-5.2V4.86s0-2.93-2.93-2.93H4.13s-2.93 0-2.93 2.93v37.57s0 2.93 2.93 2.93h15.01M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5" style="clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round;stroke-linejoin:round"></path></symbol><symbol id="icon-chevron-down" viewBox="0 0 16 16"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"></path></symbol><symbol id="icon-eds-i-arrow-right-medium" viewBox="0 0 24 24"><path d="m12.728 3.293 7.98 7.99a.996.996 0 0 1 .281.561l.011.157c0 .32-.15.605-.384.788l-7.908 7.918a1 1 0 0 1-1.416-1.414L17.576 13H4a1 1 0 0 1 0-2h13.598l-6.285-6.293a1 1 0 0 1-.082-1.32l.083-.095a1 1 0 0 1 1.414.001Z"></path></symbol><symbol id="icon-eds-i-check-circle-medium" viewBox="0 0 24 24"><path d="M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm0 2a9 9 0 1 0 0 18 9 9 0 0 0 0-18Zm5.125 4.72a1 1 0 0 1 .156 1.405l-6 7.5a1 1 0 0 1-1.421.143l-3-2.5a1 1 0 0 1 1.28-1.536l2.217 1.846 5.362-6.703a1 1 0 0 1 1.406-.156Z"></path></symbol><symbol id="icon-eds-i-chevron-down-medium" viewBox="0 0 16 16"><path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-chevron-down-small" viewBox="0 0 16 16"><path d="M13.692 5.278a1 1 0 0 1 .03 1.414L9.103 11.51a1.491 1.491 0 0 1-2.188.019L2.278 6.692a1 1 0 0 1 1.444-1.384L8 9.771l4.278-4.463a1 1 0 0 1 1.318-.111l.096.081Z"></path></symbol><symbol id="icon-eds-i-chevron-right-medium" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id="icon-eds-i-chevron-right-small" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id="icon-eds-i-chevron-up-medium" viewBox="0 0 16 16"><path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-close-medium" viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-copy-link" viewBox="0 0 24 24"><path fill-rule="evenodd" clip-rule="evenodd" d="M19.4594 8.57015C19.0689 8.17963 19.0689 7.54646 19.4594 7.15594L20.2927 6.32261C20.2927 6.32261 20.2927 6.32261 20.2927 6.32261C21.0528 5.56252 21.0528 4.33019 20.2928 3.57014C19.5327 2.81007 18.3004 2.81007 17.5404 3.57014L16.7071 4.40347C16.3165 4.794 15.6834 4.794 15.2928 4.40348C14.9023 4.01296 14.9023 3.3798 15.2928 2.98927L16.1262 2.15594C17.6673 0.614803 20.1659 0.614803 21.707 2.15593C23.2481 3.69705 23.248 6.19569 21.707 7.7368L20.8737 8.57014C20.4831 8.96067 19.85 8.96067 19.4594 8.57015Z"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M18.0944 5.90592C18.4849 6.29643 18.4849 6.9296 18.0944 7.32013L16.4278 8.9868C16.0373 9.37733 15.4041 9.37734 15.0136 8.98682C14.6231 8.59631 14.6231 7.96314 15.0136 7.57261L16.6802 5.90594C17.0707 5.51541 17.7039 5.5154 18.0944 5.90592Z"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M13.5113 6.32243C13.9018 6.71295 13.9018 7.34611 13.5113 7.73664L12.678 8.56997C12.678 8.56997 12.678 8.56997 12.678 8.56997C11.9179 9.33006 11.9179 10.5624 12.6779 11.3224C13.438 12.0825 14.6703 12.0825 15.4303 11.3224L16.2636 10.4891C16.6542 10.0986 17.2873 10.0986 17.6779 10.4891C18.0684 10.8796 18.0684 11.5128 17.6779 11.9033L16.8445 12.7366C15.3034 14.2778 12.8048 14.2778 11.2637 12.7366C9.72262 11.1955 9.72266 8.69689 11.2637 7.15578L12.097 6.32244C12.4876 5.93191 13.1207 5.93191 13.5113 6.32243Z"></path><path d="M8 20V22H19.4619C20.136 22 20.7822 21.7311 21.2582 21.2529C21.7333 20.7757 22 20.1289 22 19.4549V15C22 14.4477 21.5523 14 21 14C20.4477 14 20 14.4477 20 15V19.4549C20 19.6004 19.9426 19.7397 19.8408 19.842C19.7399 19.9433 19.6037 20 19.4619 20H8Z"></path><path d="M4 13H2V19.4619C2 20.136 2.26889 20.7822 2.74705 21.2582C3.22434 21.7333 3.87105 22 4.5451 22H9C9.55228 22 10 21.5523 10 21C10 20.4477 9.55228 20 9 20H4.5451C4.39957 20 4.26028 19.9426 4.15804 19.8408C4.05668 19.7399 4 19.6037 4 19.4619V13Z"></path><path d="M4 13H2V4.53808C2 3.86398 2.26889 3.21777 2.74705 2.74178C3.22434 2.26666 3.87105 2 4.5451 2H9C9.55228 2 10 2.44772 10 3C10 3.55228 9.55228 4 9 4H4.5451C4.39957 4 4.26028 4.05743 4.15804 4.15921C4.05668 4.26011 4 4.39633 4 4.53808V13Z"></path></symbol><symbol id="icon-eds-i-download-medium" viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-info-filled-medium" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-institution-medium" viewBox="0 0 24 24"><g><path fill-rule="evenodd" clip-rule="evenodd" d="M11.9967 1C11.6364 1 11.279 1.0898 10.961 1.2646C10.9318 1.28061 10.9035 1.29806 10.8761 1.31689L2.79765 6.87C2.46776 7.08001 2.20618 7.38466 2.07836 7.76668C1.94823 8.15561 1.98027 8.55648 2.12665 8.90067C2.42086 9.59246 3.12798 10 3.90107 10H4.99994V16H4.49994C3.11923 16 1.99994 17.1193 1.99994 18.5V19.5C1.99994 20.8807 3.11923 22 4.49994 22H19.4999C20.8807 22 21.9999 20.8807 21.9999 19.5V18.5C21.9999 17.1193 20.8807 16 19.4999 16H18.9999V10H20.0922C20.8653 10 21.5725 9.59252 21.8667 8.90065C22.0131 8.55642 22.0451 8.15553 21.9149 7.7666C21.7871 7.38459 21.5255 7.07997 21.1956 6.86998L13.1172 1.31689C13.0898 1.29806 13.0615 1.28061 13.0324 1.2646C12.7143 1.0898 12.357 1 11.9967 1ZM4.6844 8L11.9472 3.00755C11.9616 3.00295 11.9783 3 11.9967 3C12.015 3 12.0318 3.00295 12.0461 3.00755L19.3089 8H4.6844ZM16.9999 16V10H14.9999V16H16.9999ZM12.9999 16V10H10.9999V16H12.9999ZM8.99994 16V10H6.99994V16H8.99994ZM3.99994 18.5C3.99994 18.2239 4.2238 18 4.49994 18H19.4999C19.7761 18 19.9999 18.2239 19.9999 18.5V19.5C19.9999 19.7761 19.7761 20 19.4999 20H4.49994C4.2238 20 3.99994 19.7761 3.99994 19.5V18.5Z"></path></g></symbol><symbol id="icon-eds-i-mail-medium" viewBox="0 0 24 24"><path d="m19.462 0c1.413 0 2.538 1.184 2.538 2.619v12.762c0 1.435-1.125 2.619-2.538 2.619h-16.924c-1.413 0-2.538-1.184-2.538-2.619v-12.762c0-1.435 1.125-2.619 2.538-2.619zm.538 5.158-7.378 6.258a2.549 2.549 0 0 1 -3.253-.008l-7.369-6.248v10.222c0 .353.253.619.538.619h16.924c.285 0 .538-.266.538-.619zm-.538-3.158h-16.924c-.264 0-.5.228-.534.542l8.65 7.334c.2.165.492.165.684.007l8.656-7.342-.001-.025c-.044-.3-.274-.516-.531-.516z"></path></symbol><symbol id="icon-eds-i-menu-medium" viewBox="0 0 24 24"><path d="M21 4a1 1 0 0 1 0 2H3a1 1 0 1 1 0-2h18Zm-4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h14Zm4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h18Z"></path></symbol><symbol id="icon-eds-i-search-medium" viewBox="0 0 24 24"><path d="M11 1c5.523 0 10 4.477 10 10 0 2.4-.846 4.604-2.256 6.328l3.963 3.965a1 1 0 0 1-1.414 1.414l-3.965-3.963A9.959 9.959 0 0 1 11 21C5.477 21 1 16.523 1 11S5.477 1 11 1Zm0 2a8 8 0 1 0 0 16 8 8 0 0 0 0-16Z"></path></symbol><symbol id="icon-eds-i-user-single-medium" viewBox="0 0 24 24"><path d="M12 1a5 5 0 1 1 0 10 5 5 0 0 1 0-10Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6Zm-.406 9.008a8.965 8.965 0 0 1 6.596 2.494A9.161 9.161 0 0 1 21 21.025V22a1 1 0 0 1-1 1H4a1 1 0 0 1-1-1v-.985c.05-4.825 3.815-8.777 8.594-9.007Zm.39 1.992-.299.006c-3.63.175-6.518 3.127-6.678 6.775L5 21h13.998l-.009-.268a7.157 7.157 0 0 0-1.97-4.573l-.214-.213A6.967 6.967 0 0 0 11.984 14Z"></path></symbol><symbol id="icon-eds-i-warning-filled-medium" viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"></path></symbol><symbol id="icon-expand-image" viewBox="0 0 18 18"><path d="m7.49754099 11.9178212c.38955542-.3895554.38761957-1.0207846-.00290473-1.4113089-.39324695-.3932469-1.02238878-.3918247-1.41130883-.0029047l-4.10273549 4.1027355.00055454-3.5103985c.00008852-.5603185-.44832171-1.006032-1.00155062-1.0059446-.53903074.0000852-.97857527.4487442-.97866268 1.0021075l-.00093318 5.9072465c-.00008751.553948.44841131 1.001882 1.00174994 1.0017946l5.906983-.0009331c.5539233-.0000875 1.00197907-.4486389 1.00206646-1.0018679.00008515-.5390307-.45026621-.9784332-1.00588841-.9783454l-3.51010549.0005545zm3.00571741-5.83449376c-.3895554.38955541-.3876196 1.02078454.0029047 1.41130883.393247.39324696 1.0223888.39182478 1.4113089.00290473l4.1027355-4.10273549-.0005546 3.5103985c-.0000885.56031852.4483217 1.006032 1.0015506 1.00594461.5390308-.00008516.9785753-.44874418.9786627-1.00210749l.0009332-5.9072465c.0000875-.553948-.4484113-1.00188204-1.0017499-1.00179463l-5.906983.00093313c-.5539233.00008751-1.0019791.44863892-1.0020665 1.00186784-.0000852.53903074.4502662.97843325 1.0058884.97834547l3.5101055-.00055449z" fill-rule="evenodd"></path></symbol><symbol id="icon-github" viewBox="0 0 100 100"><path fill-rule="evenodd" clip-rule="evenodd" d="M48.854 0C21.839 0 0 22 0 49.217c0 21.756 13.993 40.172 33.405 46.69 2.427.49 3.316-1.059 3.316-2.362 0-1.141-.08-5.052-.08-9.127-13.59 2.934-16.42-5.867-16.42-5.867-2.184-5.704-5.42-7.17-5.42-7.17-4.448-3.015.324-3.015.324-3.015 4.934.326 7.523 5.052 7.523 5.052 4.367 7.496 11.404 5.378 14.235 4.074.404-3.178 1.699-5.378 3.074-6.6-10.839-1.141-22.243-5.378-22.243-24.283 0-5.378 1.94-9.778 5.014-13.2-.485-1.222-2.184-6.275.486-13.038 0 0 4.125-1.304 13.426 5.052a46.97 46.97 0 0 1 12.214-1.63c4.125 0 8.33.571 12.213 1.63 9.302-6.356 13.427-5.052 13.427-5.052 2.67 6.763.97 11.816.485 13.038 3.155 3.422 5.015 7.822 5.015 13.2 0 18.905-11.404 23.06-22.324 24.283 1.78 1.548 3.316 4.481 3.316 9.126 0 6.6-.08 11.897-.08 13.526 0 1.304.89 2.853 3.316 2.364 19.412-6.52 33.405-24.935 33.405-46.691C97.707 22 75.788 0 48.854 0z"></path></symbol><symbol id="icon-springer-arrow-left"><path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"></path></symbol><symbol id="icon-springer-arrow-right"><path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"></path></symbol><symbol id="icon-submit-open" viewBox="0 0 16 17"><path d="M12 0c1.10457 0 2 .895431 2 2v5c0 .276142-.223858.5-.5.5S13 7.276142 13 7V2c0-.512836-.38604-.935507-.883379-.993272L12 1H6v3c0 1.10457-.89543 2-2 2H1v8c0 .512836.38604.935507.883379.993272L2 15h6.5c.276142 0 .5.223858.5.5s-.223858.5-.5.5H2c-1.104569 0-2-.89543-2-2V5.828427c0-.530433.210714-1.039141.585786-1.414213L4.414214.585786C4.789286.210714 5.297994 0 5.828427 0H12Zm3.41 11.14c.250899.250899.250274.659726 0 .91-.242954.242954-.649606.245216-.9-.01l-1.863671-1.900337.001043 5.869492c0 .356992-.289839.637138-.647372.637138-.347077 0-.647371-.285256-.647371-.637138l-.001043-5.869492L9.5 12.04c-.253166.258042-.649726.260274-.9.01-.242954-.242954-.252269-.657731 0-.91l2.942184-2.951303c.250908-.250909.66127-.252277.91353-.000017L15.41 11.14ZM5 1.413 1.413 5H4c.552285 0 1-.447715 1-1V1.413ZM11 3c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Zm0 2c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Z" fill-rule="nonzero"></path></symbol></svg>
</div>
</footer>




    

    

<div class="c-site-messages message u-hide u-hide-print c-site-messages--nature-briefing c-site-messages--nature-briefing-email-variant c-site-messages--nature-briefing-redesign-2020 sans-serif " data-component-id="nature-briefing-banner" data-component-expirydays="30" data-component-trigger-scroll-percentage="15" data-track="in-view" data-track-action="in-view" data-track-category="nature briefing" data-track-label="Briefing banner visible: Flagship">

    
    <div class="c-site-messages__banner-large">

        
<div class="c-site-messages__close-container">
    <button class="c-site-messages__close" data-track="click" data-track-category="nature briefing" data-track-label="Briefing banner dismiss: Flagship">
        <svg width="25px" height="25px" focusable="false" aria-hidden="true" viewBox="0 0 25 25" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
            <title>Close banner</title>
            <defs></defs>
            <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
                <rect opacity="0" x="0" y="0" width="25" height="25"></rect>
                <path d="M6.29679575,16.2772478 C5.90020818,16.6738354 5.90240728,17.3100587 6.29617427,17.7038257 C6.69268654,18.100338 7.32864195,18.0973145 7.72275218,17.7032043 L12,13.4259564 L16.2772478,17.7032043 C16.6738354,18.0997918 17.3100587,18.0975927 17.7038257,17.7038257 C18.100338,17.3073135 18.0973145,16.671358 17.7032043,16.2772478 L13.4259564,12 L17.7032043,7.72275218 C18.0997918,7.32616461 18.0975927,6.68994127 17.7038257,6.29617427 C17.3073135,5.89966201 16.671358,5.90268552 16.2772478,6.29679575 L12,10.5740436 L7.72275218,6.29679575 C7.32616461,5.90020818 6.68994127,5.90240728 6.29617427,6.29617427 C5.89966201,6.69268654 5.90268552,7.32864195 6.29679575,7.72275218 L10.5740436,12 L6.29679575,16.2772478 Z" fill="#ffffff"></path>
            </g>
        </svg>
        <span class="visually-hidden">Close</span>
    </button>
</div>


        <div class="c-site-messages__form-container">

            <div class="grid grid-12 last">
                <div class="grid grid-4">
                    <img alt="Nature Briefing" src="/static/images/logos/nature-briefing-logo-n150-white-d81c9da3ec.svg" width="250" height="40">
                    <p class="c-site-messages--nature-briefing__strapline extra-tight-line-height">Sign up for the <em>Nature Briefing</em> newsletter — what matters in science, free to your inbox daily.</p>
                </div>
                <div class="grid grid-8 last">
                    <form action="https://www.nature.com/briefing/briefing" method="post" data-location="banner" data-track="signup_nature_briefing_banner" data-track-action="transmit-form" data-track-category="nature briefing" data-track-label="Briefing banner submit: Flagship">
                        <input id="briefing-banner-signup-form-input-track-originReferralPoint" type="hidden" name="track_originReferralPoint" value="MainBriefingBanner">
                        <input id="briefing-banner-signup-form-input-track-formType" type="hidden" name="track_formType" value="DirectEmailBanner">

                        <input type="hidden" value="false" name="gdpr_tick" id="gdpr_tick_banner">
                        <input type="hidden" value="false" name="marketing" id="marketing_input_banner">
                        <input type="hidden" value="false" name="marketing_tick" id="marketing_tick_banner">
                        <input type="hidden" value="MainBriefingBanner" name="brieferEntryPoint" id="brieferEntryPoint_banner">

                        <label class="nature-briefing-banner__email-label" for="emailAddress">Email address</label>

                        <div class="nature-briefing-banner__email-wrapper">
                            <input class="nature-briefing-banner__email-input box-sizing text14" type="email" id="emailAddress" name="emailAddress" value="" placeholder="e.g. jo.smith@university.ac.uk" required="" data-test-element="briefing-emailbanner-email-input">
                            
                            <input type="hidden" value="true" name="N:nature_briefing_daily" id="defaultNewsletter_banner">
                            <button type="submit" class="nature-briefing-banner__submit-button box-sizing text14" data-test-element="briefing-emailbanner-signup-button">Sign up</button>
                        </div>

                        <div class="nature-briefing-banner__checkbox-wrapper grid grid-12 last">
                            <input class="nature-briefing-banner__checkbox-checkbox" id="gdpr-briefing-banner-checkbox" type="checkbox" name="gdpr" value="true" data-test-element="briefing-emailbanner-gdpr-checkbox" required="">
                            <label class="nature-briefing-banner__checkbox-label box-sizing text13 sans-serif block tighten-line-height" for="gdpr-briefing-banner-checkbox">I agree my information will be processed in accordance with the <em>Nature</em> and Springer Nature Limited <a href="https://www.nature.com/info/privacy">Privacy Policy</a>.</label>
                        </div>
                    </form>
                </div>
            </div>

        </div>

    </div>

    
    <div class="c-site-messages__banner-small">

        
<div class="c-site-messages__close-container">
    <button class="c-site-messages__close" data-track="click" data-track-category="nature briefing" data-track-label="Briefing banner dismiss: Flagship">
        <svg width="25px" height="25px" focusable="false" aria-hidden="true" viewBox="0 0 25 25" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
            <title>Close banner</title>
            <defs></defs>
            <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
                <rect opacity="0" x="0" y="0" width="25" height="25"></rect>
                <path d="M6.29679575,16.2772478 C5.90020818,16.6738354 5.90240728,17.3100587 6.29617427,17.7038257 C6.69268654,18.100338 7.32864195,18.0973145 7.72275218,17.7032043 L12,13.4259564 L16.2772478,17.7032043 C16.6738354,18.0997918 17.3100587,18.0975927 17.7038257,17.7038257 C18.100338,17.3073135 18.0973145,16.671358 17.7032043,16.2772478 L13.4259564,12 L17.7032043,7.72275218 C18.0997918,7.32616461 18.0975927,6.68994127 17.7038257,6.29617427 C17.3073135,5.89966201 16.671358,5.90268552 16.2772478,6.29679575 L12,10.5740436 L7.72275218,6.29679575 C7.32616461,5.90020818 6.68994127,5.90240728 6.29617427,6.29617427 C5.89966201,6.69268654 5.90268552,7.32864195 6.29679575,7.72275218 L10.5740436,12 L6.29679575,16.2772478 Z" fill="#ffffff"></path>
            </g>
        </svg>
        <span class="visually-hidden">Close</span>
    </button>
</div>


        <div class="c-site-messages__content text14">
            <span class="c-site-messages--nature-briefing__strapline strong">Get the most important science stories of the day, free in your inbox.</span>
            <a class="nature-briefing__link text14 sans-serif" data-track="click" data-track-category="nature briefing" data-track-label="Small-screen banner CTA to site" data-test-element="briefing-banner-link" target="_blank" rel="noreferrer noopener" href="https://www.nature.com/briefing/signup/?brieferEntryPoint=MainBriefingBanner">Sign up for Nature Briefing
            </a>
        </div>

    </div>

</div>






<noscript>
    <img hidden src="https://verify.nature.com/verify/nature.png" width="0" height="0" style="display: none" alt="">
</noscript>




<script src="//content.readcube.com/ping?doi=10.1038/s41591-022-01789-0&amp;format=js&amp;last_modified=2022-05-19" async=""></script>

<eui-jizmawbklwsu></eui-jizmawbklwsu><div data-cc-ghost="" style="height: 352px;"></div><script type="text/javascript" id="fetch-contextual-ads-campaign-data" charset="">(function(){var g=function(a){a=new CustomEvent("campaignDataLoaded",{detail:a});document.dispatchEvent(a)},b=google_tag_manager["rm"]["50443292"](18);if(b){var k=1500;b=google_tag_manager["rm"]["50443292"](19);b="link"===b?google_tag_manager["rm"]["50443292"](20):google_tag_manager["rm"]["50443292"](21);var m=function(a,c){var h=!1,l=setTimeout(function(){h=!0;c(null)},k),d=new XMLHttpRequest;d.onload=function(){var e=null,f=[];if(200===d.status){try{e=JSON.parse(d.responseText)}catch(p){e={}}f=e.campaigns||[]}h||(clearTimeout(l),c(f.length?f.join(","):null))};d.open("GET",
"/platform/contextual?doi\x3d"+a);d.send()},n=function(a,c){a&&-1===a.indexOf("not set")?m(a,c):setTimeout(c,1)};n(b,function(a){window.campaignsForContextualAds=a;g(a);window.dataLayer.push({content:{article:{campaignID:a}}})})}else window.campaignsForContextualAds="",g(null)})();</script>
<script type="text/javascript" id="gtm-setup-accessdetailsloaded-handler" charset="">document.addEventListener("accessdetailsloaded",function(a){a=a.detail||{};var b={event:"update-access-details"};a.institutional_business_partner_ids&&a.resolved_by||console.log("BPID data could not be retrieved from /exposed-details");a.logged_in_to_sn_profile||console.log("logged_in_to_sn_profile could not be retrieved from /exposed-details");var c=a.institutional_business_partner_ids&&a.institutional_business_partner_ids.join?a.institutional_business_partner_ids.join(";"):"",d=a.resolved_by&&a.resolved_by.join?
a.resolved_by.join(";"):"",e=a.personal_business_partner_id_found,f=a.logged_in_to_sn_profile,g=a.snid;b.user={};b.user.profile={};b.user.profile.profileInfo={resolvedBy:d||null,bpid:c||null,personal:e||null,logged_in_to_sn_profile:f,snid:g||null};b.session={};b.session.authentication={};b.session.authentication.token=a.token||null;b.session.authentication.legacy={};window.dataLayer.push(b);window.idpUserDataLoaded=!0},!1);window.dataLayer.push({event:"accessdetailsloaded-handler-added"});
window.accessDetailsLoadedHandlerAdded=!0;</script><script type="text/javascript" id="gtm-mediatrust" charset="">var s=document.getElementsByTagName("script")[0],p=document.createElement("script");p.async="async";p.src="https://scripts.webcontentassessor.com/scripts/93dabb8d80079a87fec7bb6f67b807fce90e1688f8957ad7ad152bfd58ea01c2";s.parentNode.insertBefore(p,s);</script><script id="crossmark-script" text="" charset="" type="text/javascript" src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script><script type="text/javascript" id="polyfill-matches" charset="">Element.prototype.matches||(Element.prototype.matches=Element.prototype.matchesSelector||Element.prototype.mozMatchesSelector||Element.prototype.msMatchesSelector||Element.prototype.oMatchesSelector||Element.prototype.webkitMatchesSelector||function(a){a=(this.document||this.ownerDocument).querySelectorAll(a);for(var b=a.length;0<=--b&&a.item(b)!==this;);return-1<b});</script><script type="text/javascript" id="fetch-idp-user-data" charset="">(function(a){if("function"===typeof window.CustomEvent)return!1;var c=function(d,b){b=b||{};var e=document.createEvent("CustomEvent");e.initCustomEvent(d,b.bubbles||!1,b.cancelable||!1,b.detail||a);return e};c.prototype=window.Event.prototype;window.CustomEvent=c})();var parse=function(a,c){try{return 200===a?JSON.parse(c):null}catch(d){return null}},dispatch=function(a){a=new CustomEvent("accessdetailsloaded",{detail:a});document.dispatchEvent(a)},site=google_tag_manager["rm"]["50443292"](59),idpUrl;
switch(site){case "nature":idpUrl=-1<window.location.hostname.indexOf("local-www")||-1<window.location.hostname.indexOf("test-www")?"https://staging-idp.nature.com/exposed-details":"https://idp.nature.com/exposed-details";break;case "link":idpUrl=-1<window.location.hostname.indexOf("link-qa")?"https://staging-idp.springer.com/exposed-details":"https://idp.springer.com/exposed-details";break;case "springer":idpUrl=-1<window.location.hostname.indexOf("local-www")||-1<window.location.hostname.indexOf("test-www")?
"https://staging-idp.springer.com/exposed-details":"https://idp.springer.com/exposed-details"}if(void 0!==idpUrl){var transport=new XMLHttpRequest;transport.open("GET",idpUrl,!0);transport.withCredentials=!0;transport.onreadystatechange=function(){4===transport.readyState&&dispatch(parse(transport.status,transport.responseText))};transport.send()}else dispatch(null);</script><script src="https://verify.nature.com/verify/nature.min.js"></script><script type="text/javascript" id="create-ad-slots" charset="">function createAndLoadAds(){function h(b){"nature"===a&&google_tag_manager["rm"]["50443292"](87)(b);"bmc"!==a&&"springeropen"!==a||google_tag_manager["rm"]["50443292"](99)(b);("link"===a&&"oscar"===google_tag_manager["rm"]["50443292"](100)||"springer"===a||"link"===a&&!0===google_tag_manager["rm"]["50443292"](101))&&google_tag_manager["rm"]["50443292"](126)(b);"link"===a&&"bunsen"===google_tag_manager["rm"]["50443292"](127)&&google_tag_manager["rm"]["50443292"](152)(b);"link"===a&&"Core"===google_tag_manager["rm"]["50443292"](153)&&google_tag_manager["rm"]["50443292"](165)(b)}window.googletag=window.googletag||{cmd:[]};var a=google_tag_manager["rm"]["50443292"](166),e=google_tag_manager["rm"]["50443292"](168);
if(-1===window.location.search.indexOf("hide_ads\x3dtrue"))if(window.adSlots&&0!==Object.keys(window.adSlots).length)console.log("Ads previously loaded. Will not update ad slots until next page load.");else{window.adSlots||(window.adSlots={});window.getAd=function(b,f){for(var c in window.adSlots)if(-1<c.indexOf(b)){if("object"===f)return adSlots[c];if("slot"===f)return adSlots[c].slot}};googletag.cmd.push(function(){googletag.pubads().setPrivacySettings({limitedAds:e});console.log("limitedAds is ",
e);googletag.pubads().setRequestNonPersonalizedAds(google_tag_manager["rm"]["50443292"](170));googletag.pubads().enableSingleRequest();googletag.pubads().disableInitialLoad()});for(var g=document.querySelectorAll("[data-gpt]"),d=0;g[d];++d)h(g[d]);googletag.cmd.push(function(){googletag.enableServices()})}}createAndLoadAds();</script>
</body></html>